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DNA methylation is a common epigenetic mark that affects gene regulation, genomic 
stability and chromatin structure. In mammals, methylation is mainly found in the CpG 
dinucleotides. The CpG methylation signals can be recognised by the Methyl-CpG-
Binding Protein (MBP) family which includes MeCP2, MBD1, MBD2, MBD3, MBD4 
and Kiaso. MeCP2 and MBD1-4 (except mammalian MBD3) recognise methyl-CpG via 
their MBD domain whereas Kaiso interprets methylation through its Zn finger DNA 
binding domain. The TRD domains of MeCP2, MBD1 and MBD2 have been reported to 
recruit transcriptional co-repressors to the methylated DNA. A thymine DNA glycosylase 
domain is located at the C-terminal region of MBD4. This study concerns the molecular 
details of the methyl-CpG recognition by the MBD domain of MeCP2. To achieve this, 
the MeCP2 MBD domain has been expressed, purified and co-crystallised with a 20 bp 
DNA fragment from the BDNF promoter. The DNA-protein cocrystal diffracted X-rays to 
a maximum resolution of 2.5Å using synchrotron sources. It belongs to space group C2 
with unit cell dimensions: a = 79.71Å, b = 53.60Å, c = 65.73Å, and β = 132.1˚. The X-ray 
structure of the MeCP2 MBD-DNA complex was solved using the SAD method. 
Structural analyses of the refined X-ray structure reveal that the methyl groups of the 
DNA make contact with a predominantly hydrophilic surface that includes tightly bound 
water molecules. From a structure of the MBD domain in MBD1, established by NMR, 
the binding specificity of the MBD domain had been thought to depend on hydrophobic 
interactions between the cytosine methyl groups and a hydrophobic patch within the 
MBD domain. The findings of this study suggest that MeCP2 recognises the hydration 
pattern of the major groove of methylated DNA rather than cytosine methylation per se. 
The X-ray structure also identifies a unique role of T158 and R106, the sites of the two 
most frequent Rett missense mutations. Both residues stabilise the tandem Asx-ST motif 
at the C-terminal region of MBD domain. Disruption of this tandem motif destabilises the 
DNA-protein interaction. The BDNF sequence in this study contains an AT run which 
displays unique properties of AT tract DNA. Previously, mutation of the AT run has been 
reported to decrease MeCP2 binding specificity. This study however demonstrated that a 
significant reduction can only be observed when both AT runs close to the methyl-CpG 
have been mutated. The X-ray structure of the MeCP2 MBD-DNA complex in this study 
rationalises the effects of the most common Rett mutations and provides a general model 
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CHAPTER 1. INTRODUCTION 
1.1 DNA METHYLATION 
DNA is made from four repeating building blocks; deoxyriboadenosine (dA), 
deoxyribocytosine (dC), deoxyriboguanosine (dG) and deoxyribothymidine (dT) 
(Figure 1-1). Their corresponding nucleosides are linked together by phosphodiester 
bonds to form polynucleotides. The DNA double helix consists of two strands of 
polynucleotides in which the nucleotide building blocks are paired in a uniquely 
complementary way (Watson and Crick, 1953). The human genome encodes over 
25,000 proteins (Venter et al., 2001). However, not all genes are equally expressed in 
different cells. Because distinct sets of genes are active in different cell types, protein 
expression profiles therefore must be regulated distinctively by cell specific chromatin 
structures which are in turn controlled by chromatin remodelling complexes. 
Chromatin remodelling complexes allow transcriptional regulators to gain access to 
their cognate DNA binding sites usually on the promoter region of genes. These 
specific DNA sequences are normally epigenetically marked so that they can be 
recognised by transcriptional regulators. Epigenetics is the study of heritable changes 
in gene function that occur without a change in DNA primary sequence (Bird, 2007). 
Epigenetic information is essential to determine distinct sets of cell type-specific gene 
activation (Brero et al., 2006). At the chromatin level, epigenetic mechanisms include 
DNA methylation and modification of various functional groups of histones such as 
methylation, acetylation and phosphorylation [reviewed by Felsenfeld and Groudine 
(2003)]. (Felsenfeld and Groudine, 2003) 
 
DNA methylation is one of the most common forms of epigenetic signals that affect 
gene regulation, genomic stability and chromatin structure (Bird, 2002). DNA 
methylation occurs in many different organisms including prokaryotes, fungi, plants 
and animals. Addition of a methyl group at the 5’ position of cytosine gives rise to 
5’methyl cytosine (m5C) or at the 6’ position of adenine; N6-methyl adenine (m6A). 
In prokaryotic systems, DNA methylation protects the host DNA from restriction 
enzyme digestion but not unmodified foreign DNA (Wilson and Murray, 1991). In 
eukaryotic cells, DNA methylation is implicated in more complex tasks including 
gene regulation, genomic imprinting, X inactivation, DNA replication and DNA 
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mismatch repair. The majority of the methylated DNA modifications are m5C, with 
some unicellular organisms showing low levels of m6A (Brero et al., 2006). In 
mammals, methylation is mainly found at CpG dinucleotides. The human genome 
consists of approximately 1% of m5C, which results in 70-80% of CpG dinucleotides 
being methylated except CpG islands, which are present in approximately 60% of the 
promoter region of human genes (Bird, 2002). Therefore m5C is considered to be the 
‘fifth’ nucleotide (Figure 1-1). Methylation in fungi and plants is not restricted to CpG 
dinucleotides but rather CpNpG sequences are the preferred methylation target [see 
review in (Selker, 1997; Tariq and Paszkowski, 2004)].  
 
Figure 1-1 Building blocks of DNA 
(a) deoxyadenosine (dA), (b) deoxyguanosine (dG), (c) deoxythymidine (dT), (d) 
deoxycytosine (dC) and (d) the fifth nucleotide; 5’methyl-deoxycytosine (m5C).     
 
Methylation signals can be interpreted by Methyl-CpG Binding Protein (MBP) 
proteins which consist of MeCP2, MBD1, MBD2, MBD3, MBD4 and Kaiso (Klose 
and Bird, 2006). The classical methyl-CpG binding domain (MBD) containing 
proteins; MeCP2 and MBD1-4 (except mammalian MBD3); recognise symmetrically 
methylated 5’CpG3’ (methyl-CpG) pairs via the MBD domain (Hendrich and Bird, 
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1998; Nan et al., 1993) whereas Kaiso recognises the methylation signal through its 
zinc finger domain (Bird and Wolffe, 1999). Three MBD family members (MeCP2, 
MBD1 and MBD2) are able to recruit co-repressor complexes that can inhibit 
transcription with the aid of chromatin modifying enzymes. Mammalian MBD3 does 
not specifically bind methylated DNA and MBD4 functions primarily as a DNA G-T 
mismatch repair enzyme (Hendrich and Bird, 1998).          
1.2 THE ROLES OF DNA METHYLATION  
Silencing of genes and repetitive elements can be achieved by histone modification 
and chromatin structure alteration. These modifications are reversible and an 
additional mechanism is essential in order to silence these elements. DNA 
methylation is one of the stable modifications that can be inherited throughout cellular 
replication. The daughter cells therefore retain the same methylation patterns as their 
precursors which is necessary for silencing of repetitive elements in genome defence 
system, genomic imprinting, X-chromosome inactivation and cell development 
(Miranda and Jones, 2007).  
 
Repetitive elements including retrotransposons and other parasitic elements which 
have accumulated in the mammalian genome during evolution represents at least 35% 
of the genome (Miranda and Jones, 2007; Yoder et al., 1997b). Many of these 
repetitive elements contain a long terminal repeat promoter which allows the 
transcription of these sequences (Kochanek et al., 1995; Yoder et al., 1997b). 
Repetitive elements pose a potential threat to genomic stability and integrity as they 
can mediate recombination of non-allelic repeats, such as chromosomal 
rearrangements or translocations, and the active retrotransposons can integrate into 
genes and interfere with gene transcription and perhaps initiate retrotransposonal 
transcription (Robertson and Wolffe, 2000). Furthermore, examination of CpG 
methylation distribution within the genome has revealed that most of the parasitic 
DNA elements and retrotransposons, for instance; endogenous retroviruses, L1 
elements and Alu elements; are considerably CpG enriched sequences (Colot and 
Rossignol, 1999; Yoder et al., 1997b). Thus, DNA methylation has been proposed to 
be part of a genome defence system to silence expression of these repetitive elements 
and limit their spread in the genome (Yoder et al., 1997b). 
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Genomic imprinting is an epigenetic mechanism of transcriptional regulation through 
expression of selected genes from one of the two parental alleles (Delaval and Feil, 
2004). The requirement for imprinting in mammals was first discovered following 
nuclear transplantation experiments. Mouse embryos that contained only the maternal 
(parthenogenoes) or paternal genomes (androgenotes) were retarded in development 
(McGrath and Solter, 1984; Surani et al., 1984). These experiments highlighted the 
importance of complementarity of male and female genomes in order to achieve 
normal development. Most of the imprinted genes are clustered in the genome rather 
than lone genes. To date, about 80 imprinted genes have been identified in human and 
mouse (http://www.mgu.har.mrc.ac.uk/research/imprinting/index.html). 
 
Expression of imprinted genes within a cluster is controlled by a CpG rich sequence 
element known as the imprinting control region (ICR) which is usually composed of 
several kilobases and is regulated by DNA methylation (Feil and Berger, 2007). DNA 
methylation of most ICRs is established during oogenesis (female gametogenesis) 
while only some of them are established during spermatogenesis (male 
gametogenesis). Following fertilisation, these methylation marks are maintained 
throughout development and govern the allelic expression of the imprinted genes. One 
of the most well studied imprinted gene clusters is insulin-like growth factor-2 gene 
(Igf2) and H19 gene on distal mouse chromosome 7 (Bartolomei et al., 1991; 
DeChiara et al., 1991). The ICR of Igf2-H19 cluster is paternally methylated while the 
unmethylated maternal copy is bound by an insulator factor namely CCCTC binding 
factor (CTCF). An insulator is a DNA sequence located between promoter and 
enhancer which blocks the interaction between the two elements (Bell et al., 1999). 
The binding of CTCF is eliminated by CpG methylation within the CTCF binding site 
in vitro (Bell and Felsenfeld, 2000). Figure 1-2 shows the reciprocal imprinting of 
Igf2-H19 genes, CTCF binds to the CpG rich non-methylated ICR on the maternal 
allele and insulates the interaction between Igf2 promoter and the enhancers located at 
the 3’ region of H19 and consequently, allows the H19 promoter to exclusively access 
the enhancers (Verona et al., 2003). The ICR methylation on paternal allele blocks 
CTCF binding, therefore preventing the formation of insulator and this architecture 
allows Igf2 promoter access to the downstream enhancers which are required for Igf2 
expression. Together with the hypermethylation of H19 promoter on the paternal 
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allele, the methylated ICR represses the transcription of H19. MeCP2 (Drewell et al., 
2002) and, recently, MBD3 (Reese et al., 2007) have been demonstrated to be 
involved in silencing at the paternal H19 allele. 
                    
 
Figure 1-2 Imprinting in the Igf2-H19 cluster 
The male ICR of Igf2-H19 cluster acquires methylation during the late stage of 
spermatogenesis. By contrast, the female ICR is protected from methylation by the bound 
zinc finger protein CTCF. After fertilisation, this epigenetic mark is maintained throughout 
the cell development. The binding of CTCF on the chromosome creates a boundary which 
prevents the interaction between Igf2 promoter and the enhancers. Accessibility of the H19 
gene to the downstream enhancer allows the transcription of the H19 gene. On the other hand, 
ICR methylation eliminates the binding of CTCF and therefore allows the Igf2 gene to access 
the enhancer. As a result, the Igf2 gene is expressed paternally. Paternal H19 gene is 
repressed because of hypermethylation spreading from the upstream methylated ICR 
(diagram was adapted from Delaval and Feil, 2004). 
 
In mammals, dosage compensation of gene expression between males (XY) and 
females (XX) is established by random inactivation of one of the two X-chromosomes 
in females. This process is known as X chromosome inactivation  (XCI) (Lyon, 
1961). Mammalian XCI is regulated by reciprocal expression of 17kb non-coding Xist 
(X-inactive specific transcript) and its antisense counterpart Tsix RNAs, both encoded 
by a region called X inactivation centre (Xic) on the X chromosome (Brockdorff et 
al., 1992; Brown et al., 1992; Lee and Lu, 1999).  XCI is initiated by expression of 
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non-coding Xist gene from the inactive X chromosome (Xi). The accumulation of Xist 
RNA transcripts silence the chromosome in Cis (Marahrens et al., 1997; Penny et al., 
1996). The Xist accumulation, however, is not required for continuing maintenance of 
the Xi silencing (Wutz and Jaenisch, 2000) but other factors such as chromatin 
modulators are involved. On active chromosome (Xa), up-regulation of Xist RNA is 
inhibited by the expression of the non-coding Tsix RNA (Lee and Lu, 1999; 
Stavropoulos et al., 2001). In regulating Tsix expression on Xa, an insulator CTCF 
binds near to the promoter of Tsix (Figure 1-3), which enables the expression of Tsix 
gene due to its accessibility to the enhancers (Chao et al., 2002) and insulates the Xist 
promoter from accessing the enhancers. On the Xi, DNA methylation on the CTCF 
array prevents the binding of CTCF on Tsix and thus allows Xist gene expression.  
 
Figure 1-3 X chromosome inactivation 
On Xa, CTCF binds to the unmethylated region near the Tsix promoter, in which, Xist 
promoter is insulated from accessing the downstream enhancers. Conversely, the interaction 
of Tsix promoter and enhancers allows Tsix transcription, which possibly induces repressive 
chromatin modification across the Xist promoter region and represses Xist expression. On Xi, 
CTCF binding is prevented by methylated CpGs near the Tsix promoter. This configuration 
enables the Xist promoter to access the downstream enhancers and create a repressive state for 
Tsix expression (diagram adapted from Chao et al., 2002).    
 
Recent evidence suggests that Xist is regulated by Tsix expression through 
modification of the chromatin structure in the Xist promoter region (Ohhata et al., 
2008; Sado et al., 2005). It is known that the promoter region of active Xist gene on 
Xi is hypomethylated, whereas that of the transcriptionally inactive Xist gene on Xa is 
hypermethylated (Norris et al., 1994). Loss of Tsix transcription across the Xist 
promoter reduces CpG methylation and also causes histone modification in the 5’ Xist 
region (Ohhata et al., 2008; Sado et al., 2005), indicating that a modified chromatin 
structure is required to promote DNA methylation. 
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1.3 ESTABLISHMENT AND MAINTENANCE OF DNA METHYLATION 
To date, five mammalian DNA cytosine methyltransferases (DNMTs) have been 
discovered, which can be divided into three families; DNMT1, DNMT2 and DNMT3 
(Figure 1-4) (Bestor, 2000). Based on their preferred DNA substrate, DNMTs can 
generally be grouped into two classes; de novo and maintenance DNMTs. The de 
novo DNA methyltransferases DNMT3A and DNMT3B are mainly responsible for 
introducing cytosine methylation at previously unmethylated CpG sites, whereas the 
maintenance methyltransferase DNMT1 duplicates the DNA methylation pattern onto 
the new DNA strand during DNA replication. The fourth DNA methyltransferase 
(DNMT2) shows little DNA methyltransferase activity in vitro  even though it is 
structurally similar to prokaryotic DNA methyltransferase (Hermann et al., 2003). 
Targeted deletion of DNMT2 does not affect DNA methylation globally in embryonic 
stem cells, indicating that this enzyme is not essential for de novo or maintenance of 
DNA methylation (Okano et al., 1998b). DNMT3L is a paralogue of DNMT3A and 
DNMT3B, which enhances the de novo DNMTs catalytic activities but does not 
physically associate with methylated DNA (Suetake et al., 2004). Nevertheless, the 
crystal structure of bacterial DNA cytosine methyltransferase complexed with 
substrate DNA suggests a similar enzymatic mechanism for mammalian DNMTs.        
 
Figure 1-4: Schematic representative of mammalian DNA methylfransferases 
The N-terminal part of DNMT1 consists of regulatory elements: charge rich region (CRR), 
PCNA binding domain (PBD); nuclear localisation signal (NLS), replication foci targeting 
domain (RFTD), CxxC motifs (Cys-rich), bromo-adjacent homology domains (BAH). In 
addition to Cys-rich domain, the N-terminal part of DNMT3A/B also contains PWWP 
domain for protein-protein interaction and ATRX domain (involved in HDAC interaction). 
The N- and C- terminal of DNMTs are linked by Gly-Lys dipeptides.  The C-terminal 
catalytic region is related to bacterial DNA methyltransferases. Black bars indicate conserved 
catalytic motifs among DNMT families (diagram was adapted from Bestor, 2000).  
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1.3.1 Mechanism of DNA methylation 
The cocrystal of M.Hhal (Klimasauskas et al., 1994) (Figure 1-5) and M.HaeIII 
(Reinisch et al., 1995) methyltransferases complexed with DNA revealed the catalytic 
mechanism of DNA methyltransferase. Both crystal structures display high similarity 
with a Cα RMSD of 1.18Å over 119 amino acids. As shown in Figure 1-6, the 
prokaryotic DNA cytosine methyltransferases catalyse the transfer of methyl group 
from S-adenosyl-L-methionine (SAM) to the C5 position of the cytosine. In order to 
capture the intermediate catalytic state, the hydrogen atom at C5 was replaced by a 
fluorine atom which cannot be released as free F+. The target cytosine is flipped out of 
the DNA helix and placed in the active site of the enzyme where the protein is 
covalently linked to the DNA. The sulphur atom of nucleophile Cys81 forms a 
covalent thioester bond to C6 of cytosine (Figure 1-5). The methyl group of SAM is 
then transferred to the C5 position of cytosine and the cofactor is converted to S-
adenosyl-L-homocysteine. Abstraction of the C5 proton allows reformation of a 
carbon-carbon double bond. The methylation is then terminated by β-elimination. The 
pyrimidine ring of cytosine is held in the catalytic pocket by a number of conserved 
amino acids among the DNMT families. This suggests a similar catalytic mechanism 
for mammalian cytosine methyltransferases.  
 
Figure 1-5 X-ray structure of the bacterial M. HhaI complexed with DNA 
The target cytosine is held in the catalytic pocket by side-chains of R165, E119 and main-
chain NH of F79. C81 (orange) forms a covalent thioester bond with C6 of cytosine (inset). 
The methyl group (grey sphere) at the C5 position of cytosine is transferred from SAM and 
the cofactor is then converted to S-adenosyl-L-homocysteine (blue). The irreplaceable 
fluorine atom (yellow sphere) halts the catalytic reaction (diagram adapted from 
Klimasauskas et al., 1994). 
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Figure 1-6 Schematic representation of DNMT catalytic pathway  
(a) The catalytic mechanism involves nucleophilic attack on C6 of cytosine by a conserved 
cystein residue to generate a covalently linked intermediate. (b) SAM is converted to S-
adenosyl-L-homocysteine by transferring the methyl group to C5 of cytosine. (c) Abstraction 
of C5 proton allows reformation of carbon-carbon double bond. (d) methyl-cytosine is 
released from the DNMT by β-elimination (diagram adapted from Bestor, 2000). 
1.3.2 DNMT1 
DNMT1 is the first mammalian DNA cytosine methyltransferase to be cloned and 
biophysically assayed (Bestor et al., 1988). It has a 5 to 30-fold preference for 
hemimethylated DNA (Yoder et al., 1997a), therefore, it has been suggested to play a 
role in maintaining methylation patterns. Yoder et al. (1997a) also reported that the 
specificity of DNMT1 is confined to the CpG motif rather than the primary DNA 
sequence or density of CpG dinucleotides. This protein contains 1620 amino acids 
and can be divided into two major domains; a large N-terminal domain with 
regulatory function and a small C-terminal domain carrying catalytic function 
(Hermann et al., 2004) (Figure 1-4). The regulatory N-terminal domain bears different 
motifs, like the charge-rich domain that interacts with the Dmap1 transcriptional 
repressor (Rountree et al., 2000), a nuclear localisation signal (NLS), a proliferating 
cell nuclear antigen (PCNA) binding motif, a Cys rich (CxxCxxC) Zn2+ binding 
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domain, a polybromo-1 region containing two BAH motifs suggested to play a role in 
protein-protein interaction, and a DNA replication foci targeting sequence that is 
responsible for DNA replication in eukaryotic cells (Hermann et al., 2004). In 
addition, DNMT1 also directly interacts with histone modifying enzymes such as 
HDAC1 and HDAC2, associating with MBD2, MBD3 (Tatematsu et al., 2000) and 
MeCP2 (Kimura and Shiota, 2003), the heterochromatin binding protein HP1 and 
SUV39H1 (Fuks et al., 2003a). All these interactions are required for transcriptional 
repression.  
     
A Lys and Gly rich sequence connects the N- and C-terminal regions of DNMT1. The 
C-terminal region contains the catalytic domain of DNMT1, which is closely related 
to prokaryotic DNA cytosine methyltranferases rather than mammalian DNA 
methyltransferases of DNMT2 and DNMT3 (Bestor, 2000). The C-terminal region 
alone however is catalytically inactive and a large part of the N-terminal domain is 
required to retain its methylating activity (Margot et al., 2000; Zimmermann et al., 
1997). This region contains all conserved motifs where a common catalytic 
architecture is shared with other DNMT families. The catalytic mechanism of all 
DNMTs that modify the 5’ position of the pyrimidine ring appear to use a similar 
mechanism to that described in Figure 1-6. Furthermore, most of the enzymes have a 
conserved prolylcysteinyl active site that provides the cysteine thiolate for the 
cytosine methylation mechanism (Figure 1-6) (Bestor and Verdine, 1994). 
Comparison of DNA cytosine methyltransfases revealed that the enzymes carry 
characteristic sequence motifs (Figure 1-4), namely motifs I to X, six of which are 
highly conserved (Lauster et al., 1989; Posfai et al., 1989). Motifs I and X form the 
Ado-Met binding site, motif IV contains the Pro-Cys dipeptide that provides the 
thiolate at C6 of the pyrimidine ring, motif VI bearing a glutamate that protonates the 
cytosine C3 position, and motif IX plays a structural role in maintaining the DNA-
protein recognition surface in the DNA major groove (Bestor and Verdine, 1994).   
1.3.3 DNMT2 
DNMT2 was discovered a decade after DNMT1 was identified and proved to be an 
enigmatic enzyme. This enzyme is a relatively small protein of 391 amino acids and 
lacks the large N-terminus present in the DNMT1 and DNMT3 families (Figure 1-4). 
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The first mammalian DNMT2 identified using a cDNA database search (Yoder and 
Bestor, 1998) shares sequence similarity to pmt1+ of Schizosaccharomyces pombe, an 
organism that is believed not to methylate its DNA (Wilkinson et al., 1995). A 
DNMT2 knockout in mouse is a homologue of pmt1+ and had no obvious effect on 
genomic methylation patterns in embryonic stem cells or on newly integrated 
retroviral DNA (Okano et al., 1998b), indicating that DNMT2 is not required for de 
novo methylation or maintenance of methylation patterns. Recently, DNMT2 has been 
reported to have a novel tRNA methyltransferase activity at the tRNAAsp anticodon 
(Goll et al., 2006). Purified DNMT2 from human and Drosophila melanogaster can 
methylate cytosine in tRNAAsp but not in DNA (Goll et al., 2006), indicating that the 
DNMT2 may function as an RNA methyltransferase despite the fact that its catalytic 
motifs are highly conserved with other DNMT families. The crystal structure of 
human DNMT2 contains the catalytic sequence motif and shows a high similarity to 
M.HhaI but methyltransferase activity was not detected (Dong et al., 2001).  
1.3.4 DNMT3 
Using a cDNA database search, mammalian DNMT3A and DNMT3B were 
identified, which show little sequence similarity to mammalian DNMT1 and DNMT2 
(Okano et al., 1998a). Nevertheless, the general architecture of DNMT3 resembles 
DNMT1 with the C-terminal region containing all the MTase motifs (Figure 1-4). 
DNMT3A and DNMT3B are closely related proteins that bear a PWWP domain and a 
CxxCxxC domain at the N-terminal tail related to that of DNMT1, ATRX and MBD1 
(Xie et al., 1999). Mammalian DNMT3A and DNMT3B are highly expressed during 
early development of mammalian embryos. Knockout of DNMT3A and DNMT3B in 
mouse ES cell abolish de novo methylation but has no effect on maintenance of 
imprinting methylation patterns (Okano et al., 1999), indicating that both enzymes are 
required for mouse de novo methylation and development. However, DNMT3A and 
DNMT3B have also been suggested to perform maintenance methylation as these 
enzymes compensate for insufficient methyltransferase activity by DNMT1 (Liang et 
al., 2002). Moreover, DNMT1 and DNMT3B knockouts, individually, in human 
cancer cells exhibited a slight reduction of overall genomic methylation, whereas 
double knockout of both DNMT1 and DNMT3B nearly eliminated methyltransferase 
activities including demethylation of repeated sequences, loss of IGF2 imprinting, 
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abrogation of silencing of tumour suppressor gene, p16INK4a (Rhee et al., 2002; Rhee 
et al., 2000). These results demonstrated that a co-operative role of DNMT1 and 
DNMT3B is established to accomplish genomic methylation. In vitro studies showed 
that the methylation target of DNMT3A and DNMT3B is not restricted to cytosine at 
CpG sites, but non-CpG sites are also methylated by both enzymes (Gowher and 
Jeltsch, 2001; Ramsahoye et al., 2000; Suetake et al., 2003).  
 
DNMT3L (DNA methyltransferase 3-like) is the third homologue of the DNMT3 
family that is expressed specifically during gametogenesis in germ cells (Aapola et 
al., 2000). DNMT3L is related to DNMT3A and DNMT3B in both C- and N-
terminals with a conserved CxxCxxC domain but lack of a PWWD domain. However, 
the key residues within the catalytic motifs are not conserved (Figure 1-4) and thus 
the protein has not been shown to contain methylation activity. DNMT3L is essential 
for establishment of a subset of methylation patterns for genomic imprinting in male 
and female germ cells (Bourc'his et al., 2001). Therefore, DNMT3L has been 
suggested to play a role in modulating methylation activities of DNMT3A and 
DNMT3B in establishment of maternal imprints (Bourc'his et al., 2001). DNMT3L 
increases the DNA methylation activity of DNMT3A and DNMT3B but not DNMT1 
(Suetake et al., 2004). Inactivating both DNMT3A and DNMT3B abolishes de novo 
methylation in mouse embryos (Okano et al., 1999). Conditional knockout of 
DNMT3A in mouse embryos showed lack of methylation at imprinted loci while 
conditional knockout of DNMT3B showed no apparent phenotypic changes compared 
with the wildtype animal (Kaneda et al., 2004). Correspondingly, the DNMT3A 
knockout was indistinguishable from the DNMT3L knockout animal, thus indicating 
that DNMT3A and DNMT3L are both required for the methylation of most imprinted 
foci in germ cells (Kaneda et al., 2004). Crystallographic studies of DNMT3L with 
DNMT3A2 (an alternative splice variant of DNMT3A), revealed that the CxxCxxC 
domain of DNMT3L connects ummethylated Lys4 of histone H3 tail to de novo 
methylation of DNA (Ooi et al., 2007). This result indicates that DNMT3L recognises 
histone H3 tails that are unmethylated at Lys4 and induces de novo methylation by 
recruitment or activation of DNMT3A2.  
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1.4 INTERPRETATION OF DNA METHYLATION 
1.4.1 Methyl-CpG binding activities 
The first evidence indicating that methyl-CpG binding proteins bind to methylated 
DNA came from restriction endonuclease accessibility assays in isolated cellular 
nuclei (Antequera et al., 1989). Protein bound nuclei were protected from restriction 
enzyme digestion at methyl-CpG sites, but naked DNA was easily digested. MeCP1 
was the first methyl-CpG binding activity identified that complexed with methyl-CpG 
moieties (at least 15 methylated CpG) regardless of the primary DNA sequence 
(Meehan et al., 1989). Four years later, a second methyl-CpG binding activity was 
reported, namely MeCP2 (Lewis et al., 1992), which was abundant in brain extract. 
MeCP2, however, is the first methyl-CpG binding protein to be cloned and 
characterised (Lewis et al., 1992). 
1.4.2 Identification of methyl-CpG binding protein family 
The Methyl-CpG binding domain (MBD) was initially mapped to an 85 amino acid 
polypeptide of MeCP2 that binds exclusively to symmetrical methyl-CpG using 
southwestern blot analysis (Nan et al., 1993). The MBD sequence of MeCP2 was then 
used as a search template in cDNA databases which subsequently identified a second 
methyl binding protein, namely Protein Containing MBD 1 (PCM1) (Cross et al., 
1997). Recombinant PCM1 bound specifically to methyl-CpG and later was renamed 
to MBD1 (Hendrich and Bird, 1998). Using a similar approach, mammalian MBD2, 
MBD3 and MBD4 were subsequently identified (Hendrich and Bird, 1998). 
Mammalian MBD2 and MBD4 bind specifically to methyl-CpG but mammalian 
MBD3 does not recognise methylated DNA in vitro and in vivo (Hendrich and Bird, 
1998). Based on their primary putative MBD sequences, the MBDs can be divided 
into two subgroups. The MBD sequence of MeCP2 shows a high similarity with 
MBD4 while MBD1, MBD2 and MBD3 are more similar to one another (Hendrich 







Figure 1-7: The methyl-CpG binding protein family 
Classical methyl-CpG binding domain proteins; MeCP2, MBD1, MBD2, MBD3 and MBD4 
interacting DNA through their MBD domain while Kaiso binds methyl-CpG via its ZF 
domain. MBD1 contains 3 CxxC zinc binding domain, one of which bind specifically to non-
methylated CpG dinucleotides and a C-terminal TRD domain. MBD2 bearing a GR repeat 
RNA binding domain and a TRD domain which overlapped the MBD domain. MBD3 
contains a polyglutamate and a well conserved MBD. MBD4 binds to methylated DNA via its 
MBD domain and the C-terminal region carrying a GT mismatch repair glycosylase.   
1.4.3 MBD1 
MBD1 was originally identified as a component of the transcriptional repressor 
MeCP1 (Cross et al., 1997). MBD1 is characterised by the presence of 3 zinc 
coordinating cysteine-rich (CxxC) domains (Cross et al., 1997; Fujita et al., 1999) 
(Figure 1-7). A similar motif is also found in DNMT1 and mammalian HRX protein 
(Cross et al., 1997). To date, five isoforms have been identified in human which are 
alternatively spliced in the region of the third CxxC (CxxC3) domain and the C-
terminus of MBD1 (Fujita et al., 1999; Jorgensen et al., 2004). The MBD domain 
located at the N-terminus of MBD1 and a short TRD domain comprises 32 amino 
acids located at the C-terminal region (Fujita et al., 1999; Ng et al., 2000).  
 
The MBD domain of MBD1 specifically binds methyl-CpG but the CxxC domains 
has been shown to interact with non-methylated DNA (Jorgensen et al., 2004). The 
major isoform of mouse cells, MBD1a, containing a CxxC3 domain represses non-
methylated reporter genes by targeting non-methylated CpG sites, for which, an intact 
MBD domain is dispensable (Jorgensen et al., 2004).  A similar non-methylated CpG 
binding has been observed in the CpG-binding protein (CGBP) and Mixed Lineage 
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Leukemia (MLL), which discriminates against DNA methylation (Birke et al., 2002; 
Lee et al., 2001).   
 
The TRD domain of MBD1 is able to repress transcription at a distance up to 2 kb 
upstream of a promoter in a histone deacetylase independent manner (Ng et al., 2000). 
MBD1 recruits histone H3-K9 methylase SETDB1 to a large subunit of Chromatin 
Assembly Factor (CAF-1) to form an S phase-specific CAF-1/MBD1/SETDB1 
complex that facilitates methylation at H3-K9 during replication-coupled chromatin 
assembly (Sarraf and Stancheva, 2004). The histone H3 methylase (Suv39h1) and the 
methyl lysine-binding protein (HP1) heterochromatin complex interact with the MBD 
domain of MBD1 but not the TRD domain (Fujita et al., 2003b). MBD1 associates 
with histone deacetylases through Suv39h1 (Fujita et al., 2003b). MBD1-containing 
chromatin-associated factor 1 (MCAF1), also known as human homologue of murine 
ATFa-associated modulator (AM) interacts with the TRD domain (Fujita et al., 
2003a; Ichimura et al., 2005). Therefore, MBD1 represses transcription by recruiting 
HP1, Suv39h1 and histone deacetylases via the MBD (Fujita et al., 2003b) and 
MCAF1 via the TRD domain (Fujita et al., 2003a). Together with SETDB1, MCAF 
enhances transcriptional repression by MBD1 (Ichimura et al., 2005). MBD1 is also 
associated with the DNA damage protein methylpurine-DNA glycosylase in DNA 
repair, suggesting a direct DNA damage sensing role by MBD1 (Watanabe et al., 
2003). 
1.4.4 MBD2 and MBD3 
There are two major isoforms of MBD2; the full length MBD2a and a truncated form; 
MBD2b; the latter lacking the N-terminal 140 amino acids (Hendrich and Bird, 1998). 
The N-terminal region of MBD2a contains a GRn repeat which has been reported to 
interact with RNA (Jeffery and Nakielny, 2004). MBD2b binds DNA in vitro in a 
methylation-dependent manner (Hendrich and Bird, 1998). Mapping of the MBD2b 
portion required for transcriptional repression revealed that the TRD domain partially 
overlapped the MBD domain (Boeke et al., 2000) (Figure 1-7). MBD2 in HeLa cells 
associates with histone deacetylase (HDAC) in the MeCP1 complex and the 
transcriptional repression is relieved by the deactylase inhibitor trichostatin (TSA) 
(Ng et al., 1999). Being a transcriptional repressor, MBD2b has also been reported to 
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contain specific demethylase activity for methylated CpG (Bhattacharya et al., 1999), 
although this has been questioned in two independent reports (Ng et al., 1999; Wade 
et al., 1999). 
 
MBD2 can recognise a single methylated CpG pair but it has been reported distinct 
from MeCP2 in that it prefers a densely methylated DNA (at least 12 mCpG pairs) for 
productive binding (Lewis et al., 1992; Meehan et al., 1989). MBD2 acts as a methyl-
binding domain in the MeCP1 complex which also contains histone deacethylases 
(HDAC1/2) and RbAp46/48 proteins (Ng et al., 1999), allowing MBD2 to target 
HDACs/chromatin remodelling activities at methylated loci (Feng and Zhang, 2001). 
MBD2 also recruits MBD3 containing Mi-2/NuRD corepressor complex to the 
methylated DNA (Hendrich et al., 2001). A recent report, however, suggests that 
MBD2 and MBD3 do not coexist in the same complex but in two distinct complexes 
namely, MBD2/NuRD and MBD3/NuRD complexes (Le Guezennec et al., 2006). 
Since MBD3 does not specifically interact with methylated DNA, it is unclear how 
the MBD3/NuRD complex is targeted to methylated DNA.  
 
MBD2 null mice are viable and fertile; with normal imprinting patterns and 
methylation levels, however, these MBD2 knockout mice show impaired nurturing 
behaviour (Hendrich et al., 2001). MBD2 deficiency is strongly correlated to 
suppression of intestinal tumorigenesis when crossed onto the ApcMin background. 
Mbd2-/-ApcMin mice live longer than ApcMin controls showing a remarkable reduction 
in tumorigenesis (Sansom et al., 2003). Even though the precise tumour suppression 
mechanism is unclear,  it is interesting to note that many important negative 
regulators, for instance, secreted frizzled-related proteins (SFRPs) of the WNT 
pathway are transcriptionally repressed in colorectal cancer, implicating these 
negative regulators as potential targets of MBD2-mediated transcriptional repression 
(Suzuki et al., 2004). This suggests a strong correlation between MBD2 and tumour 
suppressor genes. Subsequently identified target genes of MBD2 include the 
p161NK4A and p14ARF tumour-suppressor genes (Magdinier and Wolffe, 2001). 




MBD3, the smallest protein of the MBD family, consists of 285 amino acids with an 
acidic tail at the extreme C-terminus composed of 12 consecutive Glu residues 
(Figure 1-7). It shares a high amino acid sequence similarity to MBD2 with 71.1% 
overall amino acid identity (Hendrich and Bird, 1998). It is therefore believed that 
MBD2/3 represents the original methyl-CpG binding protein (Hendrich and Tweedie, 
2003). The putative ancestral MBD2/3 protein is encoded by a single gene rather than 
distinct MBD2 and MBD3 genes as in vertebrates (Hendrich and Tweedie, 2003). The 
binding properties of MBD3 vary between species. Mammalian MBD3 does not 
specifically bind to methylated DNA due to the substitution of K43H and Y47F 
(Fraga et al., 2003; Hendrich and Bird, 1998) whereas amphibian MBD3 binds 
strongly to methylated DNA (Hendrich and Bird, 1998). MBD3 is a component of the 
Mi2/NuRD chromatin-remodelling complex (Zhang et al., 1999), however, the role of 
MBD3 in the complex remained unclear. Despite MBD2 and MBD3 amino acid 
sequences being closely related, gene targeting shows that the two proteins are not 
functionally redundant in mice, as MBD3 null mice die during early embryogenesis 
whereas MBD2 null are viable and fertile (Hendrich et al., 2001). 
1.4.5 MBD4  
MBD4 shows the highest similarity to MeCP2 within the MBD domain. It consists of 
580 amino acids and has two known functional domains: the MBD and thymine DNA 
glycosylase (TDG) domains are located at the C-terminal region  (Hendrich and Bird, 
1998). The MBD domain of MBD4 recognises symmetrical methylated or 
hemimethylated DNA with a strong preference for G-T mismatch (5’TpG3’ 
complementary paired with 5’CpG3’) and the TDG domain can efficiently remove 
thymine or uracil from the mismatches CpG site in vitro (Hendrich et al., 1999). 
During DNA replication, 5’-methyl-cytosine has a higher tendency to mutate to 
thymine under spontaneous hydrolytic deamination (Figure 1-8), resulting in a G-T 
mismatch which can be repaired by thymine DNA glycosylase (Neddermann et al., 
1996; Wiebauer and Jiricny, 1989). In contrast, deamination of normal cytosine 
produces uracil, that can be efficiently detected and repaired by uracil DNA 
glycosylase (Nilsen et al., 2001). The Human Gene Mutation Database (HGMD) 
reported that the amino acid mutation C-G to T-G mismatch accounts for over 20% of 
total single amino acid substitutions (Krawczak et al., 1998). 
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Figure 1-8 Hydrolytic deamination 
Hydrolytic deamination leads to the formation of uracil whereas 5’methyl-cytosine produces 
thymine. 
 
Unlike other MBD proteins, MBD4 is not associated with histone deacetylase 
activities although its transcriptional repression activity has been reported recently 
(Kondo et al., 2005). Mutation of MBD4 has been found in TDG-deficient colorectal 
cancers, therefore, it is speculated that MBD4 can function as a bona fide tumour 
suppressor (Sansom et al., 2007).  MBD4-deficient mice are viable but exhibit a 
higher frequency of 5’methyl-cytosine mutation, in which, transition of methyl-CpG 
to TpG is 3-fold higher than wild-type mice (Millar et al., 2002; Wong et al., 2002). 
Deficiency of MBD4 in mbd4-/- mice also accelerates intestinal tumorigenesis in 
ApcMin/+ background although spontaneous tumorigenesis was not observed (Millar et 
al., 2002). These data strongly indicate that MBD4 functions as tumour suppressor via 
its DNA repair activity.  
1.4.6 KAISO 
Kaiso was first identified as a binding partner of the catenin protein p120 (Daniel and 
Reynolds, 1999). Kaiso is a bi-modal DNA binding protein that recognises methyl-
CpG containing sequences and also a consensus sequence in the absence of methyl-
CpG (Daniel et al., 2002; Prokhortchouk et al., 2001). Kaiso does not contain a 
classical MBD binding domain but interacts with methyl-CpG dinucleotides in a 
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context of mCpGmCpG via a zinc finger motif located at the C-terminus (Figure 1-7). 
It is capable of repressing transcription in a methylation dependent manner 
(Prokhortchouk et al., 2001). In a nucleotide sequence recognition mode, the Kaiso 
zinc finger motif associates with the CTGCNA sequence motif (Daniel et al., 2002). 
Depletion of Kaiso in Xenopus embryos leads to premature gene activation, abnormal 
gastrulation and early embryonic lethality (Kim et al., 2002; Ruzov et al., 2004). 
Repression by Kaiso is mediated through its stable association with the histone 
deacetylase-containing corepressor complex (NCoR) to a methylated site in the 
genome (Yoon et al., 2003). Kaiso null mice are viable and fertile with no 
abnormalities of gene development and expression. However, a hybrid of kaiso null 
mice and tumour-susceptible ApcMin/+ mice delayed the onset of intestinal 
tumourigenesis (Prokhortchouk et al., 2006). Kaiso was also found to be upregulated 
in murine intestinal tumours and was expressed in human colon cancers 
(Prokhortchouk et al., 2006). Therefore, kaiso represents a potential target for cancer 
therapy.           
1.4.7 Structure of MBD domains 
Solution structures of unliganded MBDs of MBD1 (Ohki et al., 1999) and MeCP2 
(Wakefield et al., 1999) and of a DNA-bound MBD of MBD1 (Ohki et al., 2001) 
have been reported. The structure of the MBD domain of MeCP2 is similar to the free 
MBD domain of MBD1 and in complex with DNA. As shown in Figure 1-9, the 
MBD structure is composed of a 4-stranded anti-parallel β-sheet and an α-helix. An 
extended long loop containing several positively charged residues connects β2 and 
β3. Several residues located at the C-terminal end of β2, loop L1 and the N-terminal 
end of β3 of MeCP2 MBD undergo chemical shift changes upon addition of methyl-
CpG containing DNA, suggesting that this flexible loop is involved in DNA binding 
(Wakefield et al., 1999). This is in agreement with the observation of the NMR 
structure of MBD1 MBD domain in complex with a 12 bp palindromic DNA 
containing a central methyl-CpG (Ohki et al., 2001). Ohki and coworkers also argued 
that the methyl groups of methyl-CpG are recognised by a hydrophobic patch 
comprising of V20, R22, Y34, R44 and S45 (corresponding to K109, R111, Y123, 
R133 and S134 of MeCP2) (Ohki et al., 2001). In addition, Wakefield et al (1999) 
reported that some residues located at loop L1 (G114 and A117), β3 (A131), loop L2 
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(R133), α1 (K135, V136), and the β-turn at the C-terminal region (F157, T160 and 
R162) showed amide proton chemical shift changes upon addition of methylated 
DNA.  
 
Figure 1-9: Solution structure of DNA bound MBD1 and unliganded MeCP2 
(a) MBD domain of MBD1 (green, yellow and red) complexed with methylated 12 bp 
polindromic DNA (blue) (pdb id 1IG4; Ohki et al 2001). Methyl groups of methyl-CpG are 
represented by grey spheres. (b) Unliganded MeCP2 MBD domain (pdb id 1QK9; Wakefield 
et al 1999).  
  
   
In the NMR structure of MBD1 MBD-DNA complex the following conclusions were 
drawn: The two methyl groups are separately packed into two hydrophobic pockets 
formed by the hydrophobic side-chains of Val20, Tyr34 and the aliphatic side chain of 
Arg22; and an aliphatic portion of Arg44 and Ser45 residues, respectively (Ohki et 
al., 2001). However, subsequent work described in this thesis shows that the methyl-
CpG is recognised through specific hydration at the major groove of the methylated-
DNA. The details of the new findings are presented in Chapter 5 in this thesis and a 





1.5 MECP2  
1.5.1 Architecture of MeCP2 
MeCP2 was originally identified in rat brain nuclear extract due to its ability to 
recognise single methyl-CpG dinucleotide (Lewis et al., 1992) and an AT run 
adjacent to the methyl-CpG is an additional requirement to enhance maximum 
binding (Klose et al., 2005). The full length protein contains 486 amino acids and is 
divided into several domains (Figure 1-10). The MBD domain of MeCP2 containing 
85 amino acids located at amino acids 78-163. In vitro footprinting analysis indicates 
that 12 nucleotides surrounding a methyl-CpG pair is protected from DNase I activity, 
with an approximate dissociation constant of 10-9M (Nan et al., 1993). MeCP2 also 
contains a central TRD (amino acids 207-310) domain (Nan et al., 1997) that interacts 
with various co-repressors complexes (Jones et al., 1998; Kokura et al., 2001; Nan et 
al., 1998) and a nuclear localisation signal (NLS) (Nan et al., 1996). In addition, two 
AT hooks, which are believed to interact with AT rich DNA, were identified at amino 
acid positions 185-192 and 265-277. These AT hook motifs are similar to that of the 
HMGA1 protein (Banks et al., 1999; Dragan et al., 2003). However, the AT hook 
binding specificity of MeCP2 has not been well characterised although Klose et al. 
reported that the AT hook domain had no effect on DNA binding (Klose et al., 2005). 
MeCP2 forms a complex with methyl-CpG nucleosomal DNA exposed at the major 
groove via the MBD domain (Chandler et al., 1999), indicating that accessibility of 
MeCP2 to nucleosomes is uninhibited. The C-terminal region is also required to 
facilitate the DNA-protein binding and contains a WW domain which is predicted to 
be involved in protein-protein interaction (Buschdorf and Stratling, 2004). The 
functional roles of the N-terminal (amino acids 1-77) and the C-terminal region 
containing 7x His tag and a Pro rich domain remain unknown. The expression of 
MeCP2 is from one locus located at the X-chromosome but alternative splicing gives 
rise to two isoforms (MeCP2α and MeCP2β) which differ only at their N-terminus 
(Kriaucionis and Bird, 2004; Mnatzakanian et al., 2004). The expression efficiency of 
MeCP2 is different in various tissues although both isoforms are highly expressed in 
the brain; the roles of these alternative splice variants in normal MeCP2 function 
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1.5.2 MeCP2 Binding Partners  
MeCP2 is known to recognise single methyl-CpG dinucleotides in DNA via its MBD 
domain; its TRD domain is used to recruit transcriptional repressor complexes and 
chromatin remodelling proteins (Jones et al., 1998; Nan et al., 1997). The TRD 
domain of MeCP2 is able to perform long-range transcriptional repression of up to 
2kb from the mRNA initiation site (Nan et al., 1997), and associates with the 
transcriptional repressor mSin3A and histone deacetylases (Jones et al., 1998; Nan et 
al., 1998). Gene silencing by MeCP2 is relieved by inhibition of histone deacetylase 
activity, which causes transcriptional derepression and chromatin re-modification 
(Jones et al., 1998; Nan et al., 1998). However, nuclear extracted native MeCP2 
complexes demonstrated that the Sin3A co-repressor complex does not associate 
stably with MeCP2 (Klose and Bird, 2004), suggesting that MeCP2 is a weak or 
transient component of the complex and the protein might associate with a diverse 
range of cofactors. Other complexes have been gradually identified as MeCP2 binding 
partners in regulating transcriptional repression. Among them, the TRD of MeCP2 
was reported to interact with transcription factor TFIIB by interfering with the 
assembly of the basal transcription machinery (Kaludov and Wolffe, 2000). MeCP2 
was shown to recruit histone methyltransferase SUV39H1 which leads to the H3-K9 
methylation in the differential methylated domain of H19 gene, linking the repressive 
functions of DNA methylation and histone methylation (Fuks et al., 2003a). MeCP2 
also interacts with DNMT1 in a Sin3A/HDAC independent manner, which indicates 
that MeCP2 might be involved in guiding DNMT1, which lacks an MBD domain, to 
the hemimethylated CpG site at the DNA replication fork (Kimura and Shiota, 2003). 
Recently, MeCP2 was reported to interact with RNA binding protein YB1 (Y-box 
binding protein 1) which suggests a new role for of MeCP2 in regulating RNA 
alternative splicing (Young et al., 2005). In addition to the above, MeCP2 interacts 
with various other factors in regulating gene transcription including c-ski, Brahma, 
SWI-SNF chromatin remodelling complex, group II WW domain of splicing FBPII 
and HYPC, PU1, Co-Rest, LANA, RNA and Igfbp3 (Buschdorf and Stratling, 2004; 
Harikrishnan et al., 2005; Itoh et al., 2007; Jeffery and Nakielny, 2004; Kokura et al., 
2001; Krithivas et al., 2002; Lunyak et al., 2002; Suzuki et al., 2003). The mechanism 
and contribution of these factors to the function of MeCP2 remains to be investigated.   
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1.5.3 MeCP2 and Rett Syndrome  
Rett syndrome (RTT) is a progressive neurodevelopmental disorder in early childhood 
and causes mental retardation in females, with a prevalence of 1 in 10,000 – 15,000 
female births (Hagberg, 1985; Rett, 1966). Females with classical RTT develop 
phenotypically normal until 6-18 months, then gradually lose speech and purposeful 
hand use, and acquire microcephaly, dementia, seizures, autism, ataxia, intermittent 
hyperventilation and stereotypic hand movements (Hagberg et al., 1983). After the 
initial regression, RTT patients usually stabilise and survive into adulthood. As RTT 
occurs exclusively in females, it has been suggested that the disease is an X-linked 
mutation with lethality in males due to severe encephalopathy (Bienvenu and Chelly, 
2006).  
 
Genetic mapping revealed that the disease region responsible for rare familial RTT 
located on Xq28 (Amir et al., 2000) and candidate screenings identified mutations in 
the MECP2 gene as the cause for most RTT cases (Amir et al., 1999). MECP2 
mutations account for more than 95% of sporadic cases of classical RTT in females 
(Bienvenu and Chelly, 2006). Databases of disease-causing MECP2 mutations and 
some benign polymorphisms have been compiled (see databases at the University of 
Edinburgh; www.mecp2.org.uk and RettBASE of the Children’s Hospital at 
Westmead, Australia; www.mecp2.chw.edu.au ). The compilation reveals that disease 
and non-disease causing missense mutations occur throughout the MECP2 gene with 
more than half of all RTT causing mutations clustered within the MBD domain of 
MeCP2. Deletion/ insertion mutations also span the polypeptide but predominantly at 
the C-terminal region. Other forms of mutation are silent mutations, nonsense 
mutations, and miscellaneous mutations. About 64% of all mutations are clustered in 
8 hotspots of RTT mutations; R106, R133, T158, R168, R255, R270, R294 and R306 
(Figure 1-10); seven of them bearing CpG in their codon (the codon for Arg) 
(Kriaucionis and Bird, 2003). Therefore, it is likely that the unrepaired deamination of 
methyl-CpG causes those mutations (Cooper and Youssoufian, 1988). MeCP2 
mutants display an abnormal DNA binding profile which eventually leads to over or 
underexpression of the target genes. A recent report suggests that RTT-like 
phenotypes are reversible by reinstalling MeCP2 expression in a mouse model (Guy 
et al., 2007), indicating that the defective neurons are, in fact, viable.        
 24
1.5.4 MeCP2 target genes  
MeCP2 is involved in methylation specific transcriptional repression and this 
observation has led to the hypothesis that MeCP2 deficiency in RTT causes global 
gene dysregulation. To test this hypothesis, transcriptional profiling using microarray 
analyses with MECP2-deficient mouse brain (Tudor et al., 2002), RTT patient cell 
lines (Traynor et al., 2002), post-mortem RTT brain (Colantuoni et al., 2001) and 
recently cerebellum MeCP2 null mice (Venter et al., 2001) has revealed no dramatic 
changes in genome wide transcription, indicating that MeCP2 does not function as a 
global gene repressor. One of the potential caveats is because MeCP2 regulates a 
different set of genes in different cell types and therefore the heterogeneity of the 
brain tissue would significantly mask cell-type-specific gene expression changes that 
may result from deficiency of MeCP2.  
 
Several recent successful identifications of MeCP2 target genes relied on a candidate 
gene approach. By comparing gene expression profiling of MeCP2+/y and MeCP2-/y 
mouse cortical culture which is more homogeneous than whole brain, the Brain 
Derived Neurotrophic Factor (BDNF) gene was identified as the first bona fide 
mammalian endogenous target gene of MeCP2 (Chen et al., 2003; Martinowich et al., 
2003). BDNF is known to play important roles in normal brain development and in 
learning and memory and these capabilities are disrupted in RTT patients (Chadwick 
and Wade, 2007). MeCP2 selectively binds to the BDNF promoter III and represses 
BDNF expression (Chen et al., 2003). The BDNF gene is activated upon calcium-
dependent phosphorylation at Ser421 which subsequently releases the phosphorylated 
MeCP2 (Chen et al., 2003; Zhou et al., 2006). However, a contradicting result was 
reported that the BDNF expression level was reduced in MeCP2 null mice (Chang et 
al., 2006). A transgenic approach which allowed conditional BDNF overexpression in 
MeCP2 knockout mice relieved RTT symptoms observed in MeCP2 mutants (Chang 
et al., 2006). This finding provides the first functional interaction between BDNF and 
MeCP2 in RTT disease progression. However, it is still unclear how MeCP2 and 
BDNF cooperatively regulate neuron activities.   
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In an amphibian model, the neuronal repressor Hairy2a gene was identified as an 
MeCP2 target gene (Stancheva et al., 2003). In this model, Stancheva and colleagues 
used antisense morpholino oligonucleotide injection to knock-out the MECP2 
expression. In the MeCP2 deficient frogs, significant developmental defects such as 
reduced dorsal axis and abnormal head structure have been observed (Stancheva et 
al., 2003). Disruption of MeCP2 activity also affect the primary neuron patterning 
during neuron differentiation indicating that lack of MeCP2 causes neurogenesis 
problems. The dysregulation of gene expression was analysed in the Delta/Notch 
signalling pathway, which is known as the key pathway in early neuronal 
development. MeCP2 deficiency leads to increased expression of Hairy2a gene. 
Mechanistically, MeCP2 binds to methyl-CpG of the Hairy2a promoter, where, 
MeCP2 interaction with SMRT complex via Sin3A represses Hairy2a gene. On 
activation of Delta/Notch signalling pathway, the repression complexes containing 
MeCP2, SMRT, Sin3A and HDACs leave the methyl-CpG sites.         
 
Several other methods have been used to identify primary targets of MeCP2. DLX5 
was identified by cloning fragments from MeCP2 ChIP (Horike et al., 2005). 
Upregulation of serum glucocorticoid-inducible kinase 1 (sgk) and FK506 binding 
protein 5 (Fkbp5) in MeCP2 deficient mouse brain, suggesting MeCP2 as a modulator 
of glucocorticoid-inducible gene expression (Nuber et al., 2005). Microarray analysis 
of transcriptional changes during maturation differentiation identified inhibitors of 
differentiation (ID1-4) genes as a neuronal target of MeCP2 as both MECP2-null 
mice and RTT brains show elevated ID proteins (Peddada et al., 2006). FXYD1, 
which encodes a transmembrane modulator of Na+, K+-ATPase activity, is enhanced 
in frontal cortex (FC) neurons of RTT patients and MECP2-null mice (Deng et al., 
2007). The target genes identified in these studies show dysregulation due to MeCP2 
deficiency but none of the target genes could completely explain the primary 
neurodevelopment defect observed in RTT patients.  
1.5.5 Methylation dependent and independent Mechanisms 
A series of studies have identified MeCP2 endogenous target genes that function in 
two different pathways that might contribute to RTT syndrome. The classical pathway 
involves recognition of methylated DNA at a target promoter region via the protein 
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MBD domain. The second pathway however might not involve methyl-CpG 
recognition but establishes a silent chromatin structure through formation of a 
chromatin loop. Figure 1-11 illustrates how MeCP2 functions in methylation and non-




Figure 1-11: MeCP2 regulation of chromatin remodelling and transcriptional  
(a) MeCP2 binds methylated DNA through the MBD domain and the TRD domain recruits 
chromatin-remodelling complexes that contain mSin3A co-repressor, BRM and HDACs. The 
recruited HDACs acetylates histones H3 and H4, which causes chromatin condensation and 
subsequently, limiting the accessibility of transcriptional machinery.  
(b) Membrane depolarisation followed by calcium influx leads to activation of the target 
gene. Calcium dependent phosphorylation releases the MeCP2 from its target site and 
disassembling the co-repressor complexes. The displacement of MeCP2 from its target site 
has been suggested from reduced CpG methylation at relevant CpG sequence (Martinowich et 
al., 2003). Alternatively, the dissociation could be due to CDKL5 activity which is thought to 
bind and phosphorylate MeCP2 (Mari et al., 2005).  
(c) MeCP2 binds to its target DNA sequence and result in formation of a chromatin structure, 
followed by transcriptional silencing independently of DNA methylation.  
(d) The absence of MeCP2 at the DNA methylation independent promoter leads to a relieved 
form of chromatin structure and rendering accessibility to transcriptional machinery (model 




In the methylation dependent model (Figure 1-11a and b), the MBD domain initially 
binds onto methyl-CpG sites and its TRD domain interacts with the co-repressor 
Sin3A complex which contains HDAC1/2. Deacetylation of histone H4 by HDACs 
remodels the chromatin structure, which becomes inaccessible to the transcriptional 
machinery (Bienvenu and Chelly, 2006). Various other transcriptional repression 
factors have been reported to associate with the TRD domain of MeCP2 in regulating 
transcriptional repression (see MeCP2 binding partners). However, the link between 
histone deacetylation and MeCP2-mediated transcription repression remains to be 
fully addressed. In addition, histone methylation is another important epigenetic 
development in regulating chromatin structure and activity (Kouzarides, 2002). 
MeCP2 has been reported to be involved in methylation of H3K9 on the H19 gene, 
which is associated to gene silencing (Fuks et al., 2003a; Fuks et al., 2003b). Other 
complexes are believed to mediate the association of MeCP2 and H3K9 methylation. 
MeCP2 is also reported to interact with the repressor complex RCOR1. This complex 
binds to the SCN2A gene and represses transcription through H3K9 methylation, 
which is catalysed by the histone lysine methyltransferase SUV39H1. In most cases, 
however, the role of MeCP2 remains elusive.    
  
In 2003, a novel mechanism of MeCP2 in transcriptional repression independent of 
DNA methylation was proposed (Figure 1-11c and d). In vitro biochemical studies 
and electron microscopy demonstrated that the complex of MeCP2 and unmethylated 
nucleosomal arrays resulted in extensively condensed ellipsoidal particles and 
oligomeric suprastructures (Georgel et al., 2003). Surprisingly, analysis with RTT 
mutants (R168X and R133C) indicates that chromatin condensation is dispensable of 
the MBD domain (Georgel et al., 2003). These data suggest that MeCP2 binding has 
an enormous impact on chromatin reorganisation in a methylation independent 
manner.  This result is in agreement with the finding that Dlx5-Dlx6 are targeted 
imprinted genes of MeCP2. MeCP2 mediated the silent chromatin-derived 11 kbp 
chromatin loop at Dlx5-Dlx6  whereas this loop is absent from MeCP2 null brain 
(Horike et al., 2005). Interestingly, this finding did not identify any sequences in the 
region of identified MeCP2 binding sites that were differentially methylated on the 
two parental alleles (Horike et al., 2005).  
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1.6 PROJECT AIMS  
This study concerns the molecular basis of the DNA binding specificity of the 
transcriptional repressor MeCP2, which is essential for maintenance of neuronal 
functions (Guy et al., 2007; Kishi and Macklis, 2004). The aims of the study include: 
1. Characterisation of MeCP2 binding with various DNA fragments selected 
from SELEX experiments (Klose et al., 2005) using gel retardation assays. In 
particular the role of AT runs adjacent to the methyl-CpG will be investigated.  
2. Co-crystallisation of MeCP2 MBD in complex with a methylated DNA 
fragment. 
3. Structural determination of the MeCP2 MBD-DNA complex using X-ray 
crystallography. 
4. Identification of the structural role played by several key residues in RTT 
mutation. 
 
Chapter 3 presents preliminary characterisations of various MeCP2 constructs 
complexed with methylated DNA and the selection of complexes for initial co-
crystallisation trials. Chapter 4 describes the initial crystallisation screening and 
optimisation of MeCP2 MBD in complex with various lengths of DNA containing a 
methyl-CpG and an AT run at the centre of the duplexes. This process established the 
crystallisation condition for the DNA-protein complex of an MeCP2 MBD domain 
and a 20 bp overhanging methylated DNA. This chapter also explains the X-ray 
crystallographic strategy used in solving the X-ray structure of MeCP2 MBD domain 
in complex with a methylated DNA. Chapter 5 describes the details of structural 
analysis using various programmes. Chapter 6 presents various gel shift assays which 
highlight the importance of several residues involving in methylated DNA binding. 









CHAPTER 2. MACROMOLECULAR 
CRYSTALLOGRAPHY 
2.1 INTRODUCTION 
Macromolecular crystallography is a technique used to study the structure of 
biological molecules such as proteins, nucleic acids and viruses to atomic resolution. 
High resolution X-ray crystal structures help to elucidate the details of mechanism of 
macromolecules in living cells and organisms. Most macromolecules can be 
crystallised under regulated conditions. In this state, macromolecules are arranged in a 
regular three-dimensional arrangement. Atoms in equivalent positions can diffract X-
rays to produce diffraction spots. The X-ray structure of the macromolecule can be 
determined by analysing the spot intensities and position. This chapter provides an 
introduction to the basic concept of macromolecular crystallisation and 
crystallography used in this study.  
2.2 MACROMOLECULAR CRYSTALLISATION  
Solubility of macromolecules such as proteins and DNA in aqueous solutions is a 
function of parameters such as pH, temperature, ionic strength and macromolecular 
concentration. Varying these parameters can bring the macromolecule to a 
thermodynamically metastable state known as supersaturation, in which, the amount 
of macromolecule present in the solution is higher than that of the macromolecular 
solubility. In the supersaturation state, the macromolecules can evolve kinetically into 
two different states; aggregates or nuclei; depending on the molecular interaction 
control (Durbin and Feher, 1996). To promote crystal growth for structural 
determination, the supersaturated state is controlled in a way to promote limited 
nucleation that allows crystal growth, but not over nucleation, which results in many 
microcrystals or amorphous precipitate. A crystallisation phase diagram (Figure 2-1) 
illustrates four distinct areas present in the supersaturation state: (i) at the highest 
supersaturation region, protein precipitation will occur; (ii) at the moderate 
supersaturation area, spontaneous nucleation will take place; (iii) at the area of lower 
supersaturation just below the nucleation zone, crystals are stable and may grow but 
no further nucleation takes place; and (iv) at the under saturation region, the 
macromolecule is fully dissolved and crystallisation will never occur (Chayen, 2004; 
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Chayen, 2005). One of the key steps in growing X-ray diffractable crystals is control 
of nucleation. The ideal strategy for growing large crystals is to allow restricted 
nucleation at the boundary between the nucleation and metastable zones, which 
results in a few nuclei and subsequently reduces macromolecular concentration. A 
reduction in macromolecular concentration transforms the nucleation zone to the 
metastable zone across the supersolubility curve. The metastable condition allows 
crystals to grow without additional nucleation.  
 
Figure 2-1 Schematic illustration of a protein crystallisation phase diagram 
The adjustable parameters can be precipitant and additive concentrations, pH or temperature. 
Route to nucleation and metastable zones of four major crystallisation methods are labelled as 
(a) batch method; (b) vapour diffusion; (c) dialysis and (d) free interface diffusion (diagram 
adapted from Chayen 2004). 
 
 
In practice, finding an appropriate condition for macromolecules to crystallise could 
be time and material consuming. Crystallisation experiments are based mainly on trial 
and error at the early stages of screening. However, there are two screening 
approaches for finding initial crystallisation conditions (McPherson, 2004). The first 
approach is a systematic variation of variables such as precipitant type and 
concentration; macromolecule concentration, pH, temperature and other parameters; 
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to search for initial crystallisation condition. The second is what termed as a ‘shotgun 
approach’ which is a sparse matrix screen utilising a wide range of selected conditions 
that have been proved successful in crystallising other macromolecules. The screen 
contains a wide combination of precipitants, salt, pH, ions and physical parameters 
most frequently reported in the literature. The Natrix Screen (Hampton Research) 
containing 48 conditions is an example of sparse matrix formulations selected from 
known crystallisation condition for nucleic acid-protein complexes. Once the initial 
hit is found, the crystallisation condition is optimised carefully in a relatively narrow 
range of parameters to yield an X-ray diffractable single crystal. Recent advancement 
in robotic automation and high-throughput screening allows a huge number of 
conditions to be tested within a short period of time, which requires only a small 
amount of sample. 
  
Preliminary studies prior to initial crystallisation screening are required to gain 
knowledge of biochemical properties of the macromolecules. Information such as 
solubility, macromolecular size, multimerisation state, requirement of cofactor and 
temperature stability can be acquired during macromolecule purification. Light 
scattering and circular dichroism analysis can estimate monodispersity and secondary 
structure of the protein. Lastly, analysing related macromolecular structures can guide 
a rational ‘tailoring’ of the protein of interest by modifying the protein surface by 
mutagenesis or truncating the flexible loops (Derewenda, 2004). In DNA-protein co-
crystallisation, the ratio of DNA to protein in complex form must be determined 
experimentally using various methods such as band shift assay or gel filtration 
analysis. This knowledge could significantly narrow down the search for early 
crystallisation conditions.  
2.2.1 Crystallisation methods 
The strategy used in crystallisation is to bring the macromolecule/solvent system to 
achieve supersaturation by reducing the solubility of a macromolecule by means of 
modifying the properties of the solvent or the character of the biomolecules. Several 
systems have been invented to achieve the supersaturated state of the macromolecular 
solution. These include bulk crystallisation, batch methods, dialysis, seeding, free 
interface diffusion, vapour diffusion and temperature induced methods (McPherson, 
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1999). Currently, the most popular method in crystallisation is hanging drop vapour 
diffusion.  
2.2.1.1 Vapour diffusion  
There are two common procedures in setting up vapour diffusion crystallisation. The 
mother liquor which contains the macromolecules and precipitant solution is either 
suspended (hanging drop) or supported (sitting drop) by some surfaces (Figure 2-2). 
In these approaches, the protein solution drop on the surface, usually 0.5 to 20 μl, is 
spatially separated from the reservoir, which is several magnitudes larger in volume. 
The precipitant concentration in the drop is generally lower (half, in general practice) 
than that of the reservoir solution. To achieve equilibrium in a sealed system, at a 
chosen temperature, the water or volatile material is evaporated from the drop until 
equilibration. The reservoir concentration is essentially unchanged. The drop volume 
decreases slowly which increases the macromolecular concentration. Generally, the 
precipitant concentration in the drop is half diluted by mixing with an equal volume of 
sample. The initial concentrations of the precipitant, macromolecule and additive are 
refined until supersaturation is reached upon equilibration.           
 




Figure 2-2 Vapour diffusion methods 
The mother liquor is (a) suspended on a cover slip in a hanging drop preparation and (b) 
supported on a sitting drop preparation. 
2.2.1.2 Microbatch 
Batch crystallisation is the simplest method in crystallising a protein or nucleic acid. 
The crystallisation mixture is prepared by direct mixing of an undersaturated 
macromolecule solution with a precipitant solution. The precipitant alters the protein 
solubility to create an immediate supersaturation state. If the chemical and physical 
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parameters have been carefully chosen, the solid state will be crystalline rather then 
amorphous. In the microbatch method, a 96-well microtiterplate is used as 
crystallisation platform by mixing the macromolecule and precipitant solutions under 
a layer of oil. The thickness of the oil can be used to control evaporation of water thus 
regulating nucleation which can be ceased later by increasing the oil depth (Chayen 
and Saridakis, 2002). The microbatch method has been adapted for automated high-
throughput screening experiments which consuming less than 500nl sample per well 
(Luft et al., 2001).   
2.2.1.3 Crystallisation by Dialysis 
Dialysis is a process of separating molecules in solution according to size through the 
use of semipermeable membrane containing pores of less than macromolecular 
dimension. In crystallisation by dialysis, the biological macromolecule is separated 
from a large volume of precipitant solution by a semipermeable membrane which 
allow small molecules such as ions, additives and buffer to pass through but not the 
larger size biological macromolecules. The kinetics of equilibrium depends on the 
membrane cut-off, the ratio of the precipitant concentration inside and outside the 
biological macromolecule chamber, temperature and the geometry of the cell. The 
simplest technique is to use a dialysis bag but a large volume of sample is required. 
Alternatively, microdialysis cells such as Zeppenzauer cells and dialysis buttons 
(commercially available from Hampton Research) can be used. These microdialysis 
cells have been adapted to accommodate a micro-volume of sample.     
2.2.1.4 Cryocrystallography  
Diffraction data are normally collected from crystal continuously cooled in a nitrogen 
stream. In theory, lowering the temperature should increase molecular order in the 
crystal and improve diffraction. However, freezing macromolecular crystals in liquid 
nitrogen occasionally results in ice formation which potentially damages the 
macromolecular crystal or interferes with data processing even though current 
software can handle ice-ring interference effectively. To overcome this problem, 
cryocrystallography was developed and cryoprotectants such as glycerol and low 
molecular weight PEG are introduced into the crystallisation solution or soaked into 
the crystal to prevent ice formation. Other advantages of cryocrystallography include 
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cryoprotection of macromolecular crystals against radiation damage particularly with 
intense synchrotron radiation sources. A comprehensive review and current 
advancements of this technique can be found in Garman and Owen (2006).         
2.3 CRYSTALS AND SYMMETRY  
A crystal is a solid object composed of an orderly three-dimensional array of 
molecules, held together by non-covalent interactions, which can be described as a 
three dimensional arrangement of lattice points is known as a space lattice. The lattice 
points selected as the vertices of the unit cell are chosen in a way that is consistent 
with the highest possible symmetry with the shortest cell edges. The edges are defined 
by 3 vectors a, b and c and the angles between these defined as α, β and γ (Figure 
2-3). In a unit cell, operation of the internal symmetry elements can further define the 
asymmetric unit. The asymmetric unit is the repeating object which is related to all 
other identical objects within the unit cell. (Garman and Owen, 2006) 
 
Figure 2-3 General unit cells  
A unit cell is defined by three edges a, b and c and angles α, β and γ (diagram adapted from 
Blow 2002). (Blow, 2002) 
 
On the basis of symmetry, crystals can be grouped into 7 crystal systems (Table 2-1). 
The simplest crystal system is triclinic where a ≠ b ≠ c and α ≠ β ≠ γ. If a ≠ b ≠ c and 
α = γ = 90˚, and β > 90˚, then the cell is monoclinic. In order of increasing symmetry, 
they are triclinic, monoclinic, orthorhombic, trigonal, tetragonal, hexagonal, and 
cubic. The space group describes the lattice type and the internal symmetry elements 
of the unit cell. Primitive lattice (P) contains 1/8 lattice point at each vertex of the cell 
and therefore contains a total of one lattice point per unit cell. An internal (I) or body-
centred lattice contains two lattice points per unit cell, one in the centre of the cell and 
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1/8 at each corner of the cell. A face-centred lattice (F) contains additional lattice 
points at the centre of all faces of the unit cell and thus comprises 4 lattice points. In a 
monoclinic crystal system, if a lattice point is placed on one of the faces; A, B or C; 
then new lattice types can be created. However, by changing cell orientation, A and B 
faced-centred lattices are equivalent to C-centred lattice. By combining the crystal 
systems and lattice types, only 14 Bravais (space) lattices are allowed (Table 2-1). To 
define the internal symmetry of the unit cell, three symmetry operations and elements 
are needed. Translation is a movement along the unit cell axes usually by fractions of 
the cell edges. Rotation is a movement of an object about an axis which can be 
expressed as x-fold rotation and the rotation angle is 360˚/x. The symmetry operation 
of a screw axis results from a combination of rotation and followed by translation 
parallel to the rotational axis. The combination of the various symmetry operators 
gives rise to 230 possible space groups. Because biological molecules are 
enantiomorphic, only 65 enantiomorphic space groups are considered for 
macromolecular crystals. 
 



















Cubic   
P 
P, C 
P, C, I, F 
P (or R) 
P, I 
P 
P, I, F 
None  
One 2-fold axis 
3 perpendicular 2-fold axis  
One 3-fold axis 
One 4-fold axis  
One 6-fold axis  
Four 3-fold axis  
a ≠ b ≠ c  
a ≠ b ≠ c 
a ≠ b ≠ c 
a =b ≠ c 
a =b ≠ c 
a =b ≠ c 
a = b = c 
α ≠ β ≠ γ 
α = γ = 90˚ ≠  β 
α = γ = β = 90˚ 
α = β = 90˚, γ =120 
α = β = γ = 90˚ 
α = β = 90˚, γ = 120 
α = γ = β = 90˚ 
2.3.1 Miller indices 
It is possible to draw families of planes that contain lattice points in the space lattices. 
These theoretically constructed planes intercept the unit cell axes fractionally, where 
the interception produces an integer number of equal segments for each axis a, b and 
c. The number of segments generated in each axis is called the Miller index of these 
planes and is represented by integer numbers hkl. For a given unit cell with axes a, b 
and c, if a family of planes parallel to a axis, cuts b axis by half and c axis into 3 
equal segments, then the Miller index for these parallel planes is 023. Figure 2-4 
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illustrates that the Miller index defines the direction of these planes with respect to the 
unit cell orientation of the crystal. The interplanar distance is designated as dhkl.  
 
Figure 2-4 Planes in space lattice 
Each family of planes is designated with a Miller index which can be used to define the 
direction of these planes correspond to the unit cell axes. The Miller index in this example is 
322.  
2.4 X-RAY AND DIFFRACTION 
2.4.1 X-ray 
X-rays are electromagnetic radiation of wavelengths 0.1-100Å (1 Å = 10-10 m) which 
can be produced when a metal is bombarded with electrons accelerated by an electric 
field. For macromolecular crystallography, the wavelength ranges between 0.5 to 1.6 
Å are most suitable as these waves can penetrate biological samples and be scattered 
by the entire volume of a macromolecular crystal. X-rays are produced when a high 
energy electron collides with the target metal and displaces an electron from the lower 
orbital. This vacancy is filled by an electron dropped from a higher orbital and this 
transition process emits the excess energy in the form of X-ray photons. In 
crystallography laboratories, electrons are generated from a hot filament and are 
accelerated by a large (40kV) potential. The high speed electron then collides with the 
water-cooled anode (or rotating anode) of the target metal and promotes electronic 
transitions between orbitals resulting in X-ray radiation. Two of the most common 
anode elements are copper and molybdenum. When the electron from the inner shell 
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is displaced by accelerated electron, the electron from L shell of copper will drop and 
replace displaced K electron (Kα transition) and emit X-rays with wavelength of 1.54 
Å. The initial beam however contains two wavelengths (Kα and Kβ) which will 
produce overlapping reflections and causes difficulty in indexing. To overcome this 
problem, a monochromator is used to select the stronger wavelength and produces 
monochromatic X-rays.   
 
In synchrotron radiation sources, electrons circulate at velocities near the speed of 
light in a giant ring (with circumference up to 1km). The electron is forced into a 
curved motion by powerful magnets in accelerators and additional bending is imposed 
by wigglers. The curving and bending of electrons causes emission of high energy X-
ray (synchrotron radiation). The intensity of a synchrotron X-ray beam is several 
times stronger than the in-house X-ray sources using either X-ray sealed-tube or 
rotating anode sources. This feature allows data collection to be completed in short 
time and also permits data collection from small and weakly diffracting crystals. In 
addition, synchrotron radiation produces radiation with a continuum of wavelengths 
which allows a desired wavelength to be selected, which is particularly helpful in 
solving the phase problem.  
2.4.2 X-ray diffraction 
Diffraction occurs when an incident beam is scattered by an object into directions 
other than the original direction without changing its wavelength. In macromolecular 
crystallography, X-rays interact with electrons and set the electrons oscillating with 
the X-ray frequency and emit an X-ray photon with the same wavelength in a random 
direction. Unlike visible light, X-ray radiation cannot be focused by lenses. 
Reproducing the image requires the phases of the scattered wave as well as the 
experimental measured intensity. To ‘visualise’ an X-ray diffracted image, the phases 
must be estimated by calculation. The X-ray diffraction image is recorded on devices 
which can include: X-ray sensitive film, image plate or CCD detector. These area 
detectors can record the diffraction pattern, the positions and the intensities of each 
diffracted spot. During data collection, the crystal is mounted on the goniometer head 
which is rotated by the diffractometer through an angle which allows a complete or 
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high multiplicity dataset to be collected depending on structural determination 
strategies and space group. 
2.4.3 Bragg’s Law 
As mentioned above, the X-rays diffracted from each atom are in random directions 
with an identical wavelength to the incident beam. Because the molecules are in a 
regular repeated lattice, the scattered rays will interfere constructively producing 
strong diffracted spots or destructively cancelling each other. This phenomenon can 
be explained by Bragg’s Law using an equation:  
λθ nd lhk =sin2      Equation 2-1 
where dhkl is the distance between parallel planes (hkl), θ is the angle of diffraction, λ 
is the wavelength and n is an integer. Only in the condition when the difference in 
path length for rays diffracted from successive planes is equal to an integral number 
of wavelengths (nλ) will constructively produce a strong diffracted Bragg reflection. 
At other angles of incidence, diffracted waves from successive planes interfere 
destructively and no Bragg spot will be recorded. Each family of successive planes 
that satisfy the Bragg’s Law produces a reflection. Each Bragg spot on the diffraction 
image result from a different set of Miller planes. 
 
Figure 2-5 Bragg’s Law  
 
The reciprocal lattice dimension is inversely proportional to the real space dimension. 
The base vectors of the reciprocal space are named a*, b* and c* which are 
perpendicular to the real space planes bc, ac and ab with magnitude proportional to 
1/a, 1/b and 1/c, respectively. The relationship between the real space in a crystal and 
its space occupied by the reflections in reciprocal space can be described using the 
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Ewald sphere concept (Figure 2-6). The Ewald construction is a sphere, where the 
centre C is placed in a crystal, with radius equal to 1/λ. The crystal lattice is 
represented by the reciprocal lattice, with its origin O on the Ewald sphere rotational 
axis where the direct beam ACO leaves. When a lattice point B touches the sphere, 
Bragg’s Law is fulfilled and a reflection can be recorded. As a result, the diffraction 
of each family of planes (Miller indices hkl) that satisfy Bragg’s Law will contribute 
to a reciprocal lattice point in reciprocal space. A vector (OB) is drawn perpendicular 
to each family of hkl planes with length of 1/dhkl, the points at the end of the vectors 
define the three-dimensional lattice known as the reciprocal lattice.         
 
Figure 2-6 Ewald sphere construction 
The reciprocal lattice point B is defined by the end point of vector OB with length of 1/dhkl. 
When the rotation of the crystal brings point B onto the surface of the sphere then ½ OB = CB 





 and re-arrangement of this equation proves 
the Bragg’s law; θλ sin2 hkld= . 
 
2.5 DATA COLLECTION STRATEGY 
The method of choice in data collection is the rotation method based on the principle 
that rotating a crystal around an axis should bring most of the reciprocal lattice points 
to the conditions that fulfil Bragg’s law. A single image is recorded every time the 
crystal is rotated by a definite small angle for a given length of time. This is the 
oscillation angle of the diffraction images. The objective is to bring as many as 
possible reciprocal lattice points to the Bragg’s condition in order to obtain a high 
completeness for the dataset. To collect good quality data with high completeness, 
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experimental parameters that should be considered in the data collection strategy are 
oscillation angle, total rotation range, crystal-to-detector distance, wavelength and 
exposure time. The strategy used also depends on crystal properties such as possible 
space group, crystal mosaicity, unit cell and maximum resolution. Therefore, two 
images at 90˚ apart are usually collected and analysed with data processing 
programmes in order to estimate the diffraction properties of the crystal. This 
preliminary information can be used to adjust the crystal-to-detector distance 
according to the extension of diffraction. Autoindexing of these images can predict 
the possible space group and the unit cell dimensions.  
 
Two approaches can be used to select the rotational angle (angular width) of an 
he setting of crystal-to-detector distance affects the signal-to-noise ratio in the 
individual reflection. The wide slicing (wide angle) method is based on collecting 
images with an angle greater than the mosaic spread of the crystal thus more fully- 
recorded reflections are recorded. Two-dimensional integration of reflections in each 
image can be performed with MOSFLM (Leslie, 1999) and HKL (Otwinowski and 
Minor, 1997). For the fine slicing (small angle) method, images are collected with the 
sliced angle narrower than the mosaic spread of the crystal or less than or equal to 
0.5˚. A “thin” dataset has reflections spread over several images which enable 3-
dimensional integration of reflections using programmes such as XDS and d*TREK 
(Pflugrath, 1999). The fine slicing method results in a better signal-to-noise ratio 
compared to the wide angle method. However, the fine slicing method is only 
advantageous if a detector has a very short readout time.    
 
T
recorded diffraction pattern. A long crystal-to-detector distance gives a better signal-
to-noise ratio but may restrict resolution of the data and vice versa. Therefore, crystal-
to-detector distance should be adjusted to match the maximum resolution limit which 
can be estimated by the 2 images separated by 90˚. In addition, the crystal-to-detector 
distance setting is also affected by the unit cell dimension. The highest resolution 
setting for a large unit cell dimension, such as a virus particle, would potentially lead 
to overlap reflection profiles. In some cases, the resolution is compromised for a full 
completeness dataset.  
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The beam wavelength is extremely important in collecting the anomalous signal for 
experimental phasing and therefore it must be appropriately optimised. This 
optimisation can be done at a station; such as stations BM14 at ESRF where the 
wavelength can be tuned according to the fluorescence spectrum of the anomalous 
scatterers in the crystal. Furthermore, the fluorescence spectrum also provides f’ and 
f’’ values which are required for a MAD experiment. For native data collection, any 
value of the wavelength which ensures a high intensity of the beam can be used. Most 
of the synchrotron radiation sources utilise wavelengths below 1Å as this minimises 
the absorption of radiation by the crystal, the mother liquor and air scatter.  
 
The total rotation angle is the most important factor that influences the completeness 
of data. In principle, collecting 180˚ of data will ensure a maximum completeness or 
360˚ if an anomalous scatterer is present (Dauter, 1999). The analysis of the crystal 
symmetry in relation to the geometry of the rotation method allows a complete dataset 
to be collected in which unique reflections are measured at least once. Nevertheless, 
in cases where the crystal is vulnerable to radiation damage, particularly in 3rd and 4th  
generation synchrotron radiation sources, it would be beneficial to reach high 
completeness as soon as possible using an optimal data collection strategy. For 
successful usage of anomalous data in MAD and SAD phasing, the important aspect 
of the data is its quality in terms of completeness of the Friedel pair reflections and 
high multiplicity in order to increase the signal-to-noise ratio of a weak anomalous 
signal. However, any reciprocal lattice points located in the blind region cannot be 
brought to the diffraction condition using the rotation method around a single axis 
(Figure 2-7). Nevertheless, this region can be reduced by using a shorter wavelength. 
 
Another factor that should be carefully considered is the exposure time which 
influences the reflection intensities. Longer exposure time increases the signal-to-
noise ratio and therefore improves the data quality but the crystal could suffer from 
radiation damage due to prolonged X-ray exposure and potentially ruin the later 
images. In the beam time available, it is a priority to maximally collect a complete 




   
Figure 2-7 Graphical representation of rotation method 
Rotating the Ewald sphere around the crystal rational axis will never bring the reciprocal 
lattice points located in the blind zone to the diffracting condition. A shorter wavelength 
results in a longer sphere radius (1/λ2) and therefore narrows down the blind region.  
           
2.6 DATA PROCESSING      
The objective of data processing is to identify the Miller indices (hkl) of all reflections 
recorded on the images, the diffraction intensities Ihkl, and their standard deviation 
σIhkl. This process can be divided into 3 major steps: indexing, integration and scaling 
(Leslie, 2006). The objective of indexing is to determine the indices h, k, l of each 
reflection, unit cell dimensions and the orientation of the cell edges with respect to the 
detector and X-ray beam. In addition, the Bravais lattice symmetry and the mosaicity 
of the crystal will also be estimated. These parameters will be refined using different 
algorithms. Several segments of images will be chosen to refine against crystal 
parameters (including unit cell, crystal orientation and mosaicity), detector parameters 
(detector position and orientation) and beam parameters (orientation of the primary 
beam and beam divergence) (Leslie, 2006). After these parameters refinements, all 
images can be integrated while post-refining the rest of the parameters.        
   
The integration step is to predict the diffraction spots in all images and estimate the 
intensity and standard uncertainties for each reflection. MOSFLM performs this using 
summation integration and profile fitting methods (Leslie, 2006). The summation 
integration works by defining the background and peak mask for each diffraction 
spot. To obtain the intensity, the pixel values of the peak region are summed and the 
sum of the background values are subtracted. This is particularly accurate if the 
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background value is very low compared to the intensity of the spot provided the spots 
are well resolved. For weak diffracted spots, profile fitting procedures can better 
estimate the intensity (Leslie, 2006). 
 
The final step in data processing is data reduction or scaling which can be carried out 
by the CCP4 programme SCALA. The main task of scaling is to bring all reflection 
intensities to a common scale by modelling the data collection experiment using the 
intensity values of symmetry equivalent and multiple recorded reflections collected at 
different times during the experiment (Evans, 2006). Different factors such as 
radiation damage, X-ray absorption and uneven crystal rotations are modelled and 
correction factors are calculated (Otwinowski et al., 2003). Two geometric factors are 
corrected in the scaling process. The first one is the Lorentz factors which account for 
the fact that the diffracting planes which satisfy the diffracting condition do not 
occupy such positions for an equal amount of time (Buerger, 1940). The second 
geometric factor is the polarisation factor which accounts for the fact that electrons do 
not scatter along their direction of vibration but in other directions with an intensity 
proportional to (sin α)2 (Drenth, 2007). These corrections are normally applied during 
data integration and the programme that integrates the reflections produce Lorentz 
and polarisation corrected intensities. All the correction factors are optimised in a way 
that minimises the intensity differences of symmetry related reflections. 
 
At the end of data reduction, various parameters are calculated to give an overview of 
the quality of all reflections. The log file produced contains useful information such as 
actual resolution, bad regions of data which should be excluded, anomalous signals 
for MAD and SAD phasing and overall quality of the dataset (Evans, 2006). The 
internal consistency of the dataset can be measured as an R factor. Examples of these 












    Equation 2-2 
where Ihkl,i is the ith measurement the reflection hkl and hklI  is the average intensity 
of the i observations. The value of this parameter expresses the agreement between 
symmetry related reflections. Rmerge tends to increase with the resolution and 
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multiplicity. Any significant deviation from this value may indicate a problem during 



















    Equation 2-3 
where N is the multiplicity of the data. Rpim has the advantage over Rsym because it is 
multiplicity dependent. 
2.7 ATOMIC SCATTERING FACTOR  
The atomic scattering factor or form factor (fhkl) is the sum of scattering from the 
electron cloud of an atom. It depends on the number of electrons and the scattered 





     Equation 2-4 
The atom is treated as a simple sphere of electron density. The function is different for 
each element depending on the number of electrons (the Z number) which diffract the 
X-rays. When the scattering angle is zero, fhkl value equals the number of electrons in 
the atom and this value decreases when the scattering angle increases.  
2.8 THE STRUCTURE FACTORS 
The structure factor Fhkl, the expression for the particular Bragg reflection hkl, is the 
sum of atomic scattering factors (fhkl) for all atoms in the unit cell. For a given hkl 
plane, the structure factor can be written as the summation: 
(2π + +=∑hklF
n
i hxj kyj lzj
j
j
f e     Equation 2-5 
Each atom contributes to the structure factor Fhkl and depends on two factors: (i) type 
of element fj which contributes the amplitude and, (ii) atom j position in the unit cell 
(xj, yj, zj). The total structure factor for a lattice point contains both the amplitude |Fhkl| 
and the phases (α) which can be written as: 
α=hkl hklF F hkl
ie      Equation 2-6 
The amplitude |Fhkl| is proportional to the square root of the measured intensity (Ihkl) 
of diffraction and phase (αhkl) which is 2π(hxj+kyj+lzj) in Equation 2-5. The intensity 
of diffraction depends on atomic scattering factors and position of the atoms (xj, yj, zj) 
in the unit cell. During data collection, only the intensity of diffraction (Ihkl) is 
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measured by the detector but not the phases and thus only the amplitude of the 
structure factor can be obtained from the experiment. Therefore, the phase problem 
needs to be solved in order to determine the arrangement of all atoms in the unit cell. 
2.8.1 Friedel’s Law 
Friedel’s law states that the Friedel’s pair (Fhkl and hk lF ) have the same structure 
amplitude (|Fhkl| = | hk lF |) but the phases have opposite sign (+α and –α). These 
reflections with equal amplitudes will produce diffraction spots with the same 
intensity. Friedel’s law holds as long as the anomalous scattering is absent for a 
particular wavelength used in the experiment.  
2.8.2 Electron density  
Because Fhkl and ρ(x, y, z) can be Fourier transformed reversibly, the electron density 
can be expressed as follows: 




F πρ = ∑   Equation 2-7 
By substituting Fhkl with |Fhkl|eiα, Equation 2-7 can be written as a Fourier 
summation: 
( ) ( )21 πρ − + + −= ∑ hkl, , F hkli hx ky lz
hkl
x y z e
V
α
  Equation 2-8 
The equation indicates that the electron density ρ(x, y, z) can be calculated at every 
position (x, y, z) in the unit cell. Although the |Fhkl| can be derived from Ihkl, the phase 
angle αhkl cannot be derived from the diffraction pattern. Therefore, an estimation of 
phase angle must be done in order to calculate the initial electron density map.   
2.9 CALCULATING THE PHASES 
During data collection, the crystallographer measures the intensities of waves 
scattered from planes hkl in the crystal. The amplitude of the wave |Fhkl| is 
proportional to the square root of Ihkl measured on the detector. All information of the 
phases (αhkl) is lost. Since there is no direct relationship between the amplitude and 
their phases, it is impossible to calculate an electron density map without initial phase 
information (Equation 2.8). The only relationship between amplitudes and phases is 
via molecular structure or electron density of the diffracting materials (Taylor, 2003). 
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Therefore, prior knowledge of electron density calculated from heavy atom scattering 
or known molecular structure can lead to initial phases of macromolecule. Table 2-2 
summarises various phasing techniques along with their prior knowledge that is 
required to obtain the phases for an unknown structure.  
Table 2-2 Phasing techniques  
Phasing methods  Prior structural knowledge / assumptions 
Direct methods  The electron density is positive or equal to zero, atoms can 
be described as discrete sphere  
Molecular replacement  A homologous structure is available for the unknown 
structure 
Isomorphous replacement  The position of heavy atoms attached to the macromolecule 
can be determined  
Anomalous scattering  Anomalous scatterers attached to the macromolecule can be 
located  
2.9.1 Patterson functions    
The Patterson function is a function to calculate electron density from reflection 
intensities without the use of phase information (Patterson, 1934). This function is a 
Fourier summation with intensities as coefficients which can be written as:  
(2 21 πρ − + += ∑ hkl( , , ) F hu kv lw
hkl
u v w e
V
)
   Equation 2-9  
Where u, v and w are relative coordinates in the Patterson cell that has dimensions 
equal to the real cell. In terms of convolution, the Patterson function ρ(u) can also be 
written as: 
( ) ( ) ( )dxdydzwzvyuxzyxwvu
xyz
+++×= ∫ ,,,,,, ρρρ Equation 2-10 
Equation 2-10 illustrates the physical interpretation of Patterson function. This 
expression indicates that electron density at point (u,v,w) in a Patterson function is a 
convolution resulting from multiplying the electron density at all points x, y, z by the 
electron density at points x + u, y + v and z + w. This will generate peaks 
corresponding to the atomic numbers of the two atoms at the ends of the vector u, v 
and w in the map. The Patterson map is then an inter-atomic vector map and contains 
information for the distances between atoms. If a real unit cell contains N atoms, the 
corresponding Patterson map will show N2 peaks. Of these, N peaks are superposed as 
 47
a result of self-convolution, leaving non-origin peaks of N2-N. Additionally, the 
Patterson map is centrosymmetric at the origin. For each pair of atoms there will be 
two Patterson peaks due to the two vectors with equal magnitude but in opposite 
directions. The Patterson method can be used to solve small molecule structures with 
a limited number of atoms but this does not apply to protein structures which typically 
contain thousands of non-hydrogen atoms. Nevertheless, the Patterson function is 
particularly useful to locate a limited number of heavy atoms in a large unit cell since 
the height of peaks in the Patterson map depends on atomic number.     
2.9.2 Experimental phasing 
When a novel X-ray structure cannot be solved by molecular replacement because a 
homologous model is unavailable, experimental phasing must be used to solve the 
structure crystallographically. Experimental phasing methods include single and 
multiple isomorphous replacements (SIR and MIR), single and multiple isomorphous 
replacement with anomalous scattering (SIRAS and MIRAS) and single and multiple 
wavelength anomalous dispersion (SAD and MAD). All these methods rely on the 
presence of heavy atoms in the macromolecular crystal in a high occupancy to give a 
clear signal.  
 
The first step in determining experimental phases is introducing heavy atom into the 
crystal to produce measurable changes in intensities. Protein crystals are open lattices 
that contain a high percentage of solvent. These solvent channels allow heavy atom 
compounds to diffuse into the crystal by soaking. Screening for an adequate 
compound for a given protein crystal usually involves trial and error before a useful 
derivative is found. Heavy metals can bind to protein in a number of distinct ways. 
For example, single metal ions are able to interact with the protein surface 
electrostatically; mercurial compounds tend to bind Cys sulphur or His nitrogen and 
platinum compounds bind to Cys, His and Met (Garman and Murray, 2003). The 
incorporation of heavy atoms such as replacing Met with seleno-Met by a genetic 
approach become a robust method (Hendrickson et al., 1985). To solve a novel 
structure of a nucleic acid, it is convenient to introduce heavy atoms such as 5’iodo- 




Nonetheless, several problems could adversely affect experimental phasing. One of 
the biggest problems of heavy atom derivatisation is non-isomorphism which induces 
a change in unit cell dimensions and disturbs the molecular arrangement in the crystal. 
This problem entirely jeopardises experiments such as SIR, MIR, SIRAS, and 
MIRAS. A common obstacle in heavy atom soaking is that the macromolecular 
crystal could dissolve in the heavy atom compound solution during soaking. 
Oxidation of selenium in seleno-Met derivatives causes the K-edge to move to a 
higher energy and the “white line” to be enhanced owing to changes in the chemical 
environment of the selenium during oxidation (Garman and Murray, 2003). Radiation 
damage is the common problem in MAD experiments due to the strong absorption 
properties of heavy atoms. 
2.9.3 Isomorphous replacement  
In the isomorphous replacement methods (SIR and MIR), the X-ray diffraction pattern 
of the native structure is compared to that of the heavy atom derivative crystal. 
Ideally, the conformation of the protein, unit cell dimensions, as well as orientation 
and position of the macromolecules in the native and in the derivative crystal are 
exactly the same. In this way, the intensity differences between the native and 
derivative crystal are exclusively due to the presence of heavy atoms. From these 
differences, the heavy atom position can be determined using Patterson function [eg. 
SIR2002 (Burla et al., 2004)], direct methods [eg. SHELXD (Schneider and 
Sheldrick, 2002) and SnB (Weeks and Miller, 1999)]. 
  
The structure factors from the unmodified protein crystal are the sum of the scattering 
vectors from the protein atoms. Whereas the structure factors from a heavy atom 
derivative are the sum of the scattering vectors from all the protein atoms plus the 
heavy atom. The isomorphous replacement method assumes that the scattering vector 
from the protein atoms is the same in both the native and derivative crystals. 
Therefore, the relationship of the native and derivative structure factors is: 
= −H HPF F FP      Equation 2-11 
where FH is the structure factor of heavy atoms; FHP is the structure factor of protein 
atoms plus heavy atoms and FP is the structure factor of protein atoms. To calculate 
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the FH, replacing Equation 2-11 in the Patterson function equation (Equation 2-9), 
will give the isomorphous difference Patterson function as below: 
( ) ( ) ( )2 21 πρ − + += −∑ HP P, , F F i hu kv lw
hkl
u v w e
V  Equation 2-12 
The heavy atom position in the unit cell can be determined from an isomorphous 
difference Patterson map. Together with the amplitudes |FHP| and |FP|, the phases of 
FP can be estimated using a Harker construction (Figure 2-8).  
 
Figure 2-8 Harker constructions of SIR and MIR 
(a) Phase calculation of single heavy atom in SIR and (b) two heavy atoms in MIR. (Diagram 
adapted from Taylor 2003). 
 
In SIR (Figure 2-8a), all the possible phases of FP and FPH are shown as black and 
green circles, respectively. The radius of the circles are represented by |FP| and |FPH| 
and the intercept points A and B represent the possible correct phases for FP (αa and 
αb); in which; both agree with the measured |FPH| and calculated FH. This phase 
ambiguity can be resolved by MIR. The |FPH| of a second derivative is measured and 
resulted a third interception (point C) as shown in the Harker construction for MIR 
(Figure 2-8b). Only the vector to the intercept point (point A) which agreed with all 
measured and calculated Fs give the correct phase angle for FP.  
 
Another way to solve the ambiguity in phase is using the heavy atoms which also 
serve as anomalous scattering atoms in isomorphous replacement. Where the Bijvoet 
difference [FPH(+) and FPH(-)] can be measured reliably, anomalous scatterers may  
function as the second heavy atom derivative, as in an MIR experiment. The 
complementary use of anomalous scattering and single isomorphous derivative data 
can give unique phases. This method is called single isomorphous replacement with 
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anomalous scattering (SIRAS). On the other hand, multiple isomorphous replacement 
with anomalous scattering (MIRAS) can be used with several heavy atom derivatives 
which give anomalous dispersion signals, and the Bijvoet pairs can be measured for 
each. The additional intensity observation will improve the accuracy of phase 
determination. 
2.9.4 Anomalous scattering 
The X-ray absorption of an element is a function of the X-ray wavelength and a 
sudden drop in absorption at a specific wavelength is referred to as the adsorption 
edge of the element. At the adsorption edge, an electron is ejected from an atom by 
the photon energy of the X-ray beam. The vacated position is filled by an electron 
drop from a higher shell (eg. L shell to K shell of copper) and this transition causes the 
element to emit at its characteristic wavelength. This emitted ray carries a different 
energy and the element is said to exhibit anomalous scattering at the absorption edge. 
The absorption edge of light atoms for instance oxygen, carbon and nitrogen are not 
close to the wavelength of the X-rays used in crystallography. As a result, the light 
atoms do not contribute to anomalous scattering. However, absorption edges of heavy 
atoms (such as selenium and manganese) are within this range. Anomalous scattering 
causes the anomalous scattered ray to have different intensities and phases.  
 
The anomalous scattering causes both the intensity and phase of the anomalous 
scattered rays to be altered from the normal atomic scattering factor fo. Therefore, the 







      Equation 2-13 
Where f’ and Δf” (usually referred to as f”) are the real and imaginary parts, 
respectively, of the anomalous scattering factor. Δf’ and Δf” are also known as the 
dispersion and absorption components of the anomalous scattering, respectively. The 
Δf’ has the same phase as fo whereas Δf” has a phase π/2 with respect to fo.   
 
The theoretical values of f’ and f” (Cromer and Liberman, 1970) can be computed and 
displayed using web interface such as http://skuld.bmsc.washington.edu/scatter.  
However, the extreme positions on the curves are affected by the chemical 
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environment of the heavy atom. Therefore, the values of f’ and f” must be determined 
using an X-ray fluorescence spectrum for the protein crystal under investigation. 
Figure 2-9 shows a theoretical anomalous scattering of selenium around its absorption 
edge.   
 
Figure 2-9 Anomalous scattering around selenium absorption K-edge 
The f’’ and f’ values are shown at the maximum and minimum values of ‘peak’ and 
‘inflection’, respectively. The regions far from the absorption edge are corresponding to high 
and low remote energies. (Diagram was generated from 
http://skuld.bmsc.washington.edu/scatter/AS_form.html).    
2.9.5 Breakdown of Friedel’s Law 
If atoms H exhibiting anomalous scattering coexist with the non-anomalous scattering 
atoms P, the structure factor of the Friedel’s pair can be written as: 
( ) ( ) ( ) ( )
( ) ( ) ( ) ( )
+ = + + + + +
− = − + − + −
PH P H H
PH P H H
F F F ' F "
F F F ' F "
i
i
   Equation 2-14 
Where, FP(+) and FP(-) are normal protein structure factors without anomalous 
scatter, FH’(+) and FH’(-) are real part of the anomalous structure factor (dispersive 
components) and iFH”(+) and iFH”(-) are the imaginary part of the anomalous 
structure factor (absorption components). 
  
Their contribution to the vector PH for each Friedel’s pair FPH(+) and FPH(-) can be 
represented as Figure 2-10. As a result, the intensities of a reflection hkl and its 
Friedel’s pair hkl  are no longer equal and therefore Friedel’s law is breached. The 
difference; FPH(+)2 – FPH(-)2, is known as the Bijvoet difference or the anomalous 
 52
scattering differences. These differences are useful in finding the anomalous 
scattering atoms in the crystal. 
  
Figure 2-10 Representation of the vector summation of the anomalous scattering 
Argand diagram representing the vector summation of the anomalous scattering contribution 
of atoms H to normal scattering of atoms P (Adapted from Blundell, 1976). (Blundell, 1976)  
 
2.9.6 Single- and multi-wavelength anomalous dispersion (SAD 
and MAD) 
If data sets at different wavelengths can be collected from a single crystal containing 
heavy atoms that give anomalous dispersion, then a MAD phasing experiment can be 
carried out to solve the structure. Tuneable synchrotron wavelengths enable the 
measurement to be made precisely at the chosen wavelengths. The advantage of MAD 
over SIR/MIR is that the non-isomorphism problem would not occur because the 
measurements of native and derivative structure factors are within one single crystal. 
For proteins that naturally contain a heavy atom such as metalloproteins, these heavy 
atoms can provide a source of anomalous dispersion. For proteins that lack heavy 
atoms, sulphur-Met can be replaced with seleno-Met in protein expression 
(Hendrickson et al., 1990). Moreover, the introduction of methionine into the protein 
by site-directed mutagenesis has been shown to allow phasing from a 
selenomethionyl-substituted protein crystal (Leahy et al., 1994). In general, the 
presence of one selenium atom in a protein containing less than 150 residues is 
sufficient to perform MAD (Hendrickson et al., 1990).  
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For MAD phasing, it is usual to collect three datasets at different wavelengths, known 
as ‘peak’ (λ1), ‘edge’ (inflection) (λ2) and ‘remote’ (λ3) around the absorption edge. 
At the ‘peak’ wavelength, the imaginary part f” should have largest value; at ‘edge’ 
wavelength, the real part of f’ should have its lowest value and at ‘remote’ 
wavelength, it is either longer (high remote) or shorter (low remote) than 
‘peak’/‘remote’, where f’ and f” are small (Figure 2-9). Wavelengths λ1 and λ2 
provide data rather similar to two isomorphous derivatives and λ3 functions as a 
parent. MAD can be applied as a special case for MIR by exploiting the anomalous 
scattering of existing atom. The first step in MAD is locating heavy atom position in 
the unit cell using anomalous difference Patterson function by coefficient: 
( ) ( )( )22Δ = + − −ano PH PHF F F    Equation 2-15 
Where ( ) ( )( 2+ − −PH PHF F ) represents Bijvoet difference amplitudes. The heavy 
atom vector map can then be generated to locate the heavy atom position. Accurate 
intensity measurement is important because the anomalous signal is relatively small 
compared to an isomorphous difference Patterson.   
 
Disadvantages of MAD are that multiple wavelengths have to be observed which 
increase the X-ray exposure time and the danger of radiation damage to the crystal. 
These disadvantages can be minimised if the crystal structure can be solved with a 
single wavelength. In SIR, reflection data from a single wavelength is used to provide 
strong phase information but both native and derivative crystals are required. SAD is 
an alternate method to solve X-ray structures containing an anomalous scatterer with a 
single dateset at an appropriate wavelength. In principle, any anomalous scatterer can 
be used for SAD. As for MAD, the first step in applying SAD is to locate the 
anomalous scatterers from an anomalous Patterson map using 
coefficients ( ) ( )
2
−F Fhkl hkl or by direct methods as in SHELXD (Schneider and 
Sheldrick, 2002; Uson et al., 2003) or SnB (Hauptman, 1997a; Hauptman, 1997b). 
This information is indicated in the Argand diagram shown in Figure 2-11a. The 
phase ambiguities (Figure 2-11b) generated from SAD is similar to SIR. In order to 
determine the correct enantiomorph, it is usual to refine both substructures and select 
the better of the two resulting electron density maps.       
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Figure 2-11 Illustration of SAD phasing 
(a) Argand diagram of SAD and (b) Harker construction for single wavelength SAD. The red 
lines in opposite directions indicate two possible phase angles as a result of FH”(+) and FH”(-) 
(diagrams modified from Drenth 2007) 
2.9.7 Molecular replacement 
Molecular replacement is a technique to solve the phase problem using a known 
structural model; namely phasing model; to calculate initial phases of an unknown 
structure. To successfully solve a new structure, the phasing model usually has a high 
percentage of amino acid sequence similarity (usually above 25%) and a similar 
polypeptide folding with the unknown protein. The main task of molecular 
replacement is to place the homologous model into a proper orientation and position 
in the target unit cell by 6 parameters (three rotational and three translational 
functions). Searching all 6 parameters simultaneously is computationally expensive. 
Luckily, some properties of the Patterson function can be used to define these 
parameters. The vectors of the Patterson map can be divided into two; intramolecular 
vectors (vectors between atom in the same molecule) and inter-molecular vectors 
(vectors between atoms in two molecules). Intramolecular vectors depend on the 
orientation of the molecule, not its position in the unit cell. These vectors are shorter 
than the inter-molecular vectors and are confined to a region near the Patterson map 
origin. When the molecule is rotated, these vectors rotate in the same direction as the 
molecule. The three parameters in describing orientation are the Euler angles (α, β, γ). 
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The model Patterson is rotated by an angle α around the original axis z, then by an 
angle β around axis y and followed by an angle γ around z axis, and then 
superimposed on the observed Patterson. A new orientation of the model Patterson 
will be generated. 
 
After the orientation of the phasing model has been determined by the rotation 
function, the next step is to place the model in the correct position by the translation 
function. The translation function can be performed using a cross-Patterson function. 
Cross-Patterson vectors in the Patterson map are derived from inter molecular vectors 
resulting from symmetry related models. A translation function is a calculation of 
correlation between cross-Patterson vectors of the model structure and the observed 
Patterson function.  
 
After the translation function, the structure factors of the phasing model (Fcalc) are 
calculated and compared with the observed structure factors (Fobs) by calculating an 
R-factor (Equation 2-16). The agreement between Fobs and Fcalc can also be compared 
using a correlation coefficient which is insensitive to the scaling factor. The phases of 
the unknown structure are estimated from the phase angles (αhkl) implied by the 
proper oriented and positioned phasing model which must be attached to the |Fobs| in 
order to calculate an electron density map. 
2.10 DENSITY MODIFICATION AND PHASE IMPROVEMENT  
The initial set of phase angles obtained from molecular replacement or experimental 
phasing contains errors and electron density maps calculated from these phases are 
often not readily interpretable. Density modification procedures aim to improve the 
electron density map and the phases by imposing some physical constraints on the 
electron density. A new set of amplitudes and phase angles will be calculated and 
therefore improve the electron density maps. The new amplitudes together with the 
experimental amplitudes are used to calculate appropriate weights for the combination 
of the new set of phases with the initial phases. The process is recycled until 
convergence. Three major techniques used in density modification are solvent 
flattening, histogram matching and non-crystallographic symmetry averaging 
[reviewed in Cowtan and Zhang (1999)].(Cowtan and Zhang, 1999) 
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Protein crystals contain a high percentage of solvent which contribute to a poor 
diffraction pattern because solvent components are not ordered. In the solvent 
flattening method, the electron density is divided into solvent and protein regions 
(Wang, 1985). The solvent region is modified and set to a mean value while the 
protein region of the map does not alter. The new electron density distribution is used 
to calculate structure factors and the phases of which are combined with the 
experimental phases. The combined phases and the observed structure factors are used 
to calculate an improved electron density map. The resulting map will look much 
flatter in the region assigned as ‘solvent region’. The process may be repeated 
cyclically until convergence. A complementary method to solvent flattening is 
histogram matching which may be applied to the protein region of the map (Zhang 
and Main, 1990). Given the resolution, overall B-factor, overall scale and other 
parameters, the expected form of histogram of electron density values can be 
predicted with precision. This method attempts to reassign all region of electron 
density within the protein volume to a value consistent with the predicted distribution 
of densities for the structure at the observed resolution. The modified electron density 
map can be used to calculate a new set of phase angles with improved accuracy, from 
which, an improved electron density map can be produced. The procedure is repeated 
until convergence.  
 
If there is more than one identical subunit in the asymmetric unit which is related by 
non-crystallographic symmetry (NCS), the electron density can be modified by NCS 
symmetry averaging. By knowing the type of NCS elements and the location of the 
molecules, the subunits can be moved to an identical orientation by a rotation function 
(namely self-rotation function) and the target and model Pattersons are summed and 
averaged. The averaged map displays a clearer image with higher signal-to-noise 
ratio. Algorithms to perform these three density modification techniques are 
implemented in DM (Cowtan, 1994) and RESOLVE (Terwilliger, 2003c)            
2.11 MODEL BUILDING  
The quality of electron density map resulting from phasing and density modification 
determines the model building strategies. Model building is the process of fitting a 
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realistic molecular model into the electron density map. For a good quality map 
(usually better than 2.5 Å) with clear protein main-chain connectivity and visible 
amino acid side-chains, the model can be built automatically using programmes such 
as ARP/wARP (Morris et al., 2003; Morris et al., 2004) and RESOLVE (Terwilliger, 
2003c). In brief, the strategy used in ARP/wARP involves identifying the peaks as 
free atoms (free-atom models) and the quality of phases is improved based on 
averaging techniques using the atomic coordinates. Protein elements can then be 
automatically recognised as peptide planes thus a partial atomic protein model can be 
built using the main-chain autotracing feature. The hybrid model (containing free 
atom and partial built model) is then refined using new stereochemical data and this 
improves the accuracy of the phases. Afterwards, the amino acid side-chain will be 
identified and sequence docking is performed onto the already built main-chain. After 
each cycle, new phases will be calculated and recombined with phases from the 
previous cycle to produce an improved map. These steps are iterated until no further 
improvement can be achieved. 
 
For poorer quality electron density maps (usually below 2.5 Å), the atomic picking 
approach in ARP/wARP becomes less efficient. Automatic building however can be 
still attempted using RESOLVE which claims still to function with data as low as 3 Å 
in resolution (Terwilliger, 2004; Terwilliger, 2003a; Terwilliger, 2003b). This 
approach builds the atomic model into the electron density map by linking predefined 
protein fragments selected from pre-compiled libraries. The building cycles are 
interspersed with refinement and density modification and the convergence output 
usually provides a good model for manual corrections using graphical programmes 
such as COOT (Emsley and Cowtan, 2004). 
2.12 REFINEMENT     
After a rather complete model is available its parameters have to be optimised in order 
to give a best possible fit to the crystallographic observations. The experimental data 
such as unit cell parameters, structure factor amplitudes, and experimental phases are 
considered as observations. For observations to be used in refinement, the consistency 
between them can be formally related with the variable model parameters such as 
atomic coordinates, B-factor, and occupancies through refinement functions like least 
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squares and maximum likelihood (Tronrud, 2004). In practice, the three positional 
parameters (x, y, and z) and only one isotropic B factor are refined for each non-
hydrogen atom. The number of reflections at a given resolution can be used to 
calculate the ratio of observations to parameters. For a poor ratio, additional 
observations such as geometrical restraints are incorporated into the refinement 
process. Constraints are applied when rigid geometry such as amides are involved and 
only the dihedral angles need to be varied. These assumptions are usually precise and 
valid for macromolecular structures (Engh and Huber, 1991). Restraints are applied 
when the stereochemical parameters such as bond lengths, bond angles, torsion angles 
and van der Waals contacts are allowed to vary around a standard value but penalties 
are applied when calculated values vary from target values (Drenth, 2007).      
2.13 MODEL VALIDATION 
The progress of model building and refinement should be monitored in a way that the 
observed and model structure factors converge in the final stages of structural 
refinement. There are several ways to inspect the accuracy of the final model. The 
conventional R factor (Rcryst) compares the observed structure amplitudes |Fobs| to 













    Equation 2-16 
The refinement is carried in the working set only and the free R-factor (Rfree) is 












     Equation 2-17 
Both R-factors should gradually decrease when Fcalc approaches Fobs. 
Stereochemically, the protein main-chain can be specified using two conformational 
angles, φ and ψ, for each Cα atom. All these angles can be displayed using a 
Ramachandran plot (Ramachandran et al., 1963). The final validation of the model 
can be carried out using programmes such PROCHECK (Laskowski et al., 1993), 




CHAPTER 3. PROTEIN PURIFICATION AND 
CHARACTERISATION 
3.1 INTRODUCTION 
The first step of macromolecular crystallisation is to obtain a homogenous and 
biophysically active macromolecule. The quantity and quality of mammalian protein 
required for crystallisation is difficult to achieve from mammalian cell culture system 
due to low expression profile and heterogeneity of mammalian cell extract. To highly 
express mammalian proteins, the coding gene can be incorporated into an E. coli 
expression vector. The gene expression is usually controlled by a T7 promoter located 
upstream of the RNA transcription site and the protein expression can be induced by 
addition of isopropyl-β-D-thiogalactopyranoside (IPTG). In order to obtain a 
homogenous sample, which is a prerequisite in growing macromolecular crystals, the 
protein can be purified with various biophysical (eg. salt precipitation and 
ultracentrifugation) and chromatographic techniques (eg. gel filtration, ion affinity 
and ion-exchange chromatography). The principle behind these techniques is to 
separate unwanted proteins from the protein of interest. Several methods are usually 
involved in order to obtain a homogenous sample.  
  
All plasmids carrying the human MeCP2 encoding gene were generous gifts from Dr. 
Robert J. Klose. The method for MeCP2 purification was initially described by Klose 
and Bird (2004) but has been modified in order to obtain a larger quantity of pure 
protein for initial crystallisation screening and biophysical characterisations. A 
combination of 3-step column chromatography has been used to purify MeCP2 
constructs produced using the BL21(DE3)pLys expression system. All constructs 
were C-terminally tagged with a 6xHis. Thus the first column was Ni-NTA/Talon 
metal affinity binding chromatography, which was followed by Sephacryl S200 gel 
filtration column, and lastly, Sp-Sepharose cation exchange chromatography. All 
protein required for co-crystallisation was freshly prepared and stored at 4 ˚C in a 
relatively high salt buffer (20mM HEPES pH7.6, 300mM NaCl). The sample is stable 
for 1-2 months. Purified protein intended for biophysical analysis can be stored at -80 
˚C in the presence of 10 % (v/v) glycerol for approximately 1-2 years.   
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3.1.1 Protein chromatography 
3.1.1.1 Immobilised Metal Affinity Chromatography  
All MeCP2 constructs were designed to have an uncleavable 6xHis tag at their C-
terminus, in which, the translationally premature proteins can be eliminated from co-
purification. Therefore, the first column used to separate the protein of interest from 
crude lysate was Ni-NTA or Talon affinity column. In principle, the Ni2+ is chelated 
onto a nitrilo triacetic acid (NTA) resin and protein sample is passed through a Ni-
NTA column (Figure 3-1). Recombinant protein containing the 6xHis-tag binds 
strongly to the charged resin through interactions between the immobilised metal ions 
(Ni2+ or Co2+) and the polypeptide tails whereas only a few naturally occurring metal 
binding proteins present in the sample will bind weakly to the charged resin. These 
weakly bound proteins can then be competitively removed with buffer containing a 
low concentration of imidazole which mimics the histidine side-chain. Other 
unspecifically bound proteins can be washed by increasing the imidazole 
concentration. Lastly, the 6xHis tagged recombinant protein can be eluted with a 
higher concentration of imidazole.       
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Figure 3-1 Immobilised metal affinity chromatography (IMAC) 
(a) Divalent cations such as Ni2+ or Co2+ are chelated onto a nitrilo triacetic acid (NTA) 
conjugated resin. Recombinant His-tagged protein binds strongly to the immobilised ions 
through interactions with the polyhistidine tag. (b) Protein sample is loaded onto the Ni-NTA 
column, Left panel; proteins with affinity for nickel bind to the column, Middle panel; the 
presence of low concentration of imidazole removes weak nickel binder and Right panel; 
strongly bound His-tagged protein is eluted from the column with high imidazole 
concentration.     
3.1.1.2 Sephacryl s200 gel filtration  
Since there were considerable contaminants co-eluted using IMAC, the second step 
was employed to purify MeCP2 constructs was Sephacryl S-200HR gel filtration 
chromatography. In principle, gel filtration is a purification technique that separates 
macromolecules based on molecular sizes. The stationary phase of the column 
contains a porous non-absorbing bead with a well-defined range of pore sizes (Figure 
3-2). Small proteins can enter the pores of the stationary phase whereas the larger 
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proteins are excluded from the pores and only can access into the mobile phase and 
thus they are eluted first.  
 
Figure 3-2 Size exclusion chromatography  
Protein sample is loaded onto the column containing porous matrix. Left panel shows that 
higher molecular weight proteins migrate faster than small size proteins which can enter the 
matrix pores. Middle panel; large proteins are eluted first before (right panel) lower molecular 
weight proteins.  
3.1.1.3 Sp-Sepharose cation exchange chromatography 
Ion exchange chromatography is a widely used method for protein purification. The 
ion exchangers are either positively (anion exchange) or negatively (cation exchange) 
charged matrices, onto which the charged molecules such as protein can be bound 
through electrostatic interactions (Figure 3-3). The ionic strength of electrostatic 
interaction between the charged matrix and the protein is highly dependent on the pH 
and the ionic strength of the surrounding environment as well as the net charge of the 
protein. At a low ionic strength environment, all proteins that have affinity for an ion 
exchanger will bind to the matrix. By increasing the ionic strength of the buffer using 
a higher salt concentration, salt ions will compete with the proteins for the matrix. 
Therefore, low affinity bound proteins will be eluted whilst the more tightly binding 
remains bound. The ionic strength can be increased continuously using a salt gradient 
onto the column. Proteins with higher affinity for the matrix can be sequentially 
eluted. An important feature of ion exchange chromatography is that the net charge of 
the protein can be manipulated by choosing an appropriate pH. Therefore, the binding 
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strength of the protein onto to the cation or anion exchanger can be changed by 
altering the buffer pH. As a result, a chromatographic condition can be established for 
a particular protein by tuning between pH and the ionic strength of a given buffer 
provided the pI of the protein is known. 
 
Figure 3-3 Ion exchange chromatography 
Protein sample is loaded onto the ion exchange column containing ion exchanger. Left panel; 
proteins bind to the charged matrix with different affinities depending on their net charge. 
Middle panel; introduction of a salt gradient gradually alters matrix surface charges and 
weakly bound proteins can be removed. Right panel; the matrix is fully negatively charged 
and all proteins are eluted at last.      
3.2 MATERIALS AND METHODS 
3.2.1 Transformation 
DNA plasmid was transferred into a microcentrifuge tube containing competent cells 
which were defrosted on ice. The transformation reaction was incubated on ice for 5 
min. The cells were then heat shocked for 30s at 42ºC on a heat block and 
immediately followed by a 2 min resting on ice. Room temperature SOC medium 
[2.5mM KCl, 10mM MgCl2, 10mM MgSO4, 0.4 % (w/v) glucose; 250 μl] was added 
into the transformation reaction and the mixture was incubated at 37 ºC for 1 h. The 
transformation reaction was then plated onto LB agar containing an appropriate 
antibiotic. 
 64
3.2.2 Protein expression and purification 
The recombinant plasmid encoding MeCP2 was transformed into strain 
BL21(DE3)pLys (Novagen) as above and plated onto LB agar supplemented with 
kanamycin (50μg/ml). A single colony was inoculated into 50ml LB medium and 
incubated at 37˚C overnight. An aliquot of 10ml overnight culture was transferred to 
1L LB medium containing kanamycin. Protein expression was induced by addition of 
IPTG with a final concentration of 1mM when cells grown at 37˚C reached mid-log 
phase (OD600nm = 0.6). Incubation was continued for an additional 6h at 30˚C before 
harvesting by centrifugation at 6000xg for 20min at 4˚C. Cells were resuspended in 
20ml lysis buffer (20mM Tris.HCl pH8.0, 500mM NaCl, 0.1% (v/v) NP40) 
containing a complete protease-inhibitor mix (Roche) and lysed by sonication using a 
sonicator (MSE Soniprep 150) at output 15X for a total of 2 min. Crude lysate was 
recovered by centrifugation at 64,000xg for 30min at 4˚C and loaded onto Ni-NTA 
(Novagen) column on an FPLC system (Applied Biosystems), washed with 12% 
(w/v) buffer N250 (20mM NaH2PO4, 300mM NaCl, 250mM imidazole), and protein 
was eluted with a gradient from 12-40 (w/v) % with buffer N250. Peaks fractions 
collected at approximately 25% N250 were shown by SDS-PAGE (18% w/v) to 
contain MBD protein. Positive fractions were pooled and concentrated to 2ml in a 
Vivaspin 50ml centrifugal concentrator with a 5 kDa cutoff. The protein was then 
applied onto a sephacryl-200 gel filtration column on an FPLC system which was pre-
equilibrated with GF300 (20mM HEPES pH7.6, 300mM NaCl). Fractions containing 
MBD protein, as analysed with SDS-PAGE, were pooled, and loaded onto a cation-
exchange SP-sepharose column and eluted with a linear gradient of 0-100% buffer 
CE500 (20mM HEPES pH7.6, 500mM NaCl). Peaks fractions were combined and 
dialysed overnight into CE300 (20mM HEPES pH7.9, 300mM NaCl). Protein was 
concentrated to ~30mg/ml with a Vivaspin centrifugal 5 kDa cut-off concentrator.  
3.2.3 Production of selenomethionyl MBD protein  
The recombinant plasmid was transformed into the methionine auxotroph 
B834(DE3)pLys. A single colony grown on an LB agar was used to inoculate 50ml 
LB containing 50μg/ml kanamycin. Cells were harvested from 40ml overnight culture 
by centrifugation at 5000xg for 15min at 4˚C and resuspended in 10ml minimal 
medium [2mM MgSO4, 2X M9 (37.4mM NH4Cl, 44mM KH2PO4, 95.8 mM 
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Na2HPO4 anhydrous), 90mM FeSO4.7H2O, 0.4 % (w/v) glucose, 1μg/ml vitamin 
mixture (riboflavin, niacinamide, pyridoxine monohydrochloride, and thiamine at 
1μg/ml each), selenomethionine (10 mg/ml) and the other 19 amino acids (4 mg/ml 
each), 50μg/ml kanamycin] prior to addition into 1L minimal media. Expression and 
purification of selenomethionyl protein was then performed as for the native protein 
except that 1mM of DTT was incorporated in all buffers.  
3.2.4 Measuring protein concentration 
This technique was developed based upon UV adsorption of aromatic amino acids. 
The protein concentration (mg/ml) is directly proportional to the protein absorbance at 
280nm. To determine protein concentration with possible nucleic acid contamination, 
the spectrophotometer was calibrated to zero absorbance with buffer solution (as 
blank). Then, A280nm and A260nm of the protein sample were taken and the protein 
concentration was calculated with equation below (Stoscheck, 1990): 
( ) ( ) ( )nmnm AAmlmgionConcentrat 26076.028055.1 ×−×=  Equation 3-1 
3.2.5 SDS-PAGE 
Proteins were separated by SDS-PAGE using a discontinuous buffer system 
(Laemmli, 1970). SDS-polyacrylamide gels were prepared by using the Mini Protean 
III apparatus (BioRad). Resolving gel solution [15% (w/v)] containing dH2O (3.75 
ml), 4X lower buffer [1.5M Tris-HCl (pH8.6), 0.4% (w/v) SDS; 3.75ml], 
bisacrylamide solution [30% (w/v) acrylamide, 0.8% (w/v) bisacrylamide; 7.5ml], 
10% (w/v) ammonium persulphate (93.8 μl) and TEMED (BioRad; 10μl) was 
dispensed into the assembled gel apparatus and the solution surface was levelled with 
isobutanol (~100μl). The gels were allowed to polymerise for 40 min and the 
isobutanol layer was removed via absorption with a 3MM Whatman filter paper. The 
stacking gel solution (5% w/v) containing H2O (5.84 ml), 4X upper buffer [0.5 M 
Tris-HCl (pH6.8), 0.4% (w/v) SDS; 2.5ml], bisacrylamide solution [30% (w/v); 
1.66ml], ammonium persulphate [10% (w/v); 66.6 μl) and TEMED (BioRad; 7 μl) 
was then layered onto the resolving gel and a plasmid comb was carefully inserted 
into the stacking gel solution and the gel was allowed to polymerise for 45 min.  
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Protein samples (5 μl each) were mixing with 2X loading buffer (62.5 mM Tris-HCl 
(pH 6.8), 25% (v/v) glycerol, 2% (w/v) SDS, 0.01% (w/v) bromophenol blue, 50mM 
DTT; 5 μl] and boiled for 5 min.  The boiled sample and appropriate protein markers 
were then electrophoresed with Tris-glycine [0.025 M Tris (pH8.3), 0.192 M glycine, 
1 % (w/v) SDS] at a constant voltage (200 mV) until the dye front reached the bottom 
of the resolving gel (~1 h). The gels were then stained with staining solution [0.25% 
(w/v) Coomassie blue R-250, 45% (v/v) methanol, 10% (v/v) acetic acid] for 15 min 
at room temperature with agitation and destained with destaining solution [10 % (v/v) 
methanol, 10 % (v/v) acetic acid] until the band become clear (~2-3 h). 
3.2.6 Western blot 
Immunoblotting was performed using the semi-dry Western blot method (Towbin et 
al., 1979). The polyacrylamide gel containing the fractionated proteins was 
equilibrated in transfer buffer [25 mM Tris-HCl, 190 mM glycine (pH 8.0), 20% (v/v) 
methanol)] for 10 min at room temperature. Meanwhile, a piece of nitrocellulose 
membrane and 6 pieces of Whatman 3MM filter paper, approximately the size of a 
gel, were soaked in the transfer buffer in a separate container for 5 min at room 
temperature. The filter papers (3 pieces) were placed on the lower electrode (anode) 
of the semi-dry blotter (Trans-Blot® SD, BioRad) and the air bubbles were removed 
by rolling a glass rod on top of the papers. The pre-soaked nitrocellulose membrane 
was placed on top of the filter papers and the equilibrated gel was transferred 
carefully onto the membrane. Another 3 pieces of filter paper were placed on the top 
of the gel and the air bubbles were removed as above. The upper electrode (cathode) 
and the safety cover were then assembled. Afterwards, a constant current (60mA) was 
applied for 1-2 h to transfer the proteins onto the nitrocellulose membrane. Lanes 
containing the molecular weight markers were cut from the membrane and stained 
with staining solution for 1 min and immediately soaked in destaining solution for 1 
h. The membrane was blocked with milk diluent (KPL, USA), which was 10-fold 
diluted in dH2O, for 2 h at room temperature. The nitrocellulose membrane was then 
washed 3 times with TBST [TBS (pH 7.6) supplemented with 0.05% (v/v) Tween 20] 
for 5 min intervals. The nitrocellulose membrane was incubated with mAb anti-His 
(Qiagen) (1:5000 diluted in TBST) for 1 h at room temperature with gentle agitation. 
The membrane was then washed again with TBST, which was followed by incubation 
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with alkaline phosphatase conjugated goat anti-mouse antibody (1:5000 diluted in 
TBST) for 1 h at room temperature. The immunoblotted bands were developed with 
BCIP/NBT in alkaline phosphatase buffer [100mM Tris-HCl (pH 9.5), 100mM NaCl, 
5mM MgCl2]. Colour development was terminated by incubating the nitrocellulose 
membrane with dH2O and the developed membrane was allowed to dry at room 
temperature.  
3.2.7 Site-directed mutagenesis  
A pair of mutagenic primers was designed to contain the desired point mutation. The 
plasmid bearing the native MBD coding region was used as a template for generation 
of mutant strands using PCR with PfuTurbo DNA polymerase according to the 
manufacturer’s instruction (QuikChange, Stratagene). The parental strands were then 
digested with Dpn I restriction enzyme and the treated plasmid was transformed into 
XL1-Blue supercompetent cells and plated onto LB agar plate containing kanamycin. 
After overnight incubation, single colonies were picked and inoculated into 10ml LB 
supplemented with kanamysin. Plasmids were then isolated with a Miniprep 
Extraction kit (Qiagen) and the clones were verified by DNA sequencing. Mutant 
plasmids was then transformed into B834(DE3)pLys cells and selenomethionyl 
mutant protein was expressed and purified as described above. 
3.2.8 End-labelling DNA with gamma 32P-dATP 
All oligonucleotides for EMSA were synthesized by Sigma-Genosys and purified by 
desalting. The labelling reaction containing DNA duplex (50ng), T4 polynucleotide 
kinase (New England BioLabs) (20 units); γ32P-dATP (Amersham Biosciences) (1 
μl); 10X T4 polynucleotide kinase reaction buffer (0.7 M Tris-HCl, 100 mM MgCl2, 
50 mM DTT; 3μl) was incubated at 37ºC for 1 h. Free nucleotides in the labeling 
reaction were removed with nucleotide removal kit (Qiagen) according to the 
manufacture instruction.  
3.2.9 Electrophoretic mobility shift assay (EMSA) 
Binding reactions containing 5% (w/v) ficoll-400, 20mM HEPES pH7.9, 100mM 
NaCl, 25ng/ml polydG-dC.polydG-dC (Amersham Biosciences) competitor DNA and 
recombinant protein were pre-incubated at room temperature for 10 min. Radio-
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labelled probe DNA was then added and the reaction was continued for a further 25 
min at room temperature. Sucrose tracking dye [(40% (w/v) sucrose, 0.01% (w/v) 
bromophenol blue, 0.01% (w/v) xynole xylane blue)] were added and the reaction 
loaded on to an 8% (w/v) native polyacrylamide gel which had been pre-run at 240V 
for 30min at 4˚C in 0.5X TBE. The samples were electrophoresed for 3 h under the 
same condition. Gel was transferred to a 3MM Whatmann paper and dried for 1 h at 
80˚C. Dried gels were exposed to Phosphor Imager screen overnight and developed 
with the Storm machine the following day.   
3.2.10 Mass spectrometry  
The purified protein was diluted with ammonium phosphate buffer [50mM 
(NH4)2PO4, pH7). Electrospray ionisation mass spectrometry analysis was carried out 
on a single quadropole mass spectrometer (Micromass, Wyntheshawe, UK) equipped 
with a Z-spray electrospray ionisation source. Spectra were analysed with a Mass 
Lynx v3.5 (Micromass, Wyntheshawe, UK). 
3.2.11 Gel filtration analysis 
The protein and DNA mixture containing the construct 77-167 and 20 bp BDNF 
fragments in a ratio of 1:1.3 was analysed with Superdex 75 HR 10/30 column on an 













3.3 RESULTS AND DISCUSSION  
MeCP2 domains being expressed and purified were constructs 1-205, 78-205 and 77-
167 (numbering according to human MeCP2 amino acid sequence) (Figure 1-10 and 
Figure 3-4). The largest construct comprises of the MBD domain flanked by the N-
terminal region (amino acid 1-76) of MeCP2 and a region composed of the AT hook 
motif (185GRGRGRPK192) at its C-terminus. Construct 78-205 contains the MBD 
domain and the AT hook motif at its C-terminus and the smallest construct; 77-167; 
bearing only the MBD domain. To facilitate protein purification with IMAC, an 
uncleaveable 6xHis tag was genetically fused to the C-terminus of each construct.   
 
Figure 3-4: MeCP2 constructs used in this study  
1-205, the MBD is flanked by the N-terminal region of MeCP2 consisting of 76 amino acids 
and the AT hook (amino acid sequence 185GRGRGRPK192) at the C-terminal region. 78-205, 
comprises of MBD domain and the AT hook, and 77-167, contains only the MBD domain. 
All constructs carrying a 6x His tag at their C-terminus. 
3.3.1 Purification of construct 1-205 
The largest construct was purified using 3-step chromatography: (i) IMAC with Talon 
(BDH) or Ni-NTA resin, (ii) size exclusion chromatography with Sephacryl s200HR 
and (iii) cation exchange chromatography with SP-sepharose. The elution profile 
using SDS-PAGE analysis after IMAC (Figure 3-5a) revealed that the dominant 
protein ran approximately 32 kDa on-gel corresponding to the construct 1-205 and co-
eluted with several higher/lower molecular weight species. These bands might be the 
breakdown products of the recombinant protein or the host cell proteins. These 
impurities however can be reduced by fractionation using sephacryl s200HR. Proteins 
with molecular weight larger or smaller than 32 kDa are separated from the dominant 
band (Figure 3-5b). Subsequently, most of the remaining impurities can be removed 
by SP-sepharose chromatography (Figure 3-5c). Although the elution profile of SP-
sepharose showed traces of impurities, the protein is approximately 95% pure.   
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Figure 3-5 SDS-PAGE analysis of construct 1-205 
(a) Fractionation of Ni-NTA column showing that the flow through (lanes 1 – 5) contains 
only traces of protein corresponding to 32 kDa while eluted fractions (lanes 6 – 9) contain 
mainly this species. (b) Fractionation of Sephacryl s200HR showing that the contaminants 
larger or smaller than 32kDa were separated from the dominant band and (c) Elution profile 
after SP-sepharose indicating that the construct 1-205 is approximately 95% pure. Lane M, 
protein ladder.  
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3.3.2 Construct 78-205 
Similarly, construct 78-205 was also purified with 3-step column chromatography as 
the largest construct 1-205. Eluted fractions analysed using SDS-PAGE contain a 
dominant band, approximately 16 kDa, which coexists with other contaminants 
(Figure 3-6a). After size exclusion chromatography with Sephacryl s200HR, most of 
these impurities were separated into early and later fractions of the predominant band 
(~ 16 kDa) (Figure 3-6b). The third column however removed almost all 
contaminants at least to an undetectable level (Figure 3-6c). The same strategy was 
used to purify the mutant proteins (T158M/A/S) for mutational analysis.  
3.3.3 Construct 77-167 
To purify the shortest construct used in this study, 2-step column chromatography was 
sufficient to give highly pure protein for crystallisation and biophysical analysis. The 
SDS-PAGE profile from fractions eluted from Ni-NTA/Talon IMAC shows a 
reasonably pure predominant band in between 6.5 and 16.5 kDa together with other 
impurities (Figure 3-7a). The second column using Sephacryl s200HR exclusively 
removed all contaminants (Figure 3-7b). For mutational analysis, the mutants created 
using site directed mutagenesis approach were T158M, T158S, T158A and Y123F of 
77-167. All mutants were purified using the same method.  
 
In order to solve the phase problem, seleno-Met derivatives (wildtype and A140M of 
77-167) were overexpressed and purified. All buffers used were supplemented with 
1mM DTT in order to prevent oxidation of selenium attached covalently to the 
protein. Unfortunately, not all IMAC resins are compatible with reducing agent such 
as DTT or β-mercaptoethanol. In the presence of 1mM DTT, Ni2+ attached to NTA 
resin remained in the oxidised form whereas Co2+ in Talon is reduced to thiol 
complexes which destablises the resin. Therefore, Ni-NTA IMAC was the method of 
choice for purification of seleno-Met derivatives. An additional ‘wash’ step is 
required after sample loading to remove the weak binders. The rest of the purification 
was exactly the same as the wild type protein except in the presence of 1mM DTT. 
The purified proteins were analysed with mass spectrometry and Western blotting. 
Gel shift assays were carried out to characterise their DNA binding capability and to 
provide a rough Kd determination.    
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Figure 3-6: SDS-PAGE analysis of construct 78-205 
(a) Fractionation of Ni-NTA column showing that the flow through (lanes 1 – 3) contains 
only traces of protein corresponding to 16.5 kDa while eluted fractions (lanes 4 – 10) contains 
mainly this species. (b) Elution profile after Sephacryl s200HR showing that the contaminants 
larger or smaller than 16.5 kDa were separated from the dominant band and (c) Elution 
profile after SP-sepharose indicating that the construct 78-205 is above 95% pure. Lane M, 




Figure 3-7: SDS-PAGE analysis of construct 77-167 
(a) Elution profile after Talon column showing that all fractions contains a protein with 
molecular weight in between 6.5 to 16.5 kDa and (b) Elution profile of Sephacryl s200HR 
showing that the construct 77-167 is nearly 100% pure. Lane M, protein ladder.  
 
3.3.4 Preliminary characterisation 
3.3.4.1 Mass spectrometry  
SDS-PAGE was initially used to estimate the molecular weight of MeCP2 contructs. 
The molecular weight estimated from the SDS-PAGE, however, could not represent 
the actual molecular mass of the proteins. These on-gel estimated values (Table 3-1) 
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are distinct from theoretical molecular weight. The primary sequence of constructs 
77-167, 78-205 and 1-205 contain 18.5% (18 residues), 22.4% (30 residues) and 21% 
(44 residues) positively charged amino acids (Arg and Lys), respectively. The net 
positive charged of constructs 78-205 and 1-205 is enriched by Arg-rich C-terminus 
particularly the AT hook of MeCP2. Positively charged of construct 1-205 is further 
enhanced by 13 Lys residues at the N-terminal region of MeCP2. The high content of 
basic amino acid leads to a predicted isoelectric point approximately 10. The high 
concentration of positively charged amino acids may account for the anomalous 
mobility of MeCP2 constructs in SDS-PAGE. Therefore, mass spectrometry was 
carried out to determine the accurate mass of these constructs. In principle, proteins in 
solution are transformed into ions (as an intact ionised molecule) in vacuo using an 
ion source and these ions are separated by their mass-to-charge ratio (m/z) in an 
electric or magnetic fields. These ions can then be analysed quantitatively and 
qualitatively by their m/z values and abundance.    
Table 3-1 Mass spectrometry  
Molecular weight / Da 
Construct  pI 
















Theoretical molecular weight and pI values of these constructs were calculated using the 
Protparam tool at http://www.expasy.ch/tools/protparam.html. A pI value is a pH where the 
protein has a net charge equal to zero. 
3.3.4.2 Western blot 
Western blot was carried out to analyse the purity of each purified and concentrated 
MeCP2 construct. Proteins were separated on an SDS-PAGE gel, transferred onto 
nitrocellulose membrane and immunoblotted with anti-His monoclonal antibody. 
Predominant bands corresponding to 12 kDa, 16 kDa and 32 kDa (Figure 3-8; lane 1, 
2 and 3), respectively, were observed in lanes containing 77-167 (lane 1), 78-205 
(lane 2) and 1-205 (lane 3) construct preparations. These bands were successfully 
immunoblotted with mAb anti-His and therefore might correspond to 6xHis-tagged 
recombinant MeCP2 domains. However, a small amount of other bands below/above 
the predominant ones; which can be detected with mAb anti-His; have also been 
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observed. They were thought to be the mildly truncated MeCP2 domains formed in 




Figure 3-8: Western blot of concentrated MeCP2 proteins.  
The separated proteins were stained with coommasie blue (lanes M – 3), and transferred to a 
nitrocellulose membrane and blotted against mAb anti-His (lanes 4 -6).  
 
3.3.4.3 Electrophoretic mobility shift assay (EMSA) 
The first step toward the co-crystallisation of DNA-protein complexes is to select a 
stable DNA-protein complex formed under a physiological condition. The DNA-
protein complexes can then be analysed using various methods such as EMSA, filter 
binding assays and fluorescence binding assay to characterise their binding capability. 
Oligonucleotides (probe S1 and S2) used in this study were chosen from methyl-
SELEX experiments reported in Klose et al. (2005). Both DNA sequences have been 
truncated to 19 bp to contain a central methyl-CpG pair and an AT run. The AT run of 
these sequences is located 3 bases apart from the methyl-CpG. In addition, a 19 bp 
DNA fragment corresponding to the BDNF promoter was also chosen for a 
preliminary DNA-protein binding assay because this DNA fragment also contains a 
methyl-CpG and an AT run. Most importantly, the BDNF promoter is an endogenous 
MeCP2 binding target (Chen et al., 2003; Martinowich et al., 2003). The methyl-CpG 
is separated from the AT run by only a single base pair. The truncation of these 
oligonucleotides to a relatively short length is coherent with the purpose to design a 
rational length for DNA-protein co-crystallisation. The MeCP2 constructs used in this 




The EMSA was carried out with two different protein concentrations; at 500 and 
1000nM; and DNA probes labelled with γ-P32 dATP. Figure 3-9 shows that all three 
oligonucleotides bind tightly to the shortest construct 77-167 over 78-205 and 1-205. 
The smearing effect in the lanes containing 78-205 and 1-205 indicates that the DNA-
protein complexes were not stable and dissociated while migrating in the 
polyacrylamide gel. Among the DNA duplexes, probe S1 demonstrates the strongest 
protein binding capability, followed by S2 and BDNF fragments. A possible 
explanation for the weak binding of 1-205 is that the flexible long N-terminal tail 
interrupts the methyl-CpG binding region of the MBD domain and the DNA is 
hindered from binding efficiently onto its target site. In the absent of the N-terminal 
region, only a small amount of 78-205 was involved in methylated DNA binding. The 
length of the DNA might not be long enough to accommodate the C-terminal region 
(including the AT hook). One possibility is that in the absence of its cognate binding 
region the AT hook might be relatively unstructured and this destabilises the DNA-
protein association. The DNA-dependent stabilisation of the AT hook indicates a 
longer DNA is required to form a stable DNA-protein complex. The presence of an 
AT run on the DNA might influence the groove width which is possibly involved in 
protein-DNA interaction. Together with the DNA primary sequence, the major 
difference between the 3 methylated DNA is the gap between the methyl-CpG and the 
AT run. It is unknown how this disparity influences the DNA binding.    
 
Although the protein binding efficiency of oligonucleotides S1 and S2 is higher than 
the BDNF fragment, the later was chosen to carry out the initial co-crystallisation 
screening. The main reason is that BDNF fragment is part of the BDNF promoter 
region, which has been identified as an endogenous target gene of MeCP2 (Chen et 
al., 2003; Martinowich et al., 2003). Artificially selected S1 and S2 using the methyl-
SELEX experiment might not correspond to a biologically active DNA sequence. 
However, the methyl-CpG and the newly identified AT run characteristics explained 
the DNA binding specificity of MeCP2 and highlights the importance of the AT run 
in MeCP2 cognate binding targets. Out of the three MeCP2 constructs, 77-167 forms 
the most stable complex with the BDNF fragment. Therefore, this construct was 

































































































































































































































































































3.3.5 Quantitative EMSA 
To measure the binding affinity, a quantitative EMSA analysis using 77-167 and 
probes S1, S2 and BDNF fragments was carried out (Figure 3-10). Larger constructs 
78-205 and 1-205 were excluded from this assay due to their weak binding affinity to 
the DNA fragments. The Kd values for the binding data were calculated with non-
linear hyperbolic curve fitting method as described by Valinluck and coworkers 
(Valinluck et al., 2005; Valinluck et al., 2004). Assuming that the MBD of MeCP2 
binds to the methylated DNA substrate as a monomer (Nan et al., 1993), the 
equilibration of MBD and methylated DNA can be written as: 
[ ] [ ] [ ]E O EO+  
Where [E] is unbound MBD concentration, [O] is unbound duplex concentration, and 
[EO] is MBD-DNA complex concentration. Using this single binding scheme, the 






=        Equation 3-2 
The equation can be rearranged to give: 
[ ] [ ][ ]
dK EOO
E
=     Equation 3-3 
The fraction bound was plotted as a function of protein concentration. The Fraction 
duplex bound can be calculated as: 
Fraction duplex bound = [ ][ ] [ ]OEO
EO
+
  Equation 3-4 
When unbound protein is in excess ([E] > [O], then [E]total – [EO] = [E] ≈ [E]total; 
where [E]total is the total MBD concentration including the bound and unbound 
protein. Substitution of Equation 3-3 into Equation 3-4 yields: 







   Equation 3-5 
 The dataset was fitted into the equation by non-linear regression using Grafit 
software. Among the three methylated DNAs, methylated S1 shows the highest 
affinity (70.9 nM) for construct 77-167, which is approximately 15-fold higher than 
that of the BDNF fragments (Table 3-2). The poorly fitted curve of the BDNF 
fragment roughly determined the Kd at 1μM under this assay condition. Among these 
DNA, duplex S1 binds strongest to MBD, which followed by S2 then BDNF.           
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Table 3-2 Kd of construct 77-167 binding to 19 bp DNA diplex   
Duplex  Kd (nM) 
BDNF  1039.5 ± 352.0 
S1 70.9 ± 25.6 
S2 88.5 ± 33.3 
 
These Kd values determined in this experiment can only be used as a guide to 
distinguish the relative binding affinity between the DNA fragments. These values are 
inappropriate to represent the actual Kd. Several criteria were not fulfilled in this Kd 
determination. These include: (i) the temperature was not kept constant throughout the 
experiment. The DNA-protein mixtures were incubated at room temperature to 
promote complex formation but electrophoresis was performed at 4 ˚C; (ii) re-
association of DNA-protein cannot occur once the mixtures migrated into the gel 
because the unbound DNA, unbound MBD and the complexes travelled at different 
rates. Thus, association and dissociation equilibrium cannot be achieved in EMSA 
and; (iii) the binding curve for the BDNF fragment has not reached a saturation state 
at the highest protein concentration and; (iv) only one measurement was taken. The 
actual Kd can be determined in a more precise way using isothermal titration 
calorimetric (ITC) and surface plasmon resonance (SPR). 
 
Several binding affinities of symmetrically methylated DNA and MeCP2 primarily 
using EMSA have been reported (Free et al., 2001; Nan et al., 1997; Valinluck et al., 
2005; Valinluck et al., 2004). Using the MBD fragment of MeCP2 and 27 bp 
methylated DNA, a Kd value of 15 nM has been determined whereas the binding 
affinity reduced to 1 μM with methylation free DNA (Valinluck et al., 2005; 
Valinluck et al., 2004). These reports focused on the recognition of symmetrical 
methyl-CpG by MeCP2 MBD domain under various experimental conditions. Before 
the finding of the AT run requirement, the importance of flanking DNA sequences 
was down-weighted. Based on this recent discovery (Klose et al., 2005) and newly 
identified MeCP2 target genes such as BDNF, and Dlx6 (both contain A/T bases close 
to methyl-CpG), new assays must be developed to quantitatively measured the 




Figure 3-10 Kd determination 
Left panel; binding of (a) BDNF, (b) S1 and (c) S2 duplexes to varying concentrations of 77-
167 from 0 to 3 μM.  
Right panel; non-linear regression of the plots of percentage binding of (a) BDNF, (b) S1 and 
(c) S2 duplexes versus concentration of construct 77-167. The x-axis represents MBD 
concentration (nM) and the y-axis represents fractions of probes binding. m+ and m- indicate 
methylated and unmethylated probes, respectively. 
 
 81
3.3.6 Gel exclusion analysis 
In order to prepare a DNA-protein complex for co-crystallisation, construct 77-167 
and 20 bp BDNF fragments were mixed in a ratio 1:1.3 in buffer CE100 (20mM 
HEPES pH7.6, 100mM NaCl). The mixture was incubated for 30 min at room 
temperature to promote DNA-protein complex formation. To ensure the complex 
formation, a diluted sample was analysed using a Superdex 75 HR10/30 column. 
Figure 3-11 shows the elution profile of the gel exclusion analysis. A total of two 
peaks were observed with the first peak height approximately 7.7-fold higher than the 
second peak. Because the DNA in the mixture was 30% in excess, the result 
suggested that all proteins molecules were complexed with the added DNA while the 




Figure 3-11 Gel exclusion analysis 
The DNA-protein complex was prepared by mixing the MBD and BDNF fragment in 1:1.3 
ratio. Peak 1 was eluted immediately after the void volume of Superdex 75 HR 10/30 column 
(7.7 ml) followed by peak 2. According to the calculated ratio, peak 1 and peak 2 correspond 
to the DNA-protein complex unbound duplexes as the ratio of height of these peaks is 





MeCP2 domains (77-167, 78-205 and 1-205) were successfully expressed and 
purified. Construct 77-167 can be purified using Ni-NTA column and gel filtration 
(Hi-prep 16/10 Sephacryl 200HR) to achieve homogeneity. In contrast, constructs 78-
205 and 1-205 require an additional step (SP-sepharose) to achieve purify greater than 
90%. Preliminary characterisation using a gel shift assay demonstrated that the 
smallest construct binds strongly to methylated probes S1 and S2 (Methyl-SELEX 
probes) but relatively weaker to methylated BDNF sequence. By considering the 
chances to crystallise a protein-DNA complex, the smallest construct 77-167 (MBD 
domain) and a short fragment of BDNF promoter sequence, which has been identified 
as the MeCP2 target gene, were chosen for co-crystallisation screening. The Kd values 
obtained in this study are relative values of DNA binding affinity between probes and 
cannot represent the actual dissociation constant because several requirements are not 
fulfilled. Gel filtration analysis using Superdex 75 HR 10/30 column shows that the 
ratio of DNA-protein complex to free DNA is approximately 1:0.3, which clearly 
represents the actual components in the protein-DNA mixture. As a result, DNA-
protein co-crystallisation trials were carried out using various fragments of BDNF 


















CHAPTER 4. CRYSTALLISATION AND STRUCTURAL 
DETERMINATION 
4.1 INTRODUCTION 
To crystallise a DNA-protein complex, there are more considerations than for the case 
of crystallising the protein alone. In addition to the general considerations for protein 
sample preparation such as buffer choice, concentration and purity, the experimenter 
must consider the length and terminal nucleotides of the DNA and how the complex is 
formed. Double stranded DNA has a strong preference to stack end-to-end in the 
crystal packing, therefore, the precise length of the DNA fragment and the nature of 
the stacking interactions between fragments are important determinants of the unit 
cell and crystalline order. The length of DNA used in the DNA-protein complex co-
crystallisation is usually beyond the minimal DNA sequence recognised by the 
protein. Co-crystallisation trials can begin from the minimum DNA sequence required 
for protein binding and gradually increase the number of sequences. Lengths of the 
DNA particularly successful in crystallisation trials usually correspond to the 
multiples of integral or half integral turns of the DNA.  
 
Another crucial consideration is the composition of DNA ends. Single or double 
complementary overhanging bases at either the 3’ or 5’ end are commonly included to 
promote end-to-end stacking of oligonucleotides in the crystal although blunt-ended 
oligonucleotides have been reported in a number of successful cases. Among the 
different types of overhangs that have been successfully used, the most frequent one is 
a single 5’ overhanging A on one strand and a 5’ T overhanging on the other. The 
DNA used in crystallisation can be synthesised on a 1 μmole scale and dissolved to 
give 1 mM duplexes. Single stranded DNA should be purified by reversed-phase 
HPLC to purity greater than 90%.  
 
The DNA-protein complex is prepared by adding the concentrated protein solution 
directly but slowly to the DNA solution. It is usual to have a slight excess of DNA 
(typically 10 to 20 %) rather than using a 1:1 ratio of DNA to protein. Preliminary 
characterisations such as band shift assay should be carried out to determine the actual 
stoichiometry of the mixture if this has not been done in previous biophysical assays.  
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As mentioned in Chapter 1, the NMR established MBD domain of MeCP2 displays a 
wedge shape structure composed of four anti-parallel β-strands and one α-helix 
(Wakefield et al., 1999). Some residues located at loop L1 (Gly114 and Ala117), β3 
(Ala131), loop L2 (Arg133), α1 (Lys135, Val136), and the C-terminal region 
(Phe157, Thr160 and Arg162) showed amide proton chemical shift changes upon 
addition of methylated DNA. However, none of the amino acids of β2 and β3 undergo 
significant chemical shift changes. Recently, Klose et al (2005) discovered that an AT 
run adjacent to the methyl-CpG is required for high affinity binding of MeCP2. 
Interestingly, endogenous target genes such as BDNF and Dlx6 also contain AT run(s) 
close to the mCpG (Klose et al., 2005).  In contrast to MeCP2, MBD1 does not 
require an AT run to promote tight DNA binding (Klose et al., 2005). Therefore, the 
binding specificity of MeCP2 is distinct from MBD1. Moreover, mutations of MeCP2 
are responsible for RTT with higher than 50% occurrence clustered within the MBD 
domain (Kriaucionis and Bird, 2003). Therefore, a high resolution structure of MeCP2 
in complex with methylated DNA is required to explain the molecular details 
particularly the methyl-CpG recognition in the major groove of the DNA.  
 
The first part of this chapter describes the co-crystallisation of the MeCP2 MBD 
domain in complex with a 20 bp DNA fragment of promoter III (nucleotides -108 to -
90) of the BDNF gene which contains a central methyl-CpG pair and an AT run. The 
second part of this chapter presents the strategies used in solving the X-ray structure 
of MeCP2 MBD complexed with methylated DNA. Initially, cocrystals of wild type 
MeCP2 MBD-DNA complex were obtained but an X-ray structure was not solved due 
to insufficient phase information. Later, an MBD mutant containing A140M was 
created by site-directed mutagenesis. seleno-methionyl protein was prepared and 
crystals containing an additional SeMet (A140SeMet) were successfully grown.  
From this crystal, the additional selenium signals enable several MAD datasets to be 
collected at station BM14, ESRF, Grenoble, France. However, the crystal structure of 
the MeCP2 MBD domain in complex with methylated DNA was eventually 
determined with the single-wavelength anomalous dispersion (SAD) method using the 
peak dataset of the selenium derivative.   
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4.2 MATERIAL AND METHODS 
4.2.1 Nucleic acid preparation  
Various DNA constructs were designed based on the  DNA sequence of the mouse 
BDNF promoter (Chen et al., 2003; Martinowich et al., 2003) which is situated 
upstream at -148 bp from the transcription start site of an endogenous MeCP2 target 
region. All oligonucleotides for cocrystallisation were synthesized and HPLC purified 
by Oligos Etc. (Wilsonville, Oregon, USA). The lyophilized oligonucleotides were 
resuspended in TEN buffer (10mM Tris-HCl pH8.0, 0.5mM EDTA, 100mM NaCl) to 
a concentration of 2mM. Complementary strands were mixed in equimolar amounts 
and annealed by heating to 368K and then cooled to room temperature over 3 hours.  
4.2.2 DNA-protein complex preparation  
The complex of DNA-protein was prepared by mixing 1:1.3 ratio of protein to DNA 
in CE100 (20mM HEPES pH7.9, 100mM NaCl) and the mixture was incubated at 
room temperature for 30 min to promote complex formation. The final concentration 
of the DNA and protein were 260 μM and 200 μM, respectively. 
4.2.3 Hanging drop vapour diffusion 
An equal volume of the DNA-protein complex and crystallisation solution were 
mixed and equilibrated against the crystallisation solution using a hanging drop 
vapour diffusion method (see details in Results and Discussion). Rectangular crystals 
with maximum dimension of 0.5mm grew within 3 days. The crystals were flash 
frozen in liquid nitrogen. Most crystals diffracted to ~3Å maximum resolution, but 
soaking of manganese chloride (10mM) for 15 min successfully improved the 
resolution to 2.5Å with a significant change in unit cell dimensions.  
4.2.4 Microseeding/streak seeding  
A cluster of crystals was crushed with a rounded glass rod after transferring to a 
crystallisation reagent with higher precipitant concentration. If necessary, the seed 
stock was serially diluted into the same mother liquor. A cat whisker was then drawn 
across the seed stock and streaked onto a pre-equilibrated drop containing an equal 
volume of sample and crystallisation reagent, in which, the precipitant concentration 
 86
should not promote spontaneous nucleation. Observation was then carried out the 
following day. Alternatively, crystals in the drop were gently touched with a cat 
whisker and streak seeded onto overnight equilibrated drops. Newly formed crystals 
were usually visible within 24 h. 
4.2.5 Manganese soaking 
A crystal of A140SeMet in complex with methylated DNA was transferred from the 
mother liquor to a temperature pre-equilibrated solution containing 35% (w/v) PEG 
2000, 200mM ammonium acetate, 10mM manganese chloride and 50mM sodium 
cacodylate pH6.5 and incubated for 15 min before flash frozen in liquid nitrogen.   
4.2.6 Data collection and processing 
Data collections were carried out at station BM14, ESRF, Grenoble, France or station 
MAD10.1 SRS, Daresbury, UK. All data presented in Table 4-3 were collected at 
100K. MAD data were collected from 3 wavelengths corresponding to selenium peak 
(PK), inflection point (IP), high remote (HR). SAD data for iodine were collected at 
Station MAD10.1 SRS Daresbury and Station BM14 ESRF Grenoble, France to 
maximise the anomalous signal of iodine atom. All data were indexed and integrated 
using the MOSFLM and scaled with SCALA (Potterton et al., 2002). Special 
considerations of data processing are detailed in the results section.     
4.2.7 Molecular phasing, model building and refinement  
Strategies used in experimental phasing and molecular replacement will be covered in 
the results section.   
4.3 RESULTS AND DISCUSSION 
4.3.1 Co-crystallisation  
4.3.1.1 Wild type MeCP2 MBD complexed with methylated DNA  
Based upon the preliminary characterisation with the band shift assay using different 
DNA isolated from methyl-SELEX experiments (Klose et al., 2005) and various 
MeCP2 domains, the construct bearing only the MBD domain (construct 77-167) was 
chosen for co-crystallisation with the BDNF promoter sequence. Table 4-1 shows the 
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sequences of DNA duplexes used in the initial screening of crystallisation conditions. 
Oligonucleotides ranging from 15 bp to 21 bp either single overhanging bases or 
blunt-ended have been synthesised and reversed-phase HPLC purified to purity 
greater than 90 %. These oligonucelotides were initially dissolved in TEN buffer to a 
concentration of 2mM, then mixed equi-molar to yield 1mM DNA duplexes. The 
protein was added slowly to the DNA solution to a final ratio of 1:1.3. Because the 
DNA solution contained low salt concentration (100mM), the protein immediately 
precipitated upon addition to the DNA solution. All protein precipitate however re-
dissolved upon complex formation with the DNA. In order to maximise the DNA-
protein complex formation, the mixture was then incubated for 30 min at room 
temperature. Before setting up the crystallisation plate, the solution was centrifuged at 
13,000g at 4˚ for 15 min to remove any insoluble materials. This step reduces the 
spontaneous nucleation rate as the insoluble materials like dirt can potentially 
promote undesirable nucleation which leads to high number of microcrystals. The 
crystallisation trials were then set up using the hanging drop vapour diffusion method 
and equilibrated to 17 or 4˚C.  
 
The initial screening using the 15, 16 and 18 bp duplexes (both single-base overhangs 
and blunt ended) complexed with construct 77-167 did not produce any DNA-protein 
co-crystals with the Natrix sparse matrix screens (Hampton Research). Increasing the 
length of the DNA to 20 bp and 21 bp (Table 4-1), however, successfully yielded 
crystals from the DNA-protein complexes containing the DNA duplexes with single-
base overhangs at either 4 or 17˚C from Natrix screens. The positive hits were 
obtained from conditions 25, 27 and 48 (Table 4-2). The MBD complexed with blunt 
ended DNA duplexes also produced microcrystals, nevertheless, optimisations with 
various parameters such as complex concentrations, temperature (17 °C or 4 °C), 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 4-2 Positive hits from Natrix screens (Hampton Research) 








50mM sodium cacodylate  6.5 
200mM ammonium acetate, 




50mM Tris-HCl 8.5 
200mM ammonium chloride, 
10mM calcium chloride 
These conditions yielded microcrytals from 20 and 21 bp DNA complexed with protein 
construct 77-167.  
 
The best optimised condition for single-base overhangs 21 bp DNA complexed with 
the wild type protein was 30-33% (w/v) PEG4000, 200mM NH4Cl, 10mM MgCl2 and 
50mM Na cacodylate pH5.5 – 7.0 (oligos number 1, Table 4-1). However, 
spontaneous nucleation with this condition produced low quality crystals for X-ray 
diffraction (maximum resolution ~20Å) (Figure 4-1a). Microseeding using these 
crystals as seeds improved the crystal appearance and resolution to 9Å (Figure 4-1b). 
Further rounds of seeding however did not improve the resolution limit.  
 
     (a)                           (b)  
 
Figure 4-1 Crystallisation of 21 bp BDNF fragment with MBD domain 
(a) spontaneous nucleation and (b) clusters from spontaneous nucleation was crushed and 
used as seeds for microseeding. Crystals grew after 24 hours post seeding. Fully grown 
crystals has maximum dimension approximately 0.5mm. These crystals diffracted X-rays to 
20 and 9Å, respectively, at synchrotron sources.   
 
As for 20 bp DNA duplex (oligos number 4; Table 4-1) in complex with construct 77-
167, plate-like crystals (Figure 4-2a) were grown from Natrix screen’s number 27 
(Table 4-2). These crystals diffracted X-rays to 4 - 5Å on the home source. 
Microseeding with these crystals as seeds in a lower precipitant condition [26 – 27% 
(w/v) PEG8000] improved the crystal shape (Figure 4-2b) and additional seeding with 
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serial seed dilutions successfully grew crystals with maximum dimension 0.8mm 
(Figure 4-2c) which led to the native dataset (Native; Table 4-3). The wild type DNA-
protein cocrystal diffracted X-rays (wavelength 0.9794Å) to 2.7Å resolution at station 
BM14, ESRF Grenoble.    
  
(a)                (b)      (c) 
 
 
Figure 4-2 Crystallisation of 20 bp BDNF fragment with MeCP2 MBD domain 
(a) Growth of crystals from 30% (w/v) PEG8000, 200mM Ammonium acetate, 10mM 
magnesium acetate and 50mM Na Cacodylate pH6.5. (b) microseeding with initial crystals (a) 
as seed stock. (c) Crystals grew in 27% (w/v) PEG8000 from diluted seed stock. Fully grown 
crystals with maximum dimension approximately 0.8mm and diffracted X-ray to 2.7Å.  
 
4.3.1.2 SDS-PAGE analysis 
In order to verify if these crystals were indeed a protein-DNA complex, several 
crystals were collected, washed with crystallisation solution, dissolved in SDS loading 
buffer, boiled and analysed on an SDS-PAGE (Figure 4-3). An aliquot (0.5μl) of drop 
solution was concurrently analysed in the same gel. From the Coomassie blue 
staining, a protein band corresponding to approximately 11kDa was detected in both 
preparations. Surprisingly, another species with molecular weight approximately 
30kDa was also found in the melted crystal solution (Figure 4-3, lane 1). This 
unknown species could be covalently linked dimer of the protein or DNA. A duplicate 
of the gel was stained with ethidium bromide. Two bands were detected which were 
believed to be denatured oligonucleotides (lower band) and reannealed DNA duplexes 
(upper band) in the stained gel. These results strongly argued that the crystal 






(a)       (b) 
 
Figure 4-3: SDS-PAGE analysis of protein-DNA cocrystal.  
Several crystals were mounted and dissolved in SDS-PAGE loading buffer, boiled for 10 min 
and separated on two 18% (w/v) SDS-PAGE gels (lanes 1 in both gels). An aliquot (0.5μl) of 
the drop solution was also analysed on the same gels (lane 2 in both gels). Gel (a) stained with 
Coomassie blue and gel (b) stained with ethidium bromide. Protein and DNA bands are 
indicated by arrows. Lane M; protein marker.   
 
4.3.1.3 Iodinated derivatives 
An attempt to solve the native structure of MeCP2 MBD in complex with the 20bp 
BDNF fragment using the native data was made. Molecular replacement using the 
NMR established models (Ohki et al., 2001; Wakefield et al., 1999) and various 
standard B-DNA as phasing models were not successful in generating an interpretable 
electron density map for the protein region although reasonable solutions were 
produced. This result indicated that experimental phasing using heavy atoms would be 
required to solve the X-ray structure. A detailed explanation of molecular replacement 
will be discussed in the experimental phasing section in this chapter.  
 
In order to introduce a heavy atom into the DNA-protein co-crystal, 5’iodo-uracil 
(5’IdU) was directly incorporated into the oligonucleotides during synthesis. This was 
achieved by replacing T3 and T17 with 5’IdU of one strand of the duplex (oligos 
number 5; Table 4-1). Co-crystallisation of iodinated DNA and construct 77-167 was 
carried out as for native crystal. Thin plate-like crystals were grown using a similar 
crystallisation condition [25-27% (w/v) PEG8000, 200mM ammonium acetate, 10mM 
magnesium acetate and 50mM sodium cacodylate, pH6.5]. These crystals only 
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diffracted to 7.5Å at SRS, Daresbury (Figure 4-4a). Optimisations with various 
parameters, particularly PEG8000, DNA-protein complex and ion concentrations did 
not improve the quality of these iodinated DNA-protein cocrystals. Microseeding 
using the thin plate crystals as seed stock managed to increase the dimensions but not 
the thickness of the crystal (Figure 4-4b). Incorporation of 0.1-0.4% (w/v) of 
spermine, spermidine, cobalt hexamine and β-octylglucoside (Additive screens, 
Hampton Research) in the crystallisation solution drastically enhanced the nucleation 
rate and yielded relatively small crystals.  
(a)            (b)        (c) 
 
Figure 4-4 Crystallisation trials of iodo-uracil DNA-protein complex  
(a) growth of crystals from 25% (w/v) PEG8000, 200mM ammonium acetate, 10mM 
magnesium acetate and 50mM sodium cacodylate pH6.5. (b) microseeding with spontaneous 
grew crystals as seed (c) a reduction in ammonium acetate concentration.   
 
The approach followed was PEG screening. PEGs with molecular weight ranging 
from 350-20,000 kDa were used. Surprisingly, various PEG with molecular weight 
above 1000 kDa were found to be able to crystallise the iodinated DNA-protein 
complex even though most crystals were thin plates. Nevertheless, the crystallisation 
solution containing 28% (w/v) PEG2000 together with otherwise unaltered 
parameters; chunky crystals with maximum dimension larger than 1mm were grown 
within 2-3 days (Figure 4-5). The quality of the crystals including the thickness and 
resolution limit was greatly improved by substituting PEG8000 with PEG2000. This 
crystal diffracted to a maximum resolution of 3.2Å at synchrotron radiation sources. 
However, these crystals were metastable and dissolved within one week or upon 
vibration during plate observation. In subsequent experiments, crystals containing a 
single 5’iodo-uracil at position 3 and 17 (number 6 and 7; Table 4-1), respectively, 




Figure 4-5: Co-crystal of 20 bp iodinated BDNF-MBD of MeCP2  
Crystals were grown within two days in an untouched condition from 28% (w/v) PEG2000, 
200mM ammonium acetate, 10mM magnesium acetate and 50mM sodium cacodylate, pH6.5. 
Maximum dimension of this crystal is 1mm. 
 
4.3.1.4 Seleno-Met derivative (Wild type MeCP2) 
SAD phasing using the anomalous signal from iodine located in the DNA bases 
generated experimental maps which also lack interpretable protein features (see 
experimental phasing). Improvement of the experimental map was essential to show 
protein features that could be interpreted for initial model building. The next strategy 
used was incorporation of heavy atom into the protein. One of the common 
approaches is introduction of seleno-Met into the recombinant protein during protein 
production using a Met auxotroph E. coli strain (Hendrickson et al., 1990). The native 
(sulphurous) Met in the protein can be replaced efficiently with seleno-Met under 
carefully controlled experimental conditions. The selenium in reduced form can then 
be used to provide anomalous scattering at certain wavelengths which are particularly 
useful in experimental phasing by SAD and MAD (Hendrickson et al., 1990). In this 
study, the first seleno-methionyl protein expressed and purified was SeMet94-MBD 
which contains only one Seleno-Met at position 94.  
 
SeMet94-MBD was co-crystallised with the 20 bp BDNF fragment (number 4; Table 
4-1) using 26-28% (w/v) PEG8000, 200mM ammonium acetate, 10mM magnesium 
acetate and 50mM sodium cacodylate, pH6.5 and 2mM DTT (Figure 4-6a). These 
rather small crystals, however, did not diffract to a resolution better than 9Å at 
synchrotron sources. An alternative approach was to co-crystallise SeMet94-MBD 
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with the DNA containing two iodine atoms (number 5; Table 4-1). This iodinated 
DNA-protein complex was co-crystallised using the same crystallisation condition as 
above and the co-crystals were grown within 3 days with the longest dimension of 
approximately 0.2mm (Figure 4-6b). A weak selenium signal could barely be detected 
in an Se fluorescence scan at SRS Daresbury. In spite of the weak Se signal, a dataset 
with a resolution of 2.85Å at wavelength 0.975Å (according to theoretical Se K-edge) 
was collected. In order to benefit from the iodine signal, another dataset was also 
collected at wavelength 2.07Å to maximise the anomalous signal. Data at the iodine 
adsorption edge (~2.4Å) cannot be collected because this wavelength beyond the 
tuneable range of SRS, Daresbury.   
       
(a)      (b) 
 
Figure 4-6: Cocrystal containing 5’iodo-uracil and seleno-Met  
(a) cocrystals of SeMet94-MBD-methylated DNA complex were grown within 3 days using 
27-28% (w/v) PEG8000, 200mM ammonium acetate, 10mM magnesium acetate and 50mM 
sodium cacodylate, pH6.5 (b) cocrystals of SeMet94-MBD-iodinated DNA with maximum 
dimension of 200μm under the same condition as above. 
 
4.3.1.5 Seleno-Met derivative (mutant A140M) 
The only Met (Met94) in the construct 77-167 is located at the N-terminal region of 
the MBD domain. As indicated in the NMR model (Wakefield et al., 1999), the 
protein region before Asp96 is composed of mobile loops. It is possible that this 
mobility masked the Se anomalous signal from the crystal containing a single Se atom 
per 91 amino acids. A common approach to increase the number of SeMet residues in 
the protein is by substituting other amino acids with Met which do not significantly 
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alter the proteins three-dimensional structure. Following examination of the 
established NMR models and DNA binding analysis (Ohki et al., 2001; Wakefield et 
al., 1999), Ala140 located in the α-helix was replaced with Met using site-directed 
mutagenesis. The SeMet derivative of A140M (A140SeMet) was produced and 
crystallised with a 20 bp BDNF fragment (number 4, Table 4-1) using 26% (w/v) 
PEG2000, 200mM ammonium acetate, 10mM magnesium acetate, 50mM sodium 
cacodylate pH6.5 and 1mM DTT. These crystals diffracted X-rays to approximately 
3Å with very streaky spots over a wide angular range (Figure 4-9a). Soaking of these 
crystals in the precipitant solution above but replacing magnesium acetate with 
manganese chloride, improved the resolution to 2.5Å. For both crystal preparations, 




Figure 4-7 Co-crystal of A140SeMet-MBD complexed with 20bp BDNF fragment 
This crystal was grown from precipitant solution containing 26% (w/v) PEG2000, 200mM 
ammonium acetate, 10mM magnesium acetate, 50mM sodium cacodylate pH6.5 and 2mM 
DTT at 17 ˚C. Upon soaking in solution containing 10mM manganese chloride, this crystal 
diffracted X-rays to a maximum resolution of 2.5Å at station BM14, ESRF Grenoble, France.   
 
 
In summary, the MeCP2 MBD domain can be cocrystallised with single-base 
overhang 20bp methylated DNA containing symmetrical methyl-CpG dinucleotides 
and an adjacent AT run using 26-28% (w/v) PEG2000 or PEG8000, 200mM 
ammonium acetate, 10mM magnesium acetate and 50mM sodium cacodylate, pH6.5. 
The presence of 2mM DTT is required for cocrystallisation of seleno-Methionyl 
derivatives. Blunt ended DNA however did not produce reasonable size crystals for 
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X-ray data collection. This observation suggested that the end-to-end stacking of 
single-base overhangs DNA fragments (see crystal packing) is essential to form long 
pseudo-continuous double helices for cocrystallisation of the MeCP2 MBD domain 
with the 20 bp methylated DNA.  
4.3.2 Data collection 
Data collections were conducted mainly at Station BM14 ESRF Grenoble, France and 
SRS Daresbury, UK at 100K using CCD detectors. Among several datasets collected 
from native protein-DNA complexes and heavy atom derivatives, seven datasets will 
be discussed in this chapter (Table 4-3). Six out of seven datasets were collected at 
Station BM14 ESRF Grenoble except datasets from crystal IodoSe (Table 4-3), which 
were collected from SRS Daresbury. The native dataset was collected at wavelength 
0.9794Å for total rotational angle of 180˚ with reflections out to 2.7Å resolution. A 
MAD dataset, extending to 2.9Å without usage of cryoprotectant was collected from 
A140SeMet complexed with the BDNF fragment. However, the dataset with the 
highest resolution (up to 2.5Å) was collected from a similar crystal which has been 
soaked in a precipitant solution containing Mn2+. Additionally, the best diffraction 
resolution for datasets containing iodine ranged between 2.65 to 2.85Å (Table 4-3).     
 
As part of the strategy in collecting datasets containing the anomalous scatterer 
selenium, all seleno-derivative crystals were scanned for normal and anomalous 
contributions from the incorporated selenium atoms. Figure 4-8 shows the absorption 
and dispersion spectra of the selenium signal from the cocrystal of A140SeMet 
complexed with methylated DNA. The fluorescence scan was conducted from 12.63 
keV to 12.73 keV and was used to determine the wavelengths for maximum 
adsorption (Se peak) at 12678.23 keV (0.9780 Å) together with its f” (4.45) and f’ (-
7.28) values, and the inflection point (IP) at 12674.10 keV (0.9785 Å) together with 
its f” (2.15) and f’ (-8.53) values (Table 4-3). The wavelength in the high remote area 
was set at 0.9080 Å. For each wavelength, 360 oscillation images with 1˚ interval 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The datasets from iodine derivatives (crystal D21, D22 and IodoSe; Table 4-3) were 
collected in a way to maximise the anomalous signal from iodine. Because of the 
absorption edge wavelength of iodine (~2.4 Å) is beyond the adjustable synchrotron 
wavelength range, the datasets containing 2 atom of iodine per DNA molecule were 
collected at 2.07 Å at SRS Daresbury whereas other iodinated datasets were collected 
with a rather different strategy at 1.61 Å (dataset Iodo3, Table 4-3) and 1.46 Å 
(dataset Iodo17, Table 4-3) in a way to compromise the anomalous signal for the X-
ray intensity (Table 4-3).  
 
Figure 4-8 Plot of normal and anomalous scattering of selenium 
The fluorescence scan was conducted from 12.63 keV to 12.73 keV and the wavelengths for 
maximum absorption edge or selenium peak (pk), the minimum normal scattering or 
inflection point (IP) were determined. The high remote (hrm) wavelength was selected 
manually. The f” and f’ of the selenium peak and inflection point were also identified from 
the scan.  
4.3.3 Data processing and integration  
All seven datasets were auto-indexed and integrated using the MOSFLM (Leslie, 
1992) package. A general procedure was applied to all datasets except specific 
considerations discussed here. The mosaicity estimations varied considerably 
(~between 0.5 to 1.3˚) at different rotational angles. Therefore, MOSFLM failed to 
perform cell refinement in a reasonable way. To omit this refinement step during unit 
cell and space group determinations, images separated at 10˚ intervals with the first 
and the last images separated by at least 90˚ were chosen for spot searching and auto-
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indexing. The unit cell dimensions, mosaicity and tilt angles were fixed during data 
integration in order to process a consistent dataset. All data were reduced and scaled 
with SCALA and the Rmerge value of all images were examined manually and frames 
with unusual high Rmerge value were removed. The final X-ray structure of MeCP2 
MBD complexed with methylated DNA was determined from a cocrystal (crystal 
A140SeMet-Mn, Table 4-3) which had been soaked in solution containing 10mM Mn 
acetate. Details of space group and unit cell determination are presented in the 
following sections. 
4.3.3.1 Space group determination  
The co-crystal A140SeMet-Mn (Table 4-3) was transferred from the mother liquor to a 
precipitant solution containing 35% (w/v) PEG 2000, 200mM ammonium acetate, 
10mM manganese chloride and 50mM sodium cacodylate pH6.5. The crystal was 
soaked for 15 min before flash cooling in liquid nitrogen. This process unexpectedly 
improved the maximum resolution to 2.5Å with strong DNA diffraction pattern at 
~3.3 Å (Figure 4-9) which might correspond to the average distances of B-DNA base-
stacking. The DNA diffraction pattern in fact has been observed in all data with 
resolution better than 3.2Å. Auto-indexing with MOSFLM identified the most likely 
Bravais lattice to be C-centered monoclinic (space group C2) with unit cell 
dimensions of a = 79.71 Å, b = 53.60 Å, c = 65.73 Å, α = γ = 90 ° and β = 132.10 °. 
This was further supported by unmerged data analysis using POINTLESS (Evans, 
2006) which also suggested the monoclinic Laue group C 1 2/m 1, consistent with 
monoclinic space group C2. The selenium peak data from crystal A140SeMet-Mn was 
successfully indexed and processed to Rsym and Rpim of 7.5 % and 4.5 %, respectively. 
The Rsym values of high resolution data deteriorated rapidly from inflection (86 %) to 
high remote (159%) data as a result of prolonged X-ray exposure (Table 4-3). This 
indicates that the crystal suffered from serious radiation damage after Se peak data 
collection.      
4.3.3.2 Unit cell contents  
The molecular weight of mutant A140M and methylated DNA are 11163 Da and 
12260 Da, respectively. The calculated Matthew coefficient (Matthews, 1968) using 
cell content calculator in CCP4 is 2.22Å3/Da with solvent content estimation of 53 %.  
This clearly indicated that there is one DNA-protein complex per asymmetric unit.  
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(a)       (b) 
 
 
Figure 4-9 Oscillation images from crystals A140SeMet and A140SeMet-Mn  
(a) Oscillation image recorded from crystal containing A140SeMet and 20 bp DNA showing 
that most of the spots are streaky over a wide rotational angle. This crystal diffracted to 2.9Å  
(b) Oscillation image recorded from a similar crystal which has been soaked in MnCl2 for 15 
min prior to flash frozen in liquid nitrogen. Less streaky spots were observed compared to 
image (a) and the maximum resolution improved to 2.5Å. Strong reflections at approximately 
3.3Å might correspond to DNA base-stacking. Resolution rings are indicated.  
 
4.3.4 Molecular phasing 
The experimental phasing programmes used to solve the phase problem of the dataset 
collected from the cocrystal of A140SeMet-Mn (Table 4-3) complexed with 
methylated DNA were SOLVE and RESOLVE (Terwilliger, 2004) and SHELX 
C/D/E packages (Sheldrick, 2008). The complete structural model of the DNA-protein 
complex was then used as a phasing model in molecular replacement to determine the 
native structure and the iodinated structures (datasets Native, Iodo3, and Iodo17; 
Table 4-3). Model building and refinement were conducted iteratively with COOT 
(Emsley and Cowtan, 2004) and REFMAC 5.2 (Murshudov et al., 1997).  
4.3.5 Why experimental phasing with mutant A140SeMet?   
Initially, the NMR established models of MBD1 MBD complexed with methylated 
DNA (Ohki et al., 2001) and MeCP2 MBD alone (Wakefield et al., 1999) were used 
as a phasing model in solving the native structure from crystal Native (Table 4-3) 
using molecular replacement in MOLREP (Collaborative, 1994) and PHASER 
(McCoy et al., 2007) but all trials failed to yield a satisfactory solution. However, 
 101
when using various length of ideal B-DNA as a phasing model, molecular 
replacement successfully found the correct position of DNA; rigid body refinement 
led to an Rcryst/Rfree of 56.3/57.9%. The resulting electron density map was heavily 
dominated by the double helical features of the B-DNA (Figure 4-10a). This solution 
was initially doubted because the protein features could not be traced. As a result, 
5’iodouracil (5’IdU) was incorporated into the DNA during oligonucleotide synthesis, 
in which, the anomalous signal from iodine can be used for experimental phasing. In 
crystal D21 and D22, nucleotides T17 and T3 (Table 4-3), respectively, were replaced 
with 5’IdU. For crystal IodoSe, both T3 and T17 were simultaneously replaced with 
5’IdU. Both SOLVE and SHELX D managed to find the iodine positions correctly. 
SAD phasing with the anomalous contribution from iodine led to an electron density 
map which is again dominated by the DNA features. Although the electron density 
map still failed to display any interpretable electron density for the protein region, it 
confirmed the MOLREP solution above. In order to improve the electron density map, 
SeMet was incorporated into the wild type and later into the A140M mutant, from 
which the X-ray structure of the MeCP2 MBD domain in complex with the 20 bp 
methylated DNA was eventually determined.       
 
(a)                (b)  
 
 
Figure 4-10 MOLREP solution with standard B-DNA 
(a) Electron density map generated from molecular replacement using the 18 bp ideal B-DNA 
as phasing model compared with (b) Partial model of MeCP2 MBD domain complexed with 
methylated DNA in the first experimental map from SOLVE and RESOLVE (see SAD 




The wild type MeCP2 MBD domain contains only one Met (Met94), which is located 
at the N-terminus of the MBD domain according to Wakefield et al. (1999). The 
cocrystals of selenomethionine substituted protein and methylated DNA had been 
grown but failed to display a significant Se anomalous signal from an X-ray dataset 
collected with the wavelength set at the selenium K-edge. The weak anomalous signal 
in the X-ray data might because of an insufficient number of Se atom in the protein-
DNA complex. In practice, the generally accepted minimum is one Se atom for every 
14 kDa protein (Sharff et al., 2000). Therefore, one single Se atom in the MeCP2 
MBD complexed with a methylated DNA (total size approximately 23 kDa) may not 
provide sufficient anomalous signal to solve the phase problem. To enhance Se 
anomalous scattering power, Ala140 was mutated to Met by site directed 
mutagenesis. The resulting mutant; A140M; contains two Met residues (Met94 and 
Met140). It has been shown that Ala140 is located in the only α-helical region of the 
MeCP2 MBD domain (Wakefield et al., 1999). The seleno-methionyl protein 
preparation should place an additional ‘structured’ Se atom in the α-helical region of 
the protein. Together with SeMet94, SeMet140 could potentially contribute an 
anomalous signal for estimating phases in methods such as SAD and MAD.    
4.3.6 Multi-wavelength anomalous dispersion (MAD) 
The first MAD dataset was collected from a crystal containing A140SeMet (dataset 
MAD1; Table 4-3) without using a cryoprotectant. This crystal diffracted X-rays 
around Se absorption edge wavelengths to a maximum resolution of ~3.0 Å. Image 
examination revealed that most of the frames displayed streaky spots which 
substantially interfered with data processing and autoindexing. MAD or SAD phasing 
using various programmes such as SHELX C/D/E (Sheldrick, 2008), SOLVE and 
RESOLVE (Terwilliger, 2004) or AutoSHARP (Vonrhein et al., 2006) have been 
extensively tried but failed to generate a correct set of phases.  
 
Mg2+ is an essential component to enable crystallisation although it is not required for 
the formation of MeCP2-methylated DNA complexes. However, Mg2+ cannot display 
anomalous scattering that is required for MAD or SAD. In contrast, Mn2+ with atomic 
mass of 54.9 would produce anomalous scattering at its absorption edge around 
wavelength 1.896Å. Therefore, substitution of Mg2+ with Mn2+ would potentially 
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provide an anomalous signal in determining the phases of the heavy atom 
substructure. Attempts to cocrystallise the construct A140SeMet complexed with 
methylated DNA using precipitant solutions containing Mn2+ has not succeeded in 
yielding any co-crystal of MBD-DNA complex. As an alternative choice, the co-
crystal was soaked in a modified precipitant solution containing 35% (w/v) PEG2000, 
200mM ammonium acetate, 10mM MnCl2 and 50mM Na cacodylate pH6.5 for 15 
min prior to flash freezing in liquid nitrogen. Surprisingly, some significant changes 
were observed from Mn soaked crystal (crystal A140SeMet-Mn, Table 4-3) compared 
to un-soaked ones, these changes include: 
(i) improved maximum resolution from ~3.0 Å to ~2.5 Å,  
(ii) the interference of streaky spot were greatly reduced, and  
(iii) most intriguingly, changes in unit cell dimensions (Table 4-3). As a result, 
data collected from crystal A140SeMet-Mn was used for experimental 
phasing which eventually led to the final structural determination. 
Analysis for significant anomalous scattering of Se in the cocrystal A140SeMet-Mn 
was performed mainly using two programmes; SHELXC/D/E packages (Sheldrick, 
2008) and PHENIX (Adams et al., 2002). Three- or two-wavelength MAD was not 
successful in solving the phase problem. This was probably due to the deteriorated 
quality of the inflection and high energy remote data. As part of the strategy to 
maximise the reflection intensity, one minute exposure time was allowed per 
oscillation image per 1˚ rotational angle. This approach obviously accelerated the 
crystal deterioration because of longer X-ray exposures, as indicated by the high Rsym, 
Rpim and <I>/σ(I) values for the inflection (IP) and high remote (HR) data (crystal 
A140SeMet-Mn, Table 4-3). After peak data were collected, the outermost Rsym 
increased from 37.7 % (Se peak) to 86.3 % for inflection data and this was further 
exacerbated for data collected at high remote area. The outermost <I>/σ(I) value was 
decreased from 3.7 (peak) to 1.4 (inflection) and 1.0 (high remote). Nevertheless, the 
quality of the peak data, which diffracted X-rays to highest resolution of 2.5Å, was 
considered moderately good quality with an overall completeness of 98.5%, 
outermost Rsym of 37.7 %, <I>/σ(I) of 3.0 and anomalous multiplicity of 2.7 (Table 
4-3). Thus, the X-ray structure of MeCP2 MBD domain complexed with 20 bp BDNF 
fragment containing a central methy-CpG dinucleotides and 4 bp of A/T bases was 
successfully solved by SAD using the selenium peak data of the A140SeMet-Mn 
crystal.    
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4.3.7 SAD phasing with PHENIX – the successful case 
Python-based Hierarchical ENvironment for Integrated Xtallography (PHENIX) is a 
software suite for a highly automated macromolecular determination up to the stage of 
partial model building provided moderate resolution data are available (Adams et al., 
2002). In PHENIX, decision making strategies (the wizards in the programme) are 
made by considering all of the available information at each step in the process. The 
four available wizards in PHENIX are: structural solution using AutoSol, molecular 
replacement using AutoMR, model building or rebuilding using AutoBuild and 
ligands fitting using AutoFit (http://www.phenix-online.org/). All experimental 
phasing methods such as SIR, MIR, SIRAS, MIRAS, SAD, MAD are performed 
using AutoSol in PHENIX. In general, the AutoSol wizard uses the following steps in 
solving a macromolecular structure: (i) data input, analysis and scaling, (ii) heavy 
atom searching and scoring, (iii) phasing and density modification and, (iv) 
preliminary model building and refinement.  
4.3.7.1 Data input, analysis and scaling 
In PHENIX, analysis of significant anomalous contribution and heavy atom location 
are performed using SOLVE (Terwilliger, 2004). Using selenium peak data from 
crystal A140SeMet-Mn (Table 4-3), the anomalous signal-to-noise ratio (|F+-F-|/σ|F+-
F-|) of 10 resolution bins was calculated; a ratio above 1.2 was regarded as a 
significant anomalous contribution (Table 4-4). Therefore, resolution above 3Å was 
discarded from heavy atom searching in this data. Two heavy atom sites were found 
in the asymmetric unit for the Se peak data with occupancy of 100 % and 86 %, 
respectively (Table 4-5).  
























% complete 98.6 99.9 99.8 100.0 99.8 100.0 100 100.0 99.6 89.6 
N obs  796 1144 446 448 549 442 544 642 744 824 
S/|F+-F-| 20.06 11.98 9.22 8.52 7.94 6.85 5.89 5.71 3.99 0.00 
N/σ| F+-F-| 3.57 3.38 4.00 4.46 5.12 5.71 6.02 6.52 7.08 7.85 
S/N ratio 5.61 3.54 2.30 1.91 1.55 1.20 0.98 0.88 0.56 0.00 
The resolution cut-off for heavy atom search in this data was at 3Å. Abbreviations S and N 




Table 4-5 Heavy atom sites  
Site  atom Occupancy  X y z B factor 
1 Se 1.0235 0.8375 0.3649 0.1471 59.73 
2 Se 0.8609 0.9711 0.0242 0.0524 60.00 
   
4.3.7.2 SAD phasing and density modification 
The heavy atoms found in SOLVE (SAD phasing) were refined with origin-removed 
Patterson refinement (Terwilliger and Eisenberg, 1983), which resulted in an electron 
density map with mean Figure of Merit (FOM) value of 25% (Table 4-6). Density 
modification using RESOLVE with a solvent content of 54% produced a final 
electron density map with an overall correlation coefficient (CC) and FOM of 68% 
and 53%, respectively. Figure 4-11a shows the first experimental map with readily 
interpretable double stranded B-DNA and some protein features. A closer view 
(Figure 4-11b) of the non-DNA electron density shows the α-helical secondary region 
of the protein and other continuous electron densities in the major groove of the DNA. 
The first selenium atom (with occupancy 1) was found to be located in the expected 
α-helical region (Figure 4-11b) and the second Se site is located in a relatively 
disordered region of the protein.   
 
Table 4-6 FOM with resolution after experimental phasing with SOLVE 

















N data 330 590 759 905 1004 1129 1190 1208 7115 
<FOM> 0.44 0.50 0.45 0.38 0.29 0.19 0.11 0.06 0.25 
 





















Figure 4-11 First experimental map after SAD phasing with SOLVE and density 
modification with RESOLVE 
(a) Stereo diagram of the B-form DNA double helix and some of the protein features are 
shown in the first electron density map. (b) A closer stereo diagram of the only α-helical coil 
and other protein chains close to the major groove of the DNA are clearly seen. The two 
selenium atoms are represented by red spheres. 
 
 
4.3.7.3 Preliminary model building and refinement 
The electron density map resulting from SAD phasing was sufficient to begin an 
automated model building. In the PHENIX software suite, the initial macromolecular 
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model can be built using RESOLVE (Terwilliger, 2004). The protein and DNA partial 
models were built in two separate runs of model building. Thirty out of 40 bases (75 
%) was built whereas only the main protein features such as α-helix and the long loop 
can be traced (Figure 4-12b and c). The partial coordinates of DNA and protein were 
combined manually and the wrongly built polypeptides in the DNA electron density 
were removed. The partially built model with Rcyst/Rfree of 48/51% (Figure 4-12a) 
served as a starting model for continuous manual building. Manual building and 
refinement was continued iteratively using COOT (Emsley and Cowtan, 2004) and 
REFMAC 5.2 (Murshudov et al., 1997) until the model was completed with all 
observable amino acids and DNA bases, the Rcyst/Rfree improved to 25.8/30.1%. Model 
building and refinement were completed with generous helps and contributions from 
Dr. Iain McNae.  
 
At this stage, the model was submitted to the TLSMD server (Painter and Merritt, 
2006) for TLS motion groups determination. The server partitions the input structural 
model into multiple continuous chain segments based on input thermal parameters, 
each segment acting as a rigid group undergoing TLS (translation/libration/rotation) 
motion (Painter and Merritt, 2006). The multi-group TLS models were further refined 
with REFMAC5.2 (Murshudov et al., 1997). By comparing the refinement statistics 
(such as FOM, RMSD and Rcryst/Rfree values), the polypeptide chain was best divided 
into 4 TLS motion groups and each DNA strand into two TLS groups (Figure 4-13) 
and the average B-factor of each TLS segment are presented in  Table 4-7. 
 
The resulting model after REFMAC refinement was used to search for water 
molecules with COOT (Emsley and Cowtan, 2004). Using |Fo-Fc| maps with a σ level 
of 2.8, COOT located 47 water molecules. The final model of the MeCP2 MBD 
domain in complex with 20 bp promoter region of BDNF gene shows good geometry 
with final Rcyst/Rfree of 21.1/27.6 % and RMSD bonds/angles of 0.009Å /1.85˚. The 
quality of the model was validated using PROCHECK (Laskowski et al., 1993). The 
Ramachandran plot shows that 91.4% of residues lie within the most favoured region, 
only 8.6% within the additional allowed regions and none within the generously 





Figure 4-12 Partial model in the experimental map (automated built) 
(a) stereo view of the partial model of the DNA-protein complex built with RESOLVE  
(b) alpha-helical region of the protein with the selenium atom coloured in green 









Figure 4-13 TLS motion groups of A140SeMet-Mn model 
Model showing the TLS motions of (a) the polypeptide, (b) DNA strand (chain B) and (c) 
DNA strand (chain c). All TLS motion groups are coloured differently (diagrams generated 
using http://skuld.bmsc.washington.edu/~tlsmd/)      
 
Table 4-7 Mean B factor of TLS motion groups 
TLS segment Number of residue Number of Atom 
Average B factor 
<B>/Å2 
Protein (Chain A)     
91-105 15 121 65.8 
106-122 17 138 38.4 
123-151 29 236 52.1 
152-162 11 89 49.6 
DNA (chain B)    
1-15 15 307 45.7 
16-20 5 100 59.7 
DNA (chain C)    
21-32 12 246 50.8 
33-40 8 163 48.2 
  
4.3.7.4 Crystal packing  
Each unit cell (a = 79.71Å, b = 53.60 Å, c = 65.73 Å and β = 132.10˚) contains 4 
asymmetric units (Figure 4-15). The DNA molecules stacked end-to-end to form long 
pseudo-continuous double helices along the c-axis. The length of each individual 
DNA molecule equals to the length of the c-axis. Although the individual DNA 
molecules are slightly bent, the long DNA double helices are absolutely straight 
(Figure 4-15b). Figure 4-15c shows that the DNA duplex is wrapped by two extended 
arms at one side of the DNA molecule. On the opposite side of the DNA molecule, 
two DNA molecules come into contact crystallographically but run in opposite 





Figure 4-14 Analysis of stereochemical properties of A140SeMet-Mn 
(a) Ramachandran plot shows that 91.4 % of residues located within the most favoured 
region, 8.6 % of residues in the additional allowed region. (b) protein secondary structure 







     
 
Figure 4-15 Crystal packing  
(a) Stereo view along the c-axis (b) unit cell contains 4 asymmetric units (c) DNA 






4.3.7.5 Native structure determination with molecular replacement 
As discussed in section 4.3.5, molecular replacement with various lengths of standard 
B form DNA yielded an electron density map displaying double helical DNA features 
but failed to display protein features. In order to determine the MBD domain in the 
native structure, the final model of A140SeMet-Mn complexed with methylated DNA 
was used as a phasing model in MOLREP (CCP4, v6.0.2) (Potterton et al., 2002). An 
initial round of rigid body refinement was carried out after molecular replacement and 
gave a model with Rcryst/Rfree of 39.6/43.6%. The seleno-Met residues were mutated to 
sulphurous-Met and autofitted using COOT into the co FF −2 map and this was 
followed by restrained refinement with tight stereochemical restraints (weighting term 
of 0.01 to 0.05˚) until convergence with an Rcryst/Rfree of 25.1/34.9%.  
 
At this stage, the model was submitted to the TLSMD server (Painter and Merritt, 
2006) in order to perform TLS group determination. In this case, the Native model 
was segmented into 5 TLS motion groups with the polypeptide chain as one group 
and each DNA strand divided into 2 groups. The PDBIN and TLSOUT from the 
TLSMD server were used for restrained refinement in REFMAC 5.2 with tight 
geometry restraints. This round of refinement pronouncedly improved the 
convergence of the final model to Rcryst/Rfree of 23.0/29.5%.  
 
A final validation was carried out using PROCHECK (Laskowski et al., 1993). The 
Ramachandran plot shows that 77.6 % residues within the most favoured regions, 
20.7% located in additional allowed regions and 1 % in generously allowed regions. 
None of the residues are within disallowed regions (Figure 4-16). Nevertheless, some 









Figure 4-16 Analysis of stereochemical properties of the Native X-ray structure 
(a) The Ramachandran plot shows that 77.6% of residues are within most favoured region, 
20.7% within additional allowed regions and 1.7% located within generously allowed regions. 
(b) secondary structure prediction and (c) amino acid sequence corresponding to 








4.3.7.6 Iodinated structure determination using molecular replacement  
As mentioned in the earlier section, the anomalous signal from the iodine successfully 
generated an electron density map showing the DNA double helical features. 
However, the iodinated data sets provide insufficient information for determining the 
complete structure of the MBD domain of MeCP2 complexed with a 20 mer DNA. 
Nevertheless, these iodinated DNA-protein complex X-ray structures (datasets Iodo3 
and Iodo17; Table 4-3) were eventually solved with molecular replacement 
(MOLREP) using the fully refined model (A140SeMet-Mn) as the phasing model.  
 
For dataset Iodo17 (Table 4-3), molecular replacement successfully found the correct 
position. An initial round of rigid body refinement rendered the model with Rcryst/Rfree 
values of 52.6/53.6%. Subsequent refinement with 20 cycles of restrained refinement 
yielded a model with Rcryst/Rfree of 39.0/49.4%. After fixing all residues and 
nucleotides to its original sequence in the crystal, restrained refinement produced a 
model with Rcryst/Rfree of 25.6/31.7%. A total of 30 water molecules have been added 
with COOT (Emsley and Cowtan, 2004) at a sigma level 3.0 using |Fo|-|Fc| map. The 
final round of restrained refinement yielded a model with Rcryst/Rfree of 24.3/30.1% 
(Table 4-8). PROCHECK (Laskowski et al., 1993) has been carried out to validate to 
final model. The Ramachandran plot (Figure 4-17a) indicates that 94.8% of the amino 
acids are within the most favoured regions, 5.2% located within additional allowed 
regions.  
 
Similarly, dataset Iodo3 (Table 4-3) was solved using molecular replacement. Initial 
rounds of rigid body refinement generated a model with Rcryst/Rfree of 41.1/38.9%. 
Subsequent rounds of restrained refinement with tight geometry improved the 
Rcryst/Rfree values to 26.3/31.4%. Further rounds of restrained refinement after fixing 
all the nucleotides and bases yielded a model with Rcryst/Rfree of 26.6/31.8%. A total of 
12 water molecules have been added using COOT (Emsley and Cowtan, 2004). The 
final round of restrained refinement produced a model with Rcryst/Rfree of 24.9/29.5% 
(Table 4-8). The Ramachandran plot (Figure 4-17b) shows that 79.3% of residues are 
located within the most favoured regions and 20.7% amino acids are located within 
additional allowed regions. None of the residues has been found located in the 






Figure 4-17 Analysis of stereochemical properties of Iodo17 X-ray structure 
(a) Ramachandran plot shows that 94.8% and 5.2% of the amino acids located within the most 
favoured and additional allowed regions, respectively. (b) protein secondary structure 












Figure 4-18 Analysis of stereochemical properties Iodo3 X-ray structure 
(a) Ramachandran plot shows that 79.3% and 20.7% of the amino acids located within the 
most favoured and additional allowed regions, respectively. None of the residues of these 
datasets located within the generous allowed and disallowed regions. (b) Protein secondary 
structure prediction and (c) amino acid sequence corresponds to Ramachandran plot. 
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4.3.8 Which is the best model? 
The main objective of this study is to examine the molecular details of methyl-CpG 
recognition by the MBD domain of MeCP2. By comparing the quality of the 4 models 
that have been refined, the X-ray structures of A140SeMet-Mn, Iodo3 and Iodo17 
(Figure 4-19) provide sufficient molecular information for detailed structural analysis. 
Table 4-8 shows that the best refined model is A140SeMet-Mn with a final Rcyst/Rfree 
of 21.2/27.6 and RMSD bond/angles of 0.009/1.85. Nevertheless, the data quality of 
Iodo17 is generally better than A140SeMet-Mn due to 100% completeness and 9.4 
multiplicity. Secondary structure analysis using PROCHECK (Laskowski et al., 1993) 
identified an additional short α-helix of 152PND154 within MeCP2 MBD domain 
(Figure 4-19d). The highest redundancy data is dataset Iodo3 which was collected 
from more than 600 images. The polypeptide chain of Iodo3 displays an identical 
secondary structure as A140SeMet-Mn (Figure 4-19a, c). Overlay of iodinated models 
with the Native and A140SeMet-Mn indicates that the DNA-protein binding and 
crystal packing were not affected by the presence of iodine atom in the DNA (Figure 
4-20). Out of the 4 DNA duplexes, the double helix in Iodo17 is most deformed 
(Figure 4-20) but the polypeptide chain overlaid well with other models (Table 4-9). 
Overall, the quality of the Native X-ray structure is the poorest among others. It can 
be seen from the Figure 4-19(b) that β3 strand was not identified correctly using 
either DSSP (Kabsch and Sander, 1983) or PROCHECK (Laskowski et al., 1993).  
 
As will be described in Chapter 5, water molecules are pivotal to mediate contact of 
the MeCP2 MBD domain and the methyl groups. The best refined structural model 
with the highest number of water molecules was selected for detailed structural 
analysis: A140SeMet-Mn has the highest resolution data, the best refined structure and 
most importantly, contains the highest number of water molecules (total 47 water 
molecules). The quality of model Iodo17 is generally good but only 30 water 
molecules were assigned due to a relatively low resolution data. In order to ensure 
that the A140SeMet-Mn is identical in particular to the native X-ray structure, the 
models were superimposed using either Cα or all atoms (Table 4-9). Overlay of 
A140SeMet-Mn and Native using all Cα produced an RMSD fit of 0.43Å. This 
indicates that both structures are essentially identical (Figure 4-20). In fact, all models 
are identical to A140SeMet-Mn with Cα RMSD fit below 0.6Å. Nevertheless, 
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overlaying using all atoms except water molecules give RMSD fit generally higher 
than the Cα alone.   
 
 
Figure 4-19 Refined models of A140SeMet-Mn, Native, Iodo3 and Iodo17 
(a) X-ray structure of A140SeMet-Mn from selenium Peak data, (b) Native X-ray structure, (c) 




Table 4-8 Refinement statistics 
 
Crystal  A140SeMet Native  D21 D22 
Dataset A140SeMet-Mn Native Iodo17 Iodo3 
Refinement      
       Rcryst/Rfree (%) 21.2/ 27.6 23.0/ 29.5 24.3/30.1 24.9/29.5 
Geometry     
rmsd bond/angles (Å, ˚) 0.009/1.85 0.016/2.67 0.010/1.901 0.017/2.917 




Figure 4-20 Overlay A140SeMet-Mn with native and iodinated X-ray structures 
Stereo views of overlay of Iodo17 (green), Iodo3 (blue) and Native (yellow) models onto 
A140SeMet-Mn using all Cα atoms. All models show identical structure as the best refined 
A140SeMet-Mn except iodinated DNA duplex from Iodo17.  
 
Table 4-9 RMSD fit of all 4 structures using Cα and all atoms 
 Native  Iodo17 Iodo3 
A140SeMet-Mn 0.43 (0.62) 0.59 (0.98) 0.44 (0.67) 
Native  - 0.77 (1.13) 0.49 (0.76) 
Iodo17 - - 0.70 (1.09) 















CHAPTER 5. STRUCTURAL ANALYSIS 
5.1 INTRODUCTION 
The solution structure of MBD domains from MeCP2 and MBD1 were published in 
1999 (Ohki et al., 1999; Wakefield et al., 1999). These NMR structures generally 
explored the tertiary protein folding of the MBD domain and the potential residues 
that are involved in the DNA binding. Two years later, Ohki et al. reported the first 
structure of MBD protein in complex with a methylated DNA (Ohki et al., 2001). The 
authors claimed that the binding specificity of the MBD domain depends on 
hydrophobic interactions between the methyl groups of m5C and a hydrophobic patch 
comprising of 5 residues, Val20, Arg22, Tyr34, Arg44 and Ser45, within the MBD 
domain (Ohki et al., 2001). The X-ray structure determined in this study reveals, 
however, that the methyl groups make contacts with a predominantly hydrophilic 
surface that includes 5 water molecules.  
 
The Rett missense mutations occur throughout the MECP2 gene with more than half 
of disease-causing Rett missense mutations affecting the core MBD between amino 
acid 97 and 161, although this constitutes only approximately 13% of the total amino 
acid sequence. Of these; T158M, R133C, R106W account for 73% of Rett mutations 
found within the MBD domain (Kriaucionis and Bird, 2003). The crystal structure 
highlights the role of these 3 important residues in stabilising protein folding and in 
DNA-protein interactions. The X-ray structure also explains how T158 (the most 
common missense mutations of RTT) coordinates the unusual Asx-ST motif. This 
motif involves two consecutive turns at the C-terminal region of the MeCP2 MBD 
domain.     
 
Recently discovered AT bases close to the symmetrical methyl-CpG dinucleotides 
that promotes high binding of MeCP2 (Klose et al., 2005) could possibly contribute to 
DNA bending. The structure presented here shows hydrogen bonds connecting 
Val159(N) to the phosphate group of T31. The AT bases also display a high degree of 
propeller twist and distinct features of narrowing the minor groove and widening of 
major groove. These features may have a consequence of DNA bending and stability. 
However, the roles of the AT run in increasing MeCP2 binding remain unknown.       
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The X-ray structure from the crystal A140M-SeMet-Mn (with the lowest Rcryst/Rfree, 
RMSD bond/angle and highest FOM) (Table 4-8) was used for full structural analysis 
using various programmes. This structure rationalises the effects of the common Rett 
mutations and provides a new and general model for methylated-DNA binding that is 
dependent on structured water molecules discovered in this study.    
5.2 MATERIALS AND METHODS 
The final model from the selenium peak data was used for structural analysis. 
Multiple sequence alignment was performed with T-coffee (O'Sullivan et al., 2004). 
The secondary structure and geometry features were defined using DSSP (Kabsch and 
Sander, 1983) and PROMOTIF (Hutchinson and Thornton, 1996) and displayed with 
ESPript (Gouet et al., 1999). Structural motifs of the protein were analysed with 
MSDMotif (Golovin et al., 2004) and the potential hydrogen bonds were predicted 
with HBPLUS (McDonald and Thornton, 1994). The X-ray DNA geometry was 
analysed with 3DNA (Lu and Olson, 2003) and all figures with structural 
representatives (eg. lines, sticks, spheres, cartoons and electron density) were 
prepared using Pymol (DeLano, 2003). 
5.3 RESULTS AND DISCUSSION   
5.3.1 Overall structure  
To obtain a high resolution crystal structure of the MeCP2 MBD-DNA complex, the 
recent discovery of 4 or more AT bases close to the central methyl-CpG which 
promotes high affinity binding of MeCP2 (Klose et al., 2005) was taken into 
consideration. The recombinant protein of the MeCP2 MBD domain (construct 77-
167) contains 91 amino acids (Figure 5-1), immediately followed by an uncleavable 
6xHis tag at the C-terminus. This was co-crystallised with the synthetic nucleic acid 
comprising a 20 bp DNA fragment (nucleotides -108 to -90) of promoter III of the 
BDNF gene, which contains a central methyl-CpG pair and an adjacent four AT run 
(Figure 5-2a). This promoter was implicated as an MeCP2 endogenous target gene 
(Chen et al., 2003; Martinowich et al., 2003). 
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Structural analysis of the best model (A140SeMet-Mn) reveals that 75 % of the amino 
acids can be defined from the electron density map. Unfortunately, the first 14 
residues at the N-terminal region (amino acid 77-90) and the last 11 residues at the C-
terminal region (amino acid 163-167 and the 6xHis tag) however could not be traced 
at this resolution (2.5 Å). This was largely due to the floppy loops located at both C- 
and N-terminals of the construct 77-167. All 40 nucleotides can be defined as a 
slightly bent B-form Watson-Crick double-stranded DNA helix. In addition, a total of 
47 water molecules were also identified. Although Mg2+ or Mn2+ was incorporated 
into the crystallisation solution, none of these ions were identified in the X-ray 
structure. The overall structure of the MBD domain in complex with methylated DNA 
is shown in Figure 5-2b and c. The protein and DNA are represented by cartoon 
(chain A) and sticks (chains B and C), respectively, and the protein-DNA interactions 
mainly occur within the major groove which contains the m5C methyl groups. The 
single-base overhangs of 5’T1 and 5’A21 on chain B and C, respectively, form end-
to-end base stacking with the adjacent double helices. The actual sequence 
corresponding to the nucleotides -108 to -90 of promoter III of mouse BDNF gene is 
the complementary 19 base pair DNA region. 
 
Figure 5-1: Sequence comparison of methyl binding domain of the MBD protein 
family from Human (H), mouse (M), and Xenopus (X) MeCP2 MBD 
Secondary structure elements from the X-ray structure are denoted by arrows (β-strand) and 
coils (α-helix). Mutations that have been associated with neurological disease are shown.  
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(a)                  (b)                   (c) 
 
(d)      (e) 
 
 
Figure 5-2: The conformation of the X-ray structure of MeCP2-MBD complexed 
with BDNF promoter DNA at 2.5 Å is similar to the unliganded MBD 
(a) BDNF promoter DNA sequence used in the co-crystal X-ray structure. The overhanging 
T/A bases were incorporated to promote crystallisation through end-to-end DNA stacking. (b) 
The X-ray structure of MeCP2-MBD in complex with DNA. The methyl groups of the mCpG 
pair are shown as spheres.  The β-strands (green) and α-helix (blue) are connected by the 
loops L1 (R111- K119), L2 (N126- K130) and L3 (R133- V135). The tandem Asx-ST motif 
(D156- R162) is highlighted in red. (c) X-ray structure viewed along the DNA helix. (d) 
Overlay of the unliganded MeCP2 structure determined by NMR (grey) with the X-ray 
structure (blue) in complex with DNA (yellow). The Asx-ST turn of the X-ray structure is 
highlighted in red and (e) a view of the overlay along DNA double helix as (c). 
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5.3.2 Secondary structure and protein folding  
The secondary structure of the MeCP2 MBD domain in complex with 20 bp 
methylated DNA was examined using the programmes DSSP (Kabsch and Sander, 
1983) and PROMOTIF (Hutchinson and Thornton, 1996). Both programmes defined 
a consistent secondary structure as shown in Figure 5-1. In general, the MBD domain 
contains three β-sheets which consist of 19.4% while the α-helix accounts for only 
15.3% of total amino acids (Table 5-1). The secondary structure determined in this X-
ray study is similar to that of the solution structure of MeCP2 MBD alone (Wakefield 
et al., 1999) except an additional β-sheet (amino acid 96DDP98) at the N-terminus 
defined by Wakefield and coworkers (1999) (Figure 5-2c). Overlaying the X-ray and 
NMR determined MBD domains shows that both structures are similar with an 
RMSD fit for Cα atoms of 2.33 Å (Figure 5-2d, e). The most notable difference 
concerns loop L1, which is drawn towards the DNA through four hydrogen bonds 
with the phosphate backbone on the surface of the major groove that includes the pair 
of cytosine methyl groups (Figure 5-2d). A subtle conformational change also occurs 
in Loop L2 where the loop is brought closer to the DNA although no hydrogen bond 
are observed.   
 
Table 5-1 Secondary structure of X-ray MeCP2 MBD 





Amino acid sequence  
N-terminal loops 91-104 (14) RGP(Mse)†YDDPTLPEGW 
β1 105-110 (6) TRKLKQ 
L1 111-119 (9) RKSGRSAGK 
β2 120-125 (6) YDVYLI 
L2 126-130 (5) NPQGK 
β3 131-132 (2) AF 
L3 133-134 (2) RS 
α1 135-145 (11) KVELI(Mse)‡YFEKV (16.70 Å)* 
C-terminal loops 146-162 (17) GDTSLDPNDFDFTVTGR 
† in the wild type sequence, this position consists of Met94 
‡ in the wild type sequence, this position consists of Ala140  




The crystal structure of the MeCP2 MBD complexed with DNA also displays a high 
structural homology with the secondary structure of NMR established MBD1 MBD-
methylated DNA complex published by Ohki and coworkers (Ohki et al., 2001). 
Overlay using the 20 Cα atoms from strand β1, β2 and α1 gives an RMSD fit of 1.4 Å 
(Figure 5-3a). This superposition shows that, both DNA duplexes are not in a similar 
orientation (Figure 5-3b) despite the similarity of their binding proteins. Though the 
MBD1 is folded in a similar way, there are some important differences in the 
molecular details of recognition and binding. Using ensemble 1 of the MBD1 MBD-
DNA complex (pdb: 1IG4) for PROMOTIF analysis, the length of the α-helix 
comprising of 8 residues is 4.7 Å shorter than MeCP2 MBD α-helix. In the C-terminal 
region, MBD1 has a 4-residues (β-turn 151DPND154 in MeCP2) deletion and has a type 
I β-turn for amino acids 63DFKQ66 (Figure 5-1) which cannot adopt an equivalent 
Asx-ST-motif as in the MeCP2 MBD domain. MeCP2 MBD is hydrogen bonded to 
the AT run DNA phosphates which may play a role in complex formation. It is 
possible that the absence of this unique structural motif or an AT run close to methyl-
CpG resulted a different DNA orientation for the NMR established MBD1 MBD-
DNA complex.    
 
(a)    (b)            (c) 
 
Figure 5-3 Overlay of MeCP2 (X-ray) and MBD1 (NMR) MBD-DNA complexes 
(a) superposition of the MBD domains of MeCP2 (blue and red) and MBD1 (green) using 20 
Cα atoms from strands β1, β2 and α1 gives an RMSD fit of 1.4Å. Asx-ST-Turn is coloured in 
red. (b) DNA positions resulted from overlaying of their binding proteins. The BDNF and 12 
bp DNA are represented in yellow and magenta, respectively. (c) overlay of the complexes of 
MBD1 and MeCP2 MBD with their methylated DNA.  
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Analysis with PROMOTIF also highlights other characteristics of the MBD domain 
of MeCP2. All together 9 β-turns have been identified (Table 5-2). The first 2 
consecutive β-turns (97DPTL100 and 101PEGW104) preceding the first β-strand of the 
protein structure. Interestingly, Loop L1 contains 3 β-turns: 113SGRS116 (type IV), 
114GRSA117 (type I) and 116SAGK119 (type II). L2 composed of type I β-turn 
(126NPQG129). As shown in Figure 5-1, the β-turns composed of 151DPND154 before 
the conserved FDF motif is only present in MeCP2 and MBD4 but not other MBD 
proteins. This indicates that the DNA binding mode of MBD4 might closely resemble 
MeCP2. However, the requirement of AT bases for high affinity binding of MBD4 is 
still unexplained. This type I β turn could possibly position the unique structural motif 
proximal to the DNA phosphate backbone.  
 
Table 5-2 MeCP2 MBD β-turns 
Structure analysed with PROMOTIF (Hutchinson and Thornton, 1996) 
Residues  Sequence  Type i to i+3 distance (Å) 
97-100 DPTL I 5.8 
101-104 PEGW II 5.7 
113-116 SGRS IV 6.6 
114-117 GRSA I 5.4 
116-119 SAGK II 5.6 
126-129 NPQG I 5.0 
151-154 DPND I 5.7 
152-155 PNDF IV 5.9 
158-161 TVTG I 5.1 
 
 
5.3.3 Unique roles of T158 in tandem Asx-ST-motif  
Mutation of T158M, R133C and R106W account for the highest number of Rett cases 
(Kriaucionis and Bird, 2003). Using the MSDmotif server (Golovin et al., 2004), the 
structural roles of Thr158 and Arg106 in stabilising a unique structural motif; which 
comprises of two consecutive turns; have been defined (Figure 5-4a). The first 
structural motif is an Asx motif and comprises 156DFT158 followed immediately by an 
ST-β-turn (158TVTG161).  This structural motif was named as a ‘tandem Asx-ST-







Figure 5-4: T158 plays a structurally important role in forming the tandem Asx-
ST motif.  
(a) The Asx turn is composed of D156, F157 and T158 with the motif-defining hydrogen 
bond formed between the D156 carboxylate side-chain and the main-chain amine nitrogen of 
T158.  The ST-motif is the modified β-turn consisting T158, V159, T160 G161 and R162 
with the side chain hydroxyl group of T158 hydrogen bonding to the main chain nitrogen 
atoms of G161 and R162. (b) Overlay of similar structural motifs identified from Protein 
Database (Berman et al., 2000), TVDGR (1CBS, green), TVRG (1PTA, blue), TVDGR 
(1XCA, magenta), and TVTGR (4KIV, yellow), with the X-ray structure of this study (red).  
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By definition, the Asx-motif is characterised by three amino acids with residues i 
being either Asp or Asn with the carboxylate side-chain forming a hydrogen bond 
with the main-chain amine group of the third (i+2) amino acid (Wan and Milner-
White, 1999a). The ST-β-turn is characterised by a β-turn with Ser and Thr in position 
of residue i with the side-chain hydroxyl further stabilising the turn with a hydrogen 
bond to NH of i+3 and i+4 residues (Wan and Milner-White, 1999b). The Asx turn is 
formed by a hydrogen bond that connects the main-chain NH of Thr158 and the side-
chain carbonyl of Asp156 (Table 5-3 and Figure 5-4). The ST-turn is shaped by two 
hydrogen bonds connecting the side-chain hydroxyl group of Thr158 to the main-
chain amide groups of Gly161 and Arg162. Thus, Thr158 occupies a pivotal position 
that coordinates the two consecutive turns. Interesting, this tandem Asx-ST-motif is 
further stabilized by hydrogen bonds to Arg106 which connects the main-chain 
carbonyl group of Thr158 and Val159 (Figure 5-4a).  
 
Table 5-3 Hydrogen bonds in Asx-ST-motif of MeCP2 MBD domain  
Motif  Residue Atom  Residue Atom  Distance (Å) 
Asx turn  Asp156 (i) OD2 Thr158 (i+2) N 2.9 
OG1 Gly161 (i+3) N 3.1 
OG1 Arg162  N 2.7 
O Gly161 (i+3) N 3.3 
Thr158 (i) 
O Arg106 NH2 2.6 
N T31 O2P 3.2 
ST-β-turn 
Val159 (i+2) 
O Arg106 NH1 2.9 
 
In agreement with the PROMOTIF (Hutchinson and Thornton, 1996) analysis, 
MSDmotif analysis shows that 158TVTG161 belong to type I β-turn. The φ/ψ angles of 
i+1 (Val159) and i+2 (Thr160) are -55.1/-57.0˚ and -71.3/-19.4˚, respectively (Table 
5-4), and this fulfilled the requirements for a type I β-turn. Small structural motif 
searches using the MSDmotif server reveals that there are 1773 X-ray structures in the 
Protein Database (Berman et al., 2000) with resolution better than 2.5Å containing an 
equivalent β-turn, of which, only 4 bear the sequence TVXG (Table 5-4). Overlay of 
these structures with the ST-β-turn in this study gave Cα RMSD fits between 0.24 and 
0.49Å (Table 5-4 and Figure 5-4b). This highlights the defined conformation of the 
type I β-turn composed of TVXG as observed in this study. 
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Table 5-4 Overlaying of type I β-turns with 158TVTGR162 of MBD in this study    






This study  TVTGR -55.1/-57.0 -71.3/-19.4 - 
1CBS (Kleywegt et al., 1994) TVDGR -56.88/-37.13 -83.47/6.03 0.31 
1PTA (Benning et al., 2001) TVRG -69.22/-10.36 -115.67/5.48 0.24 
1XCA (Chen et al., 1998) TVDGR -50.79/-19.01 -102.23/0.83 0.40 
4KIV (Mochalkin et al., 1999) TVTGR -51.68/-19.71 -99.26/17.35 0.49 
*    To be classified as a type I β-turn, the φ and ψ angles of the residues i+1 and i+2 must be: 
-140 < φ < -20 and -90 < ψ < +40. The Cα RMSD fits were calculated by overlaying the 
selected motifs on TVTGR of this study.  
 
The location of this Asx-ST motif is not influenced by the bound DNA as it is 
invariant from the unliganded form (Wakefield et al., 1999). The conformation of the 
Asx and ST turn seems crucial in the interaction of MeCP2 with the DNA. The amine 
group of Val159 forms a hydrogen bond with atom O2P of T31 (see Table 5-3 and 
Figure 5-4a), which coincides with the start of the AT-run (nucleotide T31 on chain 
C). It is known from binding studies that MeCP2 (in contrast with MBD1) requires a 
proximal AT run for high affinity binding (Klose et al., 2005). The MBD1 sequence 
is shorter by four residues (β-turn 151DPND154 in MeCP2) in this region and cannot 
adopt an equivalent Asx-ST-motif shape. Therefore, it is hypothesised that the 
interaction of the Asx-ST-motif is important in the recognition of the proximal AT 
run by MeCP2. The missense mutation of T158M and R106W may destabilise this 
tandem Asx-ST-motif and subsequently disrupt the DNA binding. Mutational analysis 
of T158 will be discussed in Chapter 6.  
5.3.4 Interactions of MeCP2 MBD domain and BDNF fragment   
The DNA-protein interactions occur exclusively within the methyl-m5C containing 
DNA major groove, involving three base pairs (Figure 5-5a), one above and one 
below of methyl-m5C, at both strands. The MBD domain makes contacts with the 
DNA by direct and water molecules mediate protein side-chain interactions with the 
DNA bases and phosphate backbone. Surprisingly, only a minimum direct contact 
between the protein and the symmetrical methy-m5C dinucleotides was observed. The 
DNA-protein interaction analysis reveals that contacts between the MBD and methyl 
groups of m5C indeed depend upon a specific hydration pattern at the major groove of 
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the DNA. In contrast to the unmodified cytosine, the methylated cytosine bases are 
more hydrated.  
5.3.4.1 Water mediated interactions 
The contacts between the methyl-CpG binding surface of MBD1 MBD and the C5 
methyl groups were thought to be hydrophobic interactions involving a hydrophobic 
patch comprises of Val20, Arg22, Tyr34, Arg44 and Ser45 (Figure 5-1) (Ohki et al., 
2001). In contrast to Ohki et al. (2001), the methyl-CpG-binding surface in this study 
is unexpectedly hydrophilic. The C5 methyl groups (m5C8 and m5C33) form close 
contacts (less than 4Å) with 13 and 12 neighbouring atoms respectively (Figure 5-5a 
and Table 5-5). Of the 25 interactions only two (m5C33 to CG and CB of Arg133) are 
classically hydrophobic in character. MeCP2 recognition of methyl-CpG involves the 
five water molecules W12, W24, W10, W21 and W22, each making a C-H…O 
interaction with one of the methyl groups (Figure 5-5a and b). W24 and W22 form a 
tetrahedral arrangement of hydrogen bonds that bridge DNA with protein and also C-
H…O interactions with both methyl groups of the methyl-CpG dinucleotide pair 
(Figure 5-5a and b). W22 forms four hydrogen bonds with, Asp121, W24, W21 and 
N4 of m5C33 plus a C-H…O interaction with the C5 methyl group of m5C33. W24 
forms four conventional hydrogen bonds with Tyr123, Arg133, W22 and N4 of m5C8 
plus a C-H…O interaction with the methyl group of m5C8 (Figure 5-5a, b and Table 
5-5). Interestingly, C-H…O hydrogen bonds have been implicated in methyl group 
recognition during lysine methylation by SET domain lysine methyltransferases 
(Couture et al., 2006). The importance of Asp121 in maintaining the DNA-protein 
interaction has been tested using site-directed mutagenesis and the result is presented 
in Chapter 6.  
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Figure 5-5 m5C methyl groups interactions 
(a) The m5C methyl groups are shown as yellow balls. Non-bonded contacts to the m5C 
methyl groups of less than 4Å are shown as black dashed lines.  The water molecules W10, 
W12, W21, W22 and W24 are drawn as purple balls.  
(b) Hydrogen bonds are shown as black dashed lines.  The two m5C methyl…water contacts 
are drawn as dashed red lines.  Distances for all hydrogen-bonds shown in this figure are 
tabulated in Table 5-5.  Specific hydrogen bonds formed between R111 and G9 (chain B) and 
R133 and G34 (chain C) position the guanidinium groups directly over the methyl groups of 
the m5C bases. 
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Table 5-5 Hydrogen bonds and van der Waals contacts at the methyl-m5C 














CZ 3.9 Arg111 
NH2 3.6 
OD1 3.9 
OD2 3.5 Asp121 
CG 3.8 
W24  3.5 
m5C8 methyl 
W12  3.8 
C2* 3.9 









W21  3.9 
W22  3.4 
m5C33 methyl 
W10  3.8 
 
5.3.4.2 Interactions of MBD-DNA bases  
The only MeCP2-MBD residues that directly interact with DNA bases in the 
crystallised BDNF sequence are Asp121, Arg111 and Arg133 (Figure 5-5a, b and 
Table 5-5). Asp121 makes a CH…O hydrogen bond of 3.5Å with the methyl group of 
m5C8 (Figure 5-5a). The hydrogen bonds formed between the symmetrical arginine 
fingers (Arg111 and Arg133) and each guanine of the methyl-CpG pair (Figure 5-6) 
occur frequently in diverse examples of protein-DNA recognition (Luscombe et al., 
2001). Both arginine fingers lie in a plane with the guanine bases and are locked in 
position by salt bridges with the carboxylates of Asp121 and Glu137 (Table 5-6).  
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Arg133 NH2 3.1 
Tyr123 OH 2.9 
W24 
 




Asp121 OD1 2.7 
W21  3.0 
W22 
 
W24  2.6 
m5C8 methyl 3.8 
W34  2.8 
Tyr123 OH 2.7 
W12 
 
A7 O2P 2.7 
methyl 3.8 
m5C33 
O2P 2.6 W10 
 
W42  3.3 
W12  2.7 
Tyr123 OH 
W24  2.9 
m5C8 methyl 3.9 
W22  2.7 OD1 
Arg111 NH2 2.8 
m5C8 methyl 3.5 
W34  3.0 OD2 
Arg111 NE 2.7 
Asp121 
CG m5C8 methyl 3.8 
m5C8 methyl 3.9 
NE 
Asp121 OD2 2.7 
m5C8 methyl 3.6 
NH2 
Asp121 OD1 2.8 
Arg111 
CZ m5C8 methyl 3.9 
NH1 m5C33 methyl 3.9 
m5C33 methyl 3.7 
NH2 
W24  3.1 
m5C33 methyl 3.7 
NE 












Figure 5-6 Arginine fingers 
Both Arg111 and Arg133 are held in place by salt-bridge interactions with from Asp121 and 
Glu137, respectively. All the classical hydrogen bonds are within 3.5 Å.  
 
This symmetrical arrangement of the arginine side chains places the guanidinum 
groups directly above/beneath the methyl groups of the methylated cytidine bases 
with an average methyl-guanidinium distance of 3.7Å (Figure 5-5a). Specificity for 
the methyl-CpG base pair derives in part from the constrained configuration of 
arginine side-chains in contact with the juxtaposed guanines that are exclusive to the 
CpG sequence motif. These direct base contact residues are conserved in the MBD 
family (Figure 5-1), therefore, it is speculated other MBD proteins also recognise their 
endogenous target DNA with these residues.   
 
One of the key focuses of this study is to determine the methyl-CpG binding 
specificity of the MeCP2 MBD domain. The presence of structurally conserved water 
molecules due to cytosine methylation in the major groove possibly establishes the 
methylated DNA binding specificity of the protein. This methylation-specific 
hydration pattern has been noted previously and was speculated to potentially specify 
recognition of methylated DNA by proteins (Mayer-Jung et al., 1998). Mayer-Jung 
and co-workers reported that the m5C modified the hydration pattern surrounding the 
methyl groups by attracting more water molecules. Two water molecules connect the 
 135
methyl group of m5C through CH…O hydrogen bonds, and these water molecules 
also individually hydrogen bond to N4 and the m5C phosphate oxygen (Mayer-Jung 
et al., 1998). In the X-ray structure of this study, two equivalent water molecules were 
also observed for each m5C. Both W24 and W12 are C-H…O bonded to methyl 
group of m5C-8 but separately connect the O2P of A7 and N4 of m5C-8 (Figure 
5-7a). In this MeCP2 MBD-DNA complex, W22 and W10 behave similarly by 
connecting the methyl group of m5C-33 through C-H…O hydrogen bonds and 
individually bond with N4 and O2P of the same nucleotide (Figure 5-7b). In addition 
to other water molecules in the major groove, it is speculated that the string of waters, 
composed of W34, W12, W24, W22, W21, and W10, at the DNA-protein interface 
(Figure 5-5) results from cytosine methylation. In contrast, unmodified cytosine bases 
in this X-ray structure are less hydrated than the methylated cytosine and the 
hydration pattern due to the C5 methylation-specific characteristic has not been 
shown.  
 
Figure 5-7 Methylation specific hydration of methyl-CpG 
(a) Both W24 and W12 interacting with methyl group of m5C-8 though C-H…O hydrogen 
bonds but separately contacting N4 of the same nucleotide and O2P of A9.  
(b) Both W22 and W10 forming C-H…O hydrogen bonds with methyl group of m5C-33. 
W10 also mediating the contact of methyl and O2P of the same nucleotide. The electron 
density for m5C and A9 are coloured in blue and pink, respectively. Methyl groups are 
represented by yellow spheres.     
 
This observation was further supported by analysing the deposited X-ray determined 
DNA structures in the Nucleic Acid Database (NDB) (Berman et al., 1992). The NDB 
contains all types of nucleic acid structures including ligands and protein bound 
complexes determined using X-ray crystallography or NMR (Berman et al., 1992). 
All m5C containing DNA structures were mined using the NDB integrated searches. 
 136
Various searches interrogating the effect of nucleic acid modifications, nucleic acid 
conformational type and components of biomolecules were carried out (Berman et al., 
1992). In the initial round, by ignoring the base and sugar modifications, all together 
3658 hits were found. By choosing double-stranded DNA structures only and solved 
by X-ray crystallography, regardless of their conformational types, the positive 
candidates were reduced to 656 hits. Further elimination using 3Å resolution cut off 
yielding 649 hits. Out of these structures, 47 contained m5C; all water molecules 
within 4Å from the methyl groups were identified. The water molecules that bridge 
the DNA phosphate group to the methyl group and those forming CH...O bonds with 
the methyl group and simultaneously connect the N4 of 5mC were identified. Of 
these, 78% have at least one m5C base coordinating a water molecule through a 
CH…O hydrogen bond to the methyl carbon and simultaneously a conventional 
hydrogen bond to N4 (similar to the interactions shown by W22 and W24) and with 
this characteristic, 84% contain at least one water molecule bridging the DNA 
phosphate group to the methyl group of m5C (Figure 5-7). 
5.3.4.3 Interactions of MBD and DNA phosphate backbone 
The major MBD-DNA base contacts involve the recognition of symmetrical methyl-
CpG dinucleotides in the major groove of the crystallised BDNF fragment. Apart 
from the MBD-DNA base contacts, there are 7 additional classical hydrogen bonds; 
mainly composed of Ser and Lys residues; connecting the MeCP2 MBD domain to 
the DNA phosphate backbone. Figure 5-8 shows that 4 out of 7 DNA backbone 
contacts are located on loop L1. These hydrogen bonds draw the loop L1 to the DNA 
phosphate groups. The main-chain amine group of Lys112 and side-chain of Ser113 
are hydrogen bonded to O2P and O1P, respectively, of m5C-8. These interactions 
bring the first half of the loop L1 close to chain B of DNA while the second half of 
the long loop interacts with the phosphate group of G9 and T30 via hydrogen bonds 
from Ser116 and Lys119, respectively, in which, the latter bring the C-terminal end of 
this loop to chain C. This DNA induced movement of loop L1 is shown in Figure 
5-8(inset) with a Cα RMSD of 3.4Å between amino acid Arg111 to Lys119 of the X-
ray and NMR (Wakefield et al., 1999) determined MBD structures. In addition, the 
side-chains of Lys109 of β1 and Ser134 of L3 also form hydrogen bonds with A7 and 








Figure 5-8 Hydrogen bonds between the DNA phosphate backbone and MeCP2 
MBD 
The cartoon represents the complex of MeCP2 MBD-DNA with the protein side/main-chain 
(sticks) hydrogen bonded to the DNA phosphate groups. All atoms involved in direct 
hydrogen bonds (black dash lines) are labelled (Table 5-7). Chains B and C of the DNA are 
coloured in purple and yellow, respectively. The methyl groups are indicated by grey spheres. 
Four of the seven hydrogen bonds position L1 in the major groove of the DNA. A hydrogen 
bond is also formed by the amide NH group of Val159 in the middle of the tandem Asx-ST-
motif (red). The inset shows the DNA induced movement of Loop L1 of the X-ray structure 
(blue) compared to unliganded MeCP2 MBD (white loop). The RMSD calculated using Cα 
from residues 111-119 is 3.4Å.  
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The tandem Asx-ST-motif of the MeCP2 MBD also interacts with the DNA via a 
hydrogen bond between Val159(N) of the Asx-ST-motif and the phosphate oxygen of 
T31 (base-paired with A11) at the start of the AT run (11AATT14) (Table 5-7, Figure 
5-8). Runs of 4-6 consecutive A/T bases adjacent to the methyl-CpG dinucleotides are 
required to maximise the binding of MeCP2 and methylated DNA (Klose et al., 
2005). This hydrogen bond (3.19 Å) is the only the direct interaction between the 
Asx-ST-motif and the AT run of the DNA, and may possibly play a major role in 
maintaining a stable Asx-ST-motif-DNA interaction. Alteration of amino acids 
composed of Asx-ST-motif which disrupt this hydrogen bonding could significantly 
reduce MeCP2-methylated DNA binding. This will be discussed in Chapter 6.   
 
Table 5-7 Direct hydrogen bonds between MeCP2 MBD and the DNA phosphate 
backbone  
 
Residues(atom) Phosphate group(atom) Distances (Å) 
K109 (NZ) A7(O1P) 3.1 
K112(N) m5C8(O2P) 2.9 
S113(OG) m5C8(O1P) 2.6 
S116(OG) G9(O1P) 3.4 
K119(NZ) T30(O2P) 2.9 
S134(OG) m5C33(O2P) 2.5 
V136 (CB) m5C33 (O2P) 3.5 
V159(N) T31(O2P) 3.2 
 All distances are below 3.6Å 
 
The hydrogen bond that bridges Ser134 (loop L3) and Val136 (helix α1) to the 
oxygen phosphate of m5C-33 connects the N-terminal region of α-helix close to the 
DNA-protein contact interface. Water mediated contacts also contribute to the 
stabilisation of this region. Three water molecules (W5, W10 and W42) form 
hydrogen bond bridges between Ser134 and Val136 and the phosphate groups of 
m5C-33. W42 bridges the interaction between V136(CG2) to O2P of m5C-33. W5 
coordinates the interactions of side-chain Ser134 and Val136 to atom O1P of m5C-33. 
Interestingly, W10 which is also involved in CH…O hydrogen bonds to methyl 




Figure 5-9 MBD alpha-helix 1 and DNA backbone interactions 
(a) The only α-helix in the MBD domain is brought close to the DNA backbone (chain B) via 
hydrogen bonds formed between Ser134(OG) (on loop L3) and Val136(CB) (on α-1) with 
atom O2P of m5C-33. Loop L3 is coloured in gray and α-helix in blue. Methyl group of m5C-
33 is shown as spheres.   
(b) Three water molecules; W5, W10, and W42 connecting the Ser134 and Val136 to the 
phosphate oxygen of m5C-33 through several water mediated interactions. All water 
mediated interactions in this short loop are less than 4.0 Å.   
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5.3.5 DNA GEOMETRY 
The primary sequence of the double stranded DNA influences the DNA groove width, 
helical twist, bending and mechanical rigidity or resistance to bending. These special 
features help other molecules such as repressors/activators to read and recognise their 
cognate DNA binding sequence. Early reports argued that the MBD domain of 
MeCP2 binds to methylated DNA regardless of their flanking sequences. The 
requirement of an AT run adjacent to the methyl-CpG to maximise the MBD binding 
however suggests that MeCP2 target genes are sequence specific (Klose et al., 2005). 
The 20 mer BDNF gene fragment used in this study contains a central methyl-CpG 
and a run of AT bases which may exhibit the required DNA geometry. The A/T track 
DNA can be defined as a stretch of DNA containing four to six consecutive A/T bp.  
Depending on the DNA sequence, A/T track DNA is rigid and straight with a very 
narrow minor groove and a high degree of propeller twist (El Hassan and Calladine, 
1996; Mack et al., 2001; Nelson et al., 1987; Prive et al., 1987; Stefl et al., 2004; 
Wing et al., 1980). In order to study these properties, the DNA geometry of the X-ray 
structure was analysed using 3DNA (Lu and Olson, 2003).  
5.3.5.1 Geometrical description of dinucleotide steps  
The geometrical descriptions of DNA used in this section are simplified in a 
schematic diagram as shown in Figure 5-10. For the dinucleotide step parameters 
(Figure 5-10a), each block represents a base-pair with the minor groove sites coloured 
grey. The 5’ to 3’ direction of the strands is indicated (El Hassan and Calladine, 
1996). The arrows give the directions of the rotations and translation of the upper, 
relative to the lower block, which correspond to a positive value of helical twist, roll 
and slide. To illustrate the base pair parameter of propeller twist as shown in Figure 
5-10b, one base (represented by a rectangular block) is rotated relative to its pair in a 
left-handed sense (negative propeller twist) about the common long axis of the base-




Figure 5-10 Schematic representations of (a) dinucleotide step and (b) base-pair 
parameters 
5.3.5.2 Overall DNA geometry  
A schematic drawing of the 20 mer BDNF helix is presented in Figure 5-11. The X-
ray structure of the methylated BDNF fragment is a Watson-Crick right handed B-
DNA helix with an average rise per residue of 3.3 Å (Table 5-8) which is shorter than 
standard B-DNA (3.4 Å) This is consistent with the observation of a cluster of strong 
DNA reflections at resolution close to 3.3 Å (Figure 4-9, Chapter 4) corresponding to 
base pair stacking in the DNA molecules. The 20 bp DNA helix composed of two 
complete turns, with ~10 bp per turn.  
 
The minor and major groove widths were measured considering the directions of 
sugar-phosphate backbones. A useful measurement of the phosphate-phosphate 
distance across the major and minor groove opening is made by subtracting 5.8Å (the 
van der Waals radii of two phosphate groups) from the calculated values (El Hassan 
and Calladine, 1998). This value is not subtracted from the calculated phosphate-
phosphate distances presented in Table 5-8. As shown in Figure 5-12, the narrowest 
minor groove of the DNA is located at the central run of AT bases (11AATT14 paired 
with 28AATT31) with an average of 9.1 Å with the shortest distance of 8.6Å for the 
step A12T13/A29T30. On the other hand, the minor groove composed of 14TCTTC18 
paired with 24GAAGA28 also displayed the characteristic of narrow minor groove of 
A/T track DNA with an averaged groove width of 9.8 Å (Table 5-8) which is 
narrower than the standard B-DNA (11.5 Å). In fact, 50% (11AATTCTTCTA20) of the 
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BDNF sequence used in this study can be considered as A/T track although 
intercalated by base pairs C15/G27 and C18/G24. Another region of the helix that 
shows significant narrow minor groove features is 6AAm5C8 with an average minor 
groove width of 9.7 Å even though it consists only of two consecutive A/T base pairs.  
    
 
Figure 5-11 Skeletal stereo drawing of X-ray determined 20 mer BDNF fragment 
The double-stranded DNA adopted a Watson-Crick right-handed B-DNA conformation and 
consists of 2 complete turns. This drawing is presented in the same orientation as in Figure 
5-2b, where the numbering can be referred. The AT run of this DNA fragment is highlighted 
















Table 5-8 Local helix parameters 
Minor groove/Å Major groove/Å 
Step 







C2T3/A39G40 - - - - 29.0 3.0 
T3G4/C38A39 - - - - 34.5 3.2 
G4G5/C37C38 12.3 11.5 17.6 17.2 33.1 3.4 
G5A6/T36C37 10.8 11.5 17.3 17.2 40.1 3.4 
A6A7/T35T36 9.6 11.5 16.7 17.2 36.8 3.3 
A7m5C8/G34T35 9.8 11.5 17.6 17.2 37.4 3.4 
m5C8G9/m5C33G34 11.2 11.5 19.0 17.2 42.3 3.4 
G9G10/C32m5C33 12.3 11.5 17.8 17.2 27.6 3.0 
G10A11/T31C32 11.5 11.5 16.6 17.2 40.4 3.5 
A11A12/T30T31 9.7 11.5 18.7 17.2 38.2 3.2 
A12T13/A29T30 8.6 11.5 17.6 17.2 32.4 3.4 
T13T14/A28A29 9.0 11.5 20.0 17.2 35.7 3.2 
T14C15/G27A28 9.0 11.5 19.5 17.2 39.3 3.5 
C15T16/A26G27 9.2 11.5 17.4 17.2 28.7 3.3 
T16T17/A25A26 10.2 11.5 17.7 17.2 41.9 3.1 
T17C18/G24A25 10.0 11.5 16.6 17.2 42.7 3.4 
C18T19/A23G24 - - - - 29.8 3.5 
T19A20/T22A23 - - - - 45.7 3.2 
Average  10.2 11.5 17.9 17.2 36.4 3.3 
All major and minor groove widths were measured using 3DNA (Lu and Olson, 2003). Direct 
P-P distances which take into account the directions of the sugar-phosphate backbones. 
Subtract 5.8 Angstrom from the values to take account of the vdw radii of the phosphate 
groups (El Hassan and Calladine, 1998). 
 
By examining the major groove widths across the 20 bp DNA, the widest inter-
phosphate distance across the major groove is located at step T13T14/A28A29 (20Å) 
which is coincidently one step further than the narrowest phosphate-phosphate 
distance for the minor groove located at step A12T13/A29T30 (8.6Å) (Figure 5-12b). 
Overall, the DNA helix is bent due to a kink at step G10A11/T31C32 which is 
immediately after the methyl-CpG dinucleotides. Figure 5-12a shows an overlay of 
standard B-DNA and the X-ray DNA in complex with the MeCP2 MBD domain. The 
X-ray DNA is bent to left at the beginning the of AT run. The RMSD fit of the four 
phosphorous atoms corresponding to the symmetrical methyl-CpG dinucleotides is 
0.44 Å. In summary, the inter-phosphate distances in the X-ray structure showed a 
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minor groove that is significantly narrower than an ideal B-DNA minor groove 
(Figure 5-12b). Coincidently, the inter-phosphate distances of the major groove at this 
region are significantly wider than other regions of the DNA. This observation leads 
to the speculation that the DNA bend due to the AATT run is required to 





Figure 5-12: DNA minor and major groove widths 
(a) Overlay of idealized B-DNA (grey) and X-ray DNA (blue and red) in complex with 
MeCP2 MBD domain. The rmsd fit of the four phosphorous atoms corresponding to the 
mCpG dinucleotides is 0.4 Å. The AT run is shown in red and the methyl groups of the 
mCpG dincleotides are shown as spheres.  
(b) The minor groove width (red) and the major groove width (black) were calculated using 
the program 3DNA (El Hassan and Calladine, 1998; Lu and Olson, 2003). Groove widths for 
standard B-DNA are shown as a blue line (minor groove) and a green line (major groove). 








5.3.5.3 High degree of propeller twists 
One of the most obvious characteristics of the A/T track DNA is that the bases of a 
base pair are not co-planar to a common axis. This is attributed to a principal 
characteristic of A/T track: high degree of propeller twist (Drew et al., 1981; El 
Hassan and Calladine, 1996; Wing et al., 1980). A definition for propeller twist is 
given in the previous section (Figure 5-10). As shown in Table 5-9 and Figure 5-13, 
propeller twists range from -2.4 to -20.3˚ with an average of -10.6˚. As a short A/T 
tract segment, the base pairs 11AATTCTT17 exhibit a significantly high degree of 
propeller twist with an average of -15.5˚ even though intercalated by C15/G27 bp. 
 
Table 5-9 Propeller twists of BDNF and standard B-DNA in degree       
BDNF  Std B DNA 
Base pair  
Propeller twist/˚ Propeller twist/˚ 
C2/G40 -5.5 -1.3 
T3/A39 -3.3 -1.2 
G4/C38 -7.6 -1.3 
G5/C37 -10.6 -1.3 
A6/T36 -9.8 -1.2 
A7/T35 -8.8 -1.2 
m5C8/G34 -4.6 -1.3 
G9/m5C33 -7.5 -1.3 
G10/C32 -2.4 -1.3 
A11/T31 -19.7 -1.2 
A12/T30 -14.2 -1.2 
T13/A29 -15.4 -1.2 
T14/A28 -15.0 -1.2 
C15/G27 -14.2 -1.3 
T16/A26 -10.4 -1.2 
T17/A25 -19.4 -1.2 
C18/G24 -5.4 -1.3 
T19/A23 -20.3 -1.2 
A20/T22 -8.1 -1.2 
Mean  -10.6 -1.2 
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Figure 5-13 Propeller twists of BDNF sequence 
A definition for propeller twist is given in the text. Plots refer to BDNF (red) and standard B-
DNA (green) propeller twists in degree (˚). Minus signs indicate left handed twists.    
 
The high degree of propeller twist imposes two major effects on the A/T track DNA 
structure and improves overall stability of the DNA double helix. Twisting of bases 
within complementary base pairs creates an additional cross-strand diagonal hydrogen 
bond which helps purine-purine stacking interactions (Figure 5-14). In addition to the 
conventional Watson-Crick A/T base pairs, these cross-strand bifurcated hydrogen 
bonds can be seen connecting purine N6 to pyrimidine O4 in a diagonal position of 
the opposite strand (N6 of A11 to O4 of T30 and N6 of A28 to O4 of T13). Because 
of the high degree of propeller twist, the bases at the major groove site of the AT run 
are forced to point towards the 3’ end of the self-strand. This pushes the N6 of A11 
towards N4 of T30 which creates a non-Watson-crick hydrogen bond diagonally 
across the major groove (Figure 5-14c). Similarly, the amino group (N6) of A28 
functions as a bifurcated proton donor to two carbonyl oxygen located on the opposite 
strand. Moreover, each carbonyl group of T13 and T30 can accept protons from N6 of 
two purine bases. Therefore, the AA/TT base pair can adopt a zig-zag system as 




Figure 5-14 High degree of propeller twist at AT run base pair   
(a) Each base is represented by a rectangular blocks. Big and small boxes represent purine 
and pyrimidine, respectively, with the minor groove sites coloured in blue. The middle red 
line represents the centre of the helix and the bases are numbered as in Figure 5-2. The AT 
run is within the green box, which has been enlarged (different orientation) to give (c).  
(b) Stereo view of 11AATT14/28AATT31 base steps looking down the helix from A11/T31 bp. 
The black and green dashes represent the conventional Watson-Crick hydrogen bonds 
between base pair and the non-Watson-Crick hydrogen bond diagonal across the major 
groove of the AT run, respectively. All bases are labelled appropriately. 
(c) Stereo view of   11AATT14/28AATT31 base steps looking at the opening of the major 
groove at the AT run. 
(d) A zig-zag conformation of base pair step resulted from cross-strand non-Watson-Crick 
hydrogen bond. The direction of the DNA strands is indicated from 5’ to 3’.     
(e) Stereo view of overlay of the X-ray BDNF (red) and CGCGAATTCGCG (Wing et al., 
1980) (yellow spheres with sticks). The RMSD fit of the 60 ring atoms from the eight bases is 
0.267Å. The orientation and number of the bases are identical as in (c) 
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As a result, no additional hydrogen bond was observed at step A12T13/A29T30. 
Although the formation of a cross-strand hydrogen bond has not been terminated after 
the 11AATT14 bp, it has been interrupted by insertion of C15/G27. The cross-strand 
hydrogen bond at step C15T16/A26G27 does not contribute to the zigzag 
configuration because a bifurcated proton donor is absent at position C2 of G27 but 
the zigzag system is resumed at bp step T16T17/A25A26. The result is in agreement 
with other A/T track double-helix structures reported elsewhere (Fratini et al., 1982; 
Nelson et al., 1987; Wing et al., 1980). Overlay of the X-ray BDNF and a helix 
composed of CGCGAATTCGCG (Wing et al., 1980) shows strikingly similar 
features such as high degree of propeller twist and narrow minor groove of A/T track 
bp with an  RMSD fit of 0.267Å for all 60 atoms of the A/T bases (Figure 5-14d).  
 
Another important stabilising force of the A/T track DNA is the base stacking, 
especially purine-purine stacking, and this can result from a high degree of propeller 
twist which rotates bases within base pairs along their longitudinal axis, resulting in 
more interactions between neighbouring bases (Nelson et al., 1987). As shown in 
Figure 5-14b, the adenines are stacked on top of each other with their 6-membered 
rings heavily overlapped whereas the thymine bases are barely overlapped and only 
make weak van der Waal’s carbon-carbon contacts between the C5 methyl group and 
C6 of the subsequent thymine. The base-base compact stacking effect is not observed 
in GpG or methyl-CpG of the X-ray studied BDNF fragment. As a result of this 
compact stacking arrangement, the DNA sugar-phosphate backbones are closer 
compared with other regions of the DNA; this effectively narrows the minor groove 
of the AT run (Figure 5-12).  
5.3.5.4 DNA hydration 
Owing to the limited resolution (2.5 Å) of this X-ray structure, only 47 water 
molecules were located in the asymmetric unit. Along the 20 bp double helix BDNF 
fragment, the most humid region is located at the major groove where the protein and 
DNA interactions take place. The water molecules at this protein-DNA contact 
interface mediate the interactions between the methyl-recognition residues of the 
MeCP2 MBD domain and the methyl groups of methyl-CpG dinucleotides (see 
section 5.3.4.1). Some water molecules play space filling roles and stabilising the 
protein-DNA contacts. Other water molecules are positioned around the DNA helix.  
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It has been hypothesised that the high degree of propeller twist, which subsequently 
causes a narrow minor groove, might be stabilised by a spine of hydration in the AT 
rich region (Fratini et al., 1982). These spines of hydration are believed to be required 
to preserve the integrity of the B-DNA helix. The disposition of water molecules 
around the AT run is shown in Figure 5-15a. A true spine of water molecules has not 
been observed in the X-ray BDNF at this resolution. There are however three 
structured water molecules that form a “short spine of hydration”; they run down the 
wall of the minor groove composed of the AT run. As seen in Figure 5-15b, the O2 
atom of Thymine and N3 of Adenine (or Thymine O2) of adjacent base pairs are 
brought into a closer proximity by water bridging. On the minor groove site of the AT 
run, the bases are oriented towards the 5’ direction on its strand in a way that the 
displaced O2 of Thymine or N3 of Adenine can be hydrogen bonded to the water 
molecules. The distances of these water bridges are tabulated in Table 5-10. This 
pattern is the same as was described by Prive and coworkers (1987): the pyrimidine 
O2 or purine N3 of base n is water bridged to O4’atom of deoxyribose (n+1) (Prive et 
al., 1987). This configuration has been seen in diverse examples of A/T track DNA 
(Mack et al., 2001). Because the sugar-phosphate strands are brought into a close 
proximity (consequence of narrow minor groove), the water molecules also connect 
the deoxyribose 5-membered ring at O4’. As shown in Figure 5-15b, two (W30 and 
W32) of these water molecules are bridged tetrahedrally to two base atoms and two 
sugar atoms. The unfilled tetrahedral coordination of W18 was due to a sharp helical 
rise at step G10A11/T31C32 (Table 5-8), which is coincident with the kink of the 
DNA helix, making the deoxyribose O4’ of C32 unreachable by W18 (represented by 
red dashes in Figure 5-15a and b).   
 
In the A/T track DNA, atoms N6 of Adenine and O4 of Thymine are brought into a 
close proximity in the major groove by the non-Watson-Crick cross-strand hydrogen 
bonds (Figure 5-15). Together with the cross-strand water bridges in the minor 
groove, these hydrogen bonds exert forces to twist the A/T base pair in an opposite 
directions. This effect significantly enhances base-base (particularly purine-purine) 
compact stacking. This brings the adjacent base pairs into close proximity. They are 





Figure 5-15 Hydration at the AT run 
(a) Stereo view looking at the minor groove of the AT run. Running down the minor groove 
are W18, W30 and W32 with each water molecule (except W18) coordinating tetrahedrally to 
four atoms from Adenine or Thymine bases and their deoxyribose ring. Black dashes 
represent water bridged hydrogen bonds and red dashes indicate a potential hydrogen bond to 
the atom O4’ of deoxyribose C32 if the T31C32 step is undistorted. The central A/T bases are 
labelled appropriately. The distances for the water mediated hydrogen bonds are listed in 
Table 5-10. 
(b) Schematic diagram showing the water bridging system in the AT run. Each water 
molecule is hydrogen bonded to two bases and two deoxyriboses. The long and short 
horizontal grey bars represent purine and pyrimidine, respectively, and the five-membered-
ring indicates the deoxyribose. Blue and green spheres represent atom O2 of Thymine and N3 
of Adenine, respectively. The direction of each DNA strand is indicated. The red dashed line 
indicates a distance above 4Å from W18 to the deoxyribose O4’ of C32 due to a sharp helical 
rise at step G10A11/T31C32.  
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nucleotide  Atom  Distance (Å) 
W18 T31 O2 2.9 
 A12 N3 2.9 
 T13 Sugar O4’ 3.1 
W30 T30 O2 3.1 
 T13 O2 2.7 
 T14 Sugar O4’ 2.9 
 T31 Sugar O4’ 3.4 
W32 A29 N3 2.8 
 T14 O2 3.0 
 T30 Sugar O4’ 2.9 
 C15 Sugar O4’ 3.3 
 
5.4 SUMMARY 
This chapter addresses the details of molecular interactions between the MBD domain 
and the methylated DNA. The X-ray structure reveals that the recognition of methyl-
CpG by the MBD domain does indeed depend upon a modified hydration pattern in 
the DNA major groove. The binding specificity of methylated DNA has been reported 
to depend on hydrophobic interactions between the MBD domain and the methyl-
CpG (Ohki et al., 2001). However, the X-ray structure in this study shows that the 
methyl groups make contact with a predominantly hydrophilic surface that consists of 
several water molecules. The structural analysis also demonstrated that T158 and 
R106 (two of the four most frequent hotspots RTT mutations) play major roles in 
stabilising the tandem Asx-ST motif in MeCP2. Additionally, the AT track DNA in 
the X-ray structure displays unique features such as narrow minor groove and high 
degree of propeller twist. A short spine of water molecules has been observed running 
down the wall of minor groove of AT run. It is however remains elusive how these 
AT tract features enhance MeCP2 binding. 
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CHAPTER 6. MUTAGENESIS STUDIES 
6.1 INTRODUCTION 
Mutational analysis is a powerful tool to examine a hypothesis by changing amino 
acids in a protein sequence. Suspected critical residues in a protein can be substituted 
with other amino acids by altering the protein encoding DNA sequence. This can be 
achieved by site-directed mutagenesis. The amino acid substitution in site directed 
mutagenesis can be done by annealing a mutagenesis primer to a template followed 
by complementary strand synthesis using DNA polymerase. Traditionally, single-
stranded DNA of M13 was used in the following way: a primer containing the desired 
nucleotide substitution was annealed to the template and elongated using DNA 
polymerase, ligated with DNA ligase to seal the nick. The mismatched duplex was 
then transformed into the E. coli expression system (Kunkel, 1985; Sugimoto et al., 
1989; Taylor et al., 1985; Vandeyar et al., 1988). Some bacteria repair the mismatch 
to give the desired point mutation whereas some clones retain their original sequence. 
Due to the inefficiency of this method, site directed mutagenesis using double 
stranded DNA was invented (Braman et al., 1996). In general, a pair of 
complementary mutagenic primers usually between 25 and 45 bp is designed to have 
the altered sequence. After the PCR amplification, the parental plasmids can be easily 
digested with Dpn I which is an endonuclease that is specific for methylated and 
hemimethylated DNA. The mutant plasmids are then transformed into the desired 
expression system. This method is highly efficient and can be done within 2-3 days. 
The mutated gene within the mutant plasmids need to be verified with DNA 
sequencing before protein expression and purification. On the other hand, mutation of 
oligonucleotides is more straightforward. A new pair of oligonucleotides containing 
the desired nucleotide substitutions can be synthesised directly from a manufacturer.  
 
As discuss in Chapter 5, certain residues within the MBD domain are crucial in 
maintaining the protein-DNA interaction. X-ray analysis reveals that residue T158 
plays a pivotal role in shaping the Asx-ST motif which comprises 5 residues. 
Substitutions of T158 with other residues such as Ala, Met and Ser confirmed the 
importance of T158 in stabilising the Asx-ST motif. Gel shift analysis using mutant 
Y123F has been performed to assay the importance of the water bridging role of 
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Y123. This experiment highlighted the important role of the hydrated interface 
between the MBD domain and the DNA major groove. This chapter will also discuss 
the mutational analysis of the oligonucleotides of the BDNF sequence. It is speculated 
that the AT run close to the methyl-CpG plays a specific role in enhancing the MBD-
DNA interactions (Klose et al., 2005). X-ray structure analysis reveals that this 
proximal AT run connects to the Asx-ST motif via a hydrogen bond. Additionally, a 
distal AT run, which is located approximately 10 bp upstream from the methyl-CpG is 
speculated to form another interaction site between the AT hook of MeCP2 and the 
methylated DNA. Therefore, various constructs have been used to assay the DNA-
protein interactions.      
6.2 MATERIALS AND METHODS 
Materials and methods used in protein purification and gel shift assay can be found in 
Chapter 3.  
6.3 RESULTS AND DISCUSSION 
6.3.1 Mutational studies of Threonine-158 
As discussed in Chapter 5, the X-ray structure reveals that Thr158 occupies a pivotal 
position that coordinates an Asx turn and an ST-motif (Wan and Milner-White, 
1999a; Wan and Milner-White, 1999b), which we subsequently named as the Asx-ST 
motif (Ho et al., 2008). The T158M mutation is the most common missense mutation 
causing Rett syndrome. To test this, the effects of T158 mutations on DNA binding 
were assayed. As shown in Figure 6-1, T158M abolished DNA binding under the 
experimental conditions in this study. Substitution of Thr158 by smaller alanine side 
chain (T158A; also a RTT mutation) again strongly impaired DNA binding, arguing 
against a purely steric interference by the bulky methionine side chain. In contrast, 
T158S, which retains the hydroxyl group that is implicated in hydrogen bond 
stabilisation of the tandem Asx-ST motif, maintained substantial affinity for 
methylated DNA (Figure 6-1). The result also indicated that the methyl group of Ser 
is not required for the stabilisation of the Asx-ST motif.  
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Figure 6-1 Mutagenesis confirms the importance of Y123 and T158 for the MBD 
binding to methylated DNA in vitro 
(a) Electrophoretic mobility shift assays were performed with the 20 bp BDNF DNA 
sequence as probe in the presence of wild type (WT) or mutant forms of the 77-167 fragment 
of MeCP2. Binding to methylated DNA is disrupted by T158M and T158A mutations, 
whereas binding is minimally affected by the conservative T158S mutation. The Y123F 
mutation significantly reduces DNA binding.  
(b) A plot of the fraction of labelled probe complexed at protein concentrations of 250nM, 
500nM, 750nM and 1µM as measured by densitometry. Estimated standard deviations 
(shown as vertical bars) were calculated from measured intensities from three separate gels 
and scaled to the band from the probe complexed with 1µM wild type MBD which was taken 
as 100%. Plots refer to WT (black), T158A (blue), T158M (yellow), T158S (green: from two 
measurements) and Y123F (red). 
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Disruption of the Asx-ST motif as a result of the missense mutation T158M/A 
possibly impairs the two hydrogen bonds that connecting the guanidinium group of 
R106 to the main-chain carbonyl of T158 and V159 (see Figure 5-4a). This result is 
further supported by mutational analysis using R106W and T158M, where both 
mutants failed to recognise the methylated DNA (Yusufzai and Wolffe, 2000). The 
removal of the hydroxyl group of Tyr or Ser impairs the hydrogen bonds which 
functionally stabilise the ST-motif. It is also likely that interruption of the contacts 
between R106 and Asx-ST motif will destabilise the protein. In contrast to MeCP2, 
R17 of MBD1 (equivalent to R106 in MeCP2) makes contact with a β-turn composed 
of 63DFKQ66, in which, the mutation of K65A (K65 is equivalent to T158 in MeCP2) 
also abolished methylated DNA binding (Ohki et al., 2001). This suggests that the β-
turn of MBD1 MBD domain may play a similar role as the Asx-ST motif in 
maintaining the stability of the C-terminal end of the MBD domain. In general, the 
results of this study and others suggest the side-chain hydroxyl group of either Ser or 
Thr is critical to maintaining the structural role of the Asx-ST motif and the DNA 
selectivity of human MeCP2. 
6.3.2 Mutational studies of Asp121 and Tyr123 
The importance of water molecules in MBD recognition is supported by mutagenesis 
studies of MBDs from MeCP2 and MBD1. Y123 is of particularly interest, as its 
contact to the DNA is via two bridging hydrogen bonds from its hydroxyl group to 
W24 and W12 (Figure 5-5, Chapter 5). Figure 6-1b shows that the Y123F mutant 
lacks this hydroxyl group and has a reduced affinity (approximately 30% of the wild 
type protein) for methylated DNA. The loss of binding is therefore attributed solely to 
the interaction of the hydroxyl group with “structural waters” W24 and W12, because 
no other DNA contacts less than 4 Å are made by the Y123 side chain.  
 
In a corresponding mutagenesis study of MBD1, reduced methyl-CpG binding caused 
by loss of the hydroxyl group of Y34 (Y34F is equivalent to Y123F in MeCP2; see 
Figure 5-1, Chapter 5) was explained by loss of a putative hydrogen bond between 
Y34 and the amino group of m5C (Ohki et al., 2001). The X-ray structure of this 
study fails to support the equivalent Y123-m5C interaction in MeCP2, and a more 
likely explanation in the light of this closely analogous MeCP2 structure is that 
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hydrogen bonds to bridging structural water molecules have been lost in the Y123F 
mutant (Figure 5-5b, Chapter 5). Further evidence for the importance of this 
interaction comes from mutagenesis of mammalian MBD3, which does not normally 
bind specifically to the methylated DNA and has phenylalanine (F34 in MBD3) in 
place of tyrosine at the equivalent position (see Figure 5-1, Chapter 5). Interestingly, 
MBD3 can be converted into a methyl-CpG-binding protein by addition of a hydroxyl 
group via a substitution of F34Y (Fraga et al., 2003). In addition to Y123, D121 is 
involved in water coordination, even though this residue also forms a direct CH…O 
interaction with the methyl group of m5C8 (Figure 5-5, Chapter 5) and two hydrogen 
bonds to R111. Mutagenesis of this aspartate in MeCP2 (D121A or D121C; Free et 
al., 2001) or the equivalent residue in MBD1 (D32A; Ohki et al., 2001) severely 
reduces binding to methylated DNA. The mutagenesis data derived from several 
members of the MBD protein family therefore support the structural evidence that 
water is a key feature for recognition of methyl-CpG by MBD domains. 
 
The importance of water-mediated recognition mode established in this study is 
proposed to be conserved in other members of the MBD protein family. The X-ray 
structure of the MeCP2 MBD complexed with methylated DNA indeed resembles the 
solution structure of the MBD1 MBD-DNA complex structure reported by Ohki and 
coworkers (Ohki et al., 2001) with an RMSD fit of 4.2 Å (Figure 5-3a, Chapter 5). It 
was previously deduced that the recognition of the cytosine methyl groups by MBD1 
depends upon a hydrophobic patch consisting of 5 amino acids that are conserved 
among the MBD family (Ohki et al., 2001). However, water molecules were not 
considered in the MBD1 structure determination, and it is possible that analysis of 
spin diffusion effects mediated by tightly bound waters will permit reconciliation of 
the NMR data with the hydrogen bond configuration reported in this study.    
6.3.3 Mutational studies of the BDNF sequence 
The promoter region of the BDNF gene was identified as an endogenous MeCP2 
target (Chen et al., 2003; Martinowich et al., 2003). A methyl-CpG pair is located at 
position -100 bp upstream of the BDNF transcription initiation site, which is followed 
by two AT runs, namely a proximal AT run (composed of 4 bp) and distal AT run 
(composed of 8 bp), one and 10 bases, respectively, upstream from the methyl-CpG 
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(Figure 6-2a). The presence of an AT-run has been shown as a requirement to 
promote high affinity binding of MeCP2 (Klose et al., 2005). The X-ray structure 
indicates that the proximal AT-run (11AATT14) of the BDNF sequence close to the 
methyl-CpG interacts with the Asx-ST motif of the MeCP2 MBD domain (Figure 5-4, 
Chapter 5). To test the importance of AT bases of BNDF adjacent to the methy-CpG, 
the AT runs were individually or simultaneously mutated and assayed on protein 
binding using band shift experiments. As shown in Figure 6-2b, the MBD domain 
(construct 77-167) binding was not affected by the mutations of either proximal or 
distal AT runs. Because the only interaction between the MBD and the AT run is 
through a hydrogen bond connecting the T31 phosphate group and Val159(N), the 
altered AT run may not disturb the DNA-protein interactions in the major groove.    
 
 
Figure 6-2 EMSA of proximal and distal AT mutations with MeCP2 constructs 
(a) DNA probes used in the band shift assay. bdnf_nat: native BDNF sequence; pATmut: 
BDNF with proximal AT run mutated; dATmut: BDNF with distal AT run mutated; and 
2ATmut: BDNF with both AT runs mutated. All DNA probes comprise of 41 bp. (b) Band 
shift assays were performed using three MeCP2 constructs; 77-167, 78-205, 1-205, 77-
167(T158M) and 78-205(T158M).       
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Both longer constructs (78-205 and 1-205) show a significantly reduced binding when 
both AT runs were simultaneously mutated but not individually (Figure 6-2). The AT 
hook has been shown to interact with DNA bases in the minor groove of the AT tract 
DNA (Huth et al., 1997). Close sequence similarity between the AT hook of HMGA1 
and MeCP2 suggests that the AT hook of MeCP2 may interact with either proximal or 
distal AT runs. However, an AT hook mutation was shown to have little effect on 
methylated DNA binding (Klose et al., 2005). Mutation of both AT runs 
simultaneously may alter the entire DNA geometry, including the major groove (and 
its hydration pattern), which drastically affects methyl group recognition.  
6.4 SUMMARY  
To test the pivotal role of T158 in the Asx-ST motif, T158 was mutated to Met and 
the mutation abolished DNA binding. Similarly, T158A also significantly reduced the 
DNA binding specificity arguing against a purely steric interference by the 
methionine side chain. Interestingly, retaining the hydroxyl group in the T158S 
mutation rescued affinity for methylated DNA. These mutational analyses support the 
argument that the hydrogen bonds connecting the hydroxyl group of either Ser or Thr 
at position 158 to the amine group of G161 and R162 are critical in stabilising the 
MBD domain of MeCP2. To test the importance of water molecules that mediate the 
methyl group recognition, Y123 was mutated to Phe and as expected, this alteration 
reduced DNA binding. Together with other reports (Fraga et al., 2003; Ohki et al., 
2001), this result further strengthen the observed structural details. In the BDNF 
mutational studies, neither proximal nor distal AT runs to the methyl-CpG exert a 
significant effect on MBD binding specificity. Reduction was only observed when 
both AT runs close to the methylated site were mutated. This suggests that the overall 
DNA geometry was altered which subsequently affected the properties in the DNA 







CHAPTER 7. CONCLUSIONS AND FUTURE 
DIRECTIONS   
7.1 ARE THE AIMS ACHIEVED? 
The major aim of this study was to investigate the molecular details of the MeCP2 
MBD domain in complex with methylated DNA using X-ray crystallography. There 
are three basic questions which the X-ray structure of the DNA-protein complex can 
potentially address. (i) How is the methyl-CpG recognised by the MBD domain of 
MeCP2? (ii) What are the structural roles of the RTT disease hotspots such as R106 
and T158 within the MBD domain? Are these critical residues interacting with the 
methylated DNA? and (iii) How does the AT run adjacent to the methyl-CpG enhance 
the MeCP2 MBD binding?  
7.1.1 Novel X-ray structure of MeCP2 MBD complexed with 
methylated DNA 
To investigate the structural details of methyl-CpG recognition by the MBD domain 
of MeCP2, a complex of the methylated DNA and MeCP2 was characterised (Chapter 
3) and crystallised (Chapter 4). In collaboration with Dr. Robert Klose, the AT run 
next to the methyl-CpG, which maximises the protein binding, was taken into account 
in designing crystallisation trials. Cocrystals of MeCP2 MBD in complex with a 20 bp 
fragment of BDNF promoter which contains a central methy-CpG pair and an 
adjacent AT run was successfully crystallised. The best optimised crystal diffracted 
X-rays to a maximum resolution of 2.5Å using synchrotron radiation sources. The X-
ray structure was solved using the selenium ‘peak’ data with the SAD method. In 
addition, the native X-ray structure and two iodinated derivatives were also solved 
and refined. The details structural analysis was carried out using the best refined 
model. 
7.1.2 MeCP2 binding to DNA depends upon hydration at methyl-
CpG 
The molecular details reveal that the methyl groups of m5C in the major groove of the 
DNA are recognised by the MBD domain through water molecules (Ho et al., 2008). 
This novel finding contradicts the observation using an NMR model (Ohki et al., 
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2001), in which, the recognition is thought to depend on hydrophobic interaction 
between the methyl groups and a hydrophobic patch within the MBD domain. The 
hydration pattern around the 5’methyl-cytosine is modified in a way that the MBD 
can recognise the distinct hydration in the major groove of methylated DNA rather 
than methylation per se.       
7.1.3 Thr158 and Arg106 are required to maintain Asx-ST motif 
T158 is the major RTT mutation hotspot within the MBD domain. Structural 
investigation shows that this critical residue occupies a pivotal position in 
coordinating two consecutive turns, which is collectively named as the ‘Asx-ST 
motif’ (Ho et al., 2008). The T158M mutation, the highest RTT missense mutation, 
abolished DNA binding in this study. Substituting T158 by the smaller Ala side chain 
again significantly reduced DNA binding, thus arguing against purely steric 
interference by the bulky methionine side chain. Interestingly, T158S, which retains 
the hydroxyl group that is implicated in hydrogen bond stabilisation of the Asx-ST 
motif, maintained a significant affinity for the methylated DNA. In addition, the 
tandem Asx-ST motif is further stabilised by hydrogen bonds to R106 via main chain 
carbonyl groups of T158 and V159. The structural role of R133, another major RTT 
missense hotspot, is to make direct contact with the guanine of methyl-CpG. Both 
R133 and R111 are hydrogen bonded to G34 and G9 bases, respectively, via their 
arginine fingers. Mutation of R133 that abolish DNA binding have been reported 
elsewhere (Free et al., 2001; Ohki et al., 2001; Yusufzai and Wolffe, 2000). Further 
biochemical or higher X-ray resolution is desired in order to address other RTT 
disease spots within the MBD domain. Moreover, the molecular details of RTT 
mutants might provide a fundamental knowledge in RTT therapeutic approaches.  
7.1.4 How does AT run enhance MBD binding? 
The AT run adjacent to the methyl-CpG displays some unique features of AT tract 
DNA such as a narrow minor groove, high degree of propeller twist, and a distinct 
pattern of hydration along the wall of minor groove. Although the Asx-ST motif of 
the MBD domain is hydrogen bonded to the AT run through a backbone phosphate 
group, one cannot draw a conclusion that this interaction is indeed required for high 
affinity binding. As a result, the contribution of the AT run in enhancing the MBD 
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binding remains unclear. Furthermore, the interaction occurs at the C-terminus in the 
X-ray structure. It is possible that other domains, for instance, the AT hook of MeCP2 
might interact strongly with the AT run. To examine the structural role of an AT run 
next to methyl-CpG, a structure of a bigger MeCP2 construct including the AT hook 
domain in complex with methylated DNA is necessary. This large structure could 
possibly answer the question of how does the AT hook(s) bind into the minor groove 
of the DNA. The outcomes will provide invaluable information on MeCP2 binding 
partners and actual roles of MeCP2 as a transcription repressor or co-repressor.  
7.2 PDB ACCESSION NUMBER  
The atomic coordinates of the MeCP2 MBD domain cocrystallised with a 20 bp DNA 
fragment have been deposited with the Protein Data Bank (PDB) under accession 
number 3C2I. 
7.3 PUBLICATION 
Part of the crystallographic data (Chapter 4), structural details (Chapter 5) and 
mutational studies (Chapter 6) of this work has been published in Molecular Cell, 
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